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SUMMARY
Vesicular stomatitis virus (VSV) is the prototype of 
the family Rhabdoviridae. There are two serotypes of VSV - 
Indiana (IND) and New Jersey (NJ) which can be 
differentiated from one another on the basis of little or no 
cross neutralisation using antibody raised against the 
virion glycoprotein. VSV has a genome consisting of a 
non-segmented single strand of negative sense RNA 
approximately 11,000 bases in length. The genome codes for 
five proteins: L (large), M (matrix), NS (non-structural), N 
(nucleocapsid) and G (glycoprotein). The L, NS and N 
proteins associate with the genomic RNA and form the 
ribonucleoprotein core. N protein is the major structural 
component of the ribonucleoprotein core, the L and NS 
proteins function in viral transcription and replication; G 
and M comprise the viral envelope. M protein is believed to 
be located on the inner side of the envelope and is the 
group-specific antigen. G is the transmembrane glycoprotein 
and forms the spikes that project from the virion.
The NS protein of VSV is a multifunctional protein 
with a proposed role in transcription, replication and 
virion maturation. It is a phosphoprotein and evidence 
indicates that the degree of phosphorylation of NS affects 
its function. On SDS-polyacrylamide gels the NS protein 
migrates with an apparent molecular weight of 40-50,000. 
However, the molecular weight calculated from sequence data 
is approximately 30,000. Three t_s mutants of VSV New 
Jersey, Missouri strain have been shown to possess lesions 
in the NS gene and these have been classed in
complementation group E. The mutants (tsEl, tsE2, tsE3) are 
a heterogenous group. They exhibit a variety of phenotypes 
and on SDS-polyacrylamide gels the NS proteins of these 
mutants show a differential migration pattern both in 
relation to wild-type virus and to one another. It was 
therefore of interest to determine the sequence of the NS 
mRNA of wild-type virus and complementation group E mutants 
in order to precisely map the position of the mutations and 
perhaps propose a model to explain the differential 
electrophoretic migration pattern of their NS proteins.
The complete nucleotide sequences of the NS mRNAs of 
wild-type, complementation group E mutants (t sEl, t sE2, 
tsE3) and two revertant viruses (tsEl/Rl and tsE3/Rl) were 
determined from cloned full-length cDNAs. cDNA was 
synthesised using RNA prepared from infected cells as 
template and NS-specific recombinant plasmids were 
identified by a combination of Northern blot analysis and 
mRNA selection/in vitro translation.
The mRNA of wild-type VSV NJ, Missouri strain is 856 
nucleotides long excluding poly(A) and encodes a protein of 
274 amino acids (molecular weight 31,000). The protein 
initiates at AUG (position 11-13) and terminates at UAA 
(position 833-835). The NS protein is highly acidic 
especially in the amino terminal half of the molecule and 
has an overall charge of -18.5 at pH7.0. There are 46 
potential phosphorylation sites (13 threonines, 33 serines) 
in the NS protein.
The sequence of the NS gene of wild-type VSV NJ, 
Missouri strain was compared with the sequences of the NS 
genes of three other strains of VSV; together the four
sequences represent two strains from each of the two VSV 
serotypes. Comparison showed that between serotypes there 
is approximately 50% nucleotide and 33% amino acid homology.
fvUcll' o VjxVaj.
Within the IND serotype there is 97%^and 95% amino acid
(Ain.
homology; within the NJ serotype there is 85%A and 90% amino 
acid homology. Two regions are highly conserved between the 
four proteins, in particular the carboxy terminus 21 amino 
acids exhibit 90% homology when conservative changes are 
taken into consideration. The hydropathic profiles of the 
four proteins are similar and the proteins are predominantly 
hydrophi1ic.
In total there are 18 potential phosphorylation sites 
conserved bewteen the four proteins. Hsu and Kingsbury 
(1985) identified five amino acids between residues 35 and 
78 of the NS protein of VSV IND San-Juan strain as the 
constitutively phosphorylated residues of the NS protein. 
They proposed that phosphorylation of these residues was 
necessary for a basal level of NS activity. These same five 
residues were found to be strictly conserved between the 
four strains of VSV.
Analysis of the sequences of cloned cDNAs of the NS 
mRNAs of the tsEl, tsE2 and tsE3 viruses showed that tsEl 
and tsE3 each have a single mutation whereas tsE2 has a 
double mutation. Three of the four mutations occur in a 
region of 18 nucleotides (bases 92-109) indicating a 
possible 'hot-spot1 of mutation. Interestingly, this region 
encodes the most hydrophilic portion of the NS protein.
None of the mutations generate a stop codon. The NS 
mRNAs of the three complementation group E mutants are the 
same length as that of the wild-type virus and encode a
protein of the same size. All of the mutations however 
change the charge of the amino acid they affect. In tsEl a 
glutamic acid residue is changed to a lysine; in tsE2 an 
aspartic acid residue is changed to a glycine and a lysine 
residue is changed to a glutamic acid; in tsE3 a glutamic 
acid residue is changed to a glycine.
Secondary structure predictions of the NS proteins of 
wild-type and complementation group E mutants by the method 
of Chou and Fasman (1978) predict substantial alterations to 
secondary structure in the area of the mutations in all 
three mutants.
A number of revertants of tsEl and tsE3 have been 
isolated but none have been obtained from tsE2 which has a 
double mutation. The NS mRNAs of two revertant viruses - 
one of tsEl (tsEl/Rl) and one of tsE3 (tsE3/Rl) were cloned 
and sequenced. It was found that at the site of mutation in 
tsEl and tsE3 the revertant sequence corresponded to that of 
the wild-type. However, there were two further changes to 
the nucleotide sequence. The first change, at position 472, 
did not affect an amino acid; the second, at position 513, 
caused a methionine to arginine change. This is an example 
of a charge change (neutral to positive) which does not 
affect the proteins mobility on SDS-polyacrylamide gels. 
Furthermore, this change causes a minimal alteration to the 
predicted secondary structure of the revertant NS protein.
The exploitation of these full-length cloned cDNAs of 
the NS mRNAs in the study of the function and role of the NS 
protein is discussed.
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Abbreviations for buffers and media are given in the 
Materials and Methods section.
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Chapter 1
INTRODUCTION
The Rhabdoviridae »a^.a diverse family of enveloped RNA 
viruses which can infect a wide variety of vertebrates, 
invertebrates and plants. The family is of importance 
because many of its members cause disease in man and his 
domestic animals. The most important member of the family 
from this point of view is the causative agent of rabies, a 
disease which is still a great problem in many areas of the 
world. As a pathogen in man rabies virus has a long 
history. Democritus is thought to have made the first 
recorded description of canine rabies some 500 years BC 
(Steele, 1975). Although the disease in man can now be 
treated, rabid vampire bats are still responsible for the 
deaths of hundreds of thousands of cattle annually in the 
Americas (Steele, 1975). Economically important diseases 
caused by rhabdoviruses have been well documented over the 
years. Bovine ephemeral fever virus causes a three to four 
day illness in cattle which involves sudden fever with 
temperatures up to 107°F, shivering, stiffness, loss of 
appetite and lameness which can sometimes be permanent 
(Heuschele, 1970). Vesicular stomatitis virus (VSV), the 
prototype rhabdovirus, causes vesicular stomatitis disease 
which was first reported by Theiler (1901) as a disease of 
horses and mules in the Transvaal, South Africa. VSV can 
naturally infect a wide variety of mammals including man, 
but disease is most common in cattle. The symptoms of VS 
disease closely resemble those of foot and mouth disease; 
however, VSV infection is usually milder and the recovery 
more rapid and complete (Howatson, 1970). The vesicles 
found on the mouths and hooves of infected animals are 
usually accompanied by drooling saliva. Foot lesions are
more common in pigs and lesions are also found on the teats 
and udders of cows. Other symptoms can include elevated 
temperature, loss of appetite, loss of weight and in cows 
there is cessation of milk production (Hanson, 1952; 
Howatson, 1970; Bishop and Smith, 1977). An outbreak of VSV 
in California's San Joaquim Valley highlights the economic 
importance of the disease. In a two month period two 
dairies sustained losses valued at $225,000. These losses 
amounted to $202/cow in one dairy and $97/cow in the other 
dairy (Goodger et al, 1985). In humans the disease can be 
inapparent or resemble influenza, with a sore throat, fever 
and general malaise lasting several days (Howatson 1970; 
Andrewes et a l , 1978).
Lettuce necrotic yellow virus (in Australia), potato 
yellow dwarf virus (in North America) and strawberry crinkle 
virus (in USA, Britain, Australia, South Africa and New 
Zealand) all produce disease in dicotyledonous plants and 
have an insect vector (Francki, 1973). There are six 
rhabdoviruses which infect monocotyledonous plants and five 
of these cause serious field disease in cereals (Francki, 
1973; Francki and Randles, 1980).
As man spreads his commercial interests it seems that 
members of the Rhabdoviridae will always be able to cause 
problems. Many members of the family are capable of causing 
widespread and fatal disease in fish eg. infectious 
hematopoietic necrosis virus (IHNV), a pathogen of salmon 
and young trout (Amend, 1975; Pilcher and Fryer, 1978) which 
is responsible for great losses of young fish at hatcheries 
in western North America (Groberg, 1983). As the fish 
farming industry continues to grow rhabdoviruses like IHNV
3and the others capable of causing severe disease in fish 
will obviously be of even greater importance.
However, not all rhabdoviruses cause disease. The 
most interesting of the rhabdoviruses which are completely 
innocuous to their host is the sigma virus of Drosophila. 
Sigma virus is transmitted in the germ lines of male and 
female Drosophila and confers a sensitivity to CO 2 
(L'Heritier, 1958; Prinz, 1973; Teninges et a l , 1980). The 
enhanced CO2 sensitivity was thought to be a unique property 
of sigma virus; however, some of the other rhabdoviruses 
have been found to have this effect on adult insects 
(Bussereau, 1971, 1972, 1973, 1975; Bussereau et al, 1975; 
Teninges et al, 1980). Although sigma virus is unable to 
multiply in mammalian cells Brun (1984) suggested that sigma 
virus is a rhabdovirus which has become trapped in a 
non-biting dipteran and in order to ensure its survival has 
come to behave as a hereditary factor.
As already mentioned VSV is the prototype rhabdovirus. 
VSV has been more extensively studied than any other member 
of the family because it is relatively safe to work with; it 
can grow to a high titre in a number of cell lines and is 
relatively easily purified; the virion-associated RNA 
polymerase is a stable enzyme capable of synthesising large 
quantities of mRNA in vitro (Banerjee et al , 1977). The 
virus has also become an important tool in answering a 
variety of problems in molecular biology eg. glycoprotein 
metabolism and transport (Chatis and Morrison, 1979; Irving 
et al , 1979; Lingappa et a l , 1978; Rothman and Lodish, 1977; 
Rose et a l , 1980; Toneguzzo and Ghosh, 1978; Hubbard and 
Ivatt, 1981).
4After some general discussion of the taxonomy of the 
Rhabdoviridae the review will be concentrated almost 
entirely on VSV.
1. TAXONOMY
The Rhabdovi ridae family of bullet-shaped or
bacilliform RNA viruses which have been isolated from 
vertebrates, invertebrates and plants. These viruses show 
considerable variation in size, ranging between 130nm and 
380nm in length and 60nm to 95nm in width. The viruses that 
infect vertebrates are generally bullet-shaped and those 
that infect plants are bacilliform (Brown et al, 1979).
Although a large number of viruses which share the 
rhabdovirus morphology have been isolated^few have been well 
enough characterised to be classed as members of the family 
Rhabdoviridae and are termed 'possible members' (Brown et^  
a l , 1979). Viruses are considered as members only when 
morphologic studies are comprehensive and when viral RNA and 
proteins have been shown to have the same general 
characteristics as those of VSV or rabies virus (for 
vertebrate and invertebrate viruses) or lettuce necrotic 
yellow virus (for plant viruses) (Brown et al, 1979).
There are 75 members of the family Rhabdovi ridae but 
very few of these are included in the two recognised genera 
- Lyssavirus and Vesiculovirus (see Table 1.1) (Brown et a l ,
1978) . The genus Lyssavirus contains the rabies-related 
viruses and the genus Vesiculovirus the VSV-related viruses. 
The subgroup A plant viruses are four plant viruses that 
resemble VSV; the subgroup B plant viruses are plant viruses
that resemble rabies virus (Brown et al , 1979).
In general, there is no evidence for relatedness 
between plant and vertebrate viruses. Indeed there are very- 
few similarities between the individual plant viruses which 
makes subdivision into genera impossible (Brown et a l /
1979) .
2. VESICULOVIRUSES
The nine viruses which comprise the genus 
Vesiculovirus are shown in Table 1.1.
The Indiana (IND) serotype of VSV was isolated in 1925 
in Richmond/ Indiana from vesicles on the tongues of cattle 
(Cotton, 1927). The New Jersey (NJ) serotype was isolated 
in 1926 following an outbreak of the disease in New Jersey. 
All subsequent isolates have belonged to one or other of 
these serotypes. The two serotypes are differentiated on 
the basis of little or no cross-neutralisation using 
antibody raised against the virion glycoprotein (Cartwright 
and Brown, 1972; Kelley et a l , 1972).
Table 1.2 shows the subdivisions of the IND and NJ 
serotypes. The IND serotype was divided into the four 
subtypes after examination of cross-relationships by 
complement fixing and neutralisation tests (Cartwright and 
Brown, 1972). The subclassification of the five strains of 
VSV NJ in two subtypes is based on reciprocal differences in 
antibody neutralisation of virion infectivity, 
oligonucleotide maps of virion RNA, base sequence homology 
and heterologous DI particle-mediated interference 
(Reichmann et al , 1978). There is evidence that the two
6subtypes of VSV NJ differ in their biological properties 
(Khan and Lazzarini, 1977; Reichmann et al, 1978; Prevec and 
Kang, 1970). Until recently, for example, the Concan 
subtype had only been isolated from outbreaks involving 
horses and cattle while Hazelhurst isolates were from 
outbreaks involving swine. However, isolates from an 
outbreak of VSV in Colorado in 1982 were identified as 
members of the Hazelhurst subtype. These isolates were from 
horses and black flies (Simuliidae) and were similar but not 
identical to the swine isolates (Schnitzlein and Reichmann, 
1985).
3. MORPHOLOGY
Over the last 20 to 30 years, electron microscopy of 
negatively stained preparations of VSV have established its 
basic features (Howatson and Whitmore, 1962; Simpson and 
Hauser, 1966; Nakai and Howatson, 1968; Cartwright and 
Brown, 1972; Murphy and Harrison, 1973; Thomas et a l , 1985). 
A model of the virus structure is shown in Figure 1.1 
together with an electron microscope picture of a negatively 
stained virus particle. The virion is cylindrical with a 
hemispherical cap at one end which gives the particle its 
characteristic bullet shape. Intact virions are 
approximately 70nm in diameter and 180nm long (Murphy and 
Harrison, 1973). They consist of an internal 
ribonucleoprotein (RNP) core surrounded by a lipid envelope 
with glycoprotein spikes (6-10nm) projecting from it (Lenard 
and Compans, 1974; Lenard, 1978; McSharry, 1980). The RNP 
core is coiled 30 to 35 times to form a helix with almost
7the same length as the virion (Newcomb et al, 1982). Four 
different microscopy procedures were used to calculate the 
of the nucleocapsid with the conclusion that it was 
3.5-3.7nm (Thomas et a l , 1985). Nucleocapsid length was 
determined by scanning transmission electron microscopy 
(STEM) measurements of mass per unit length and total mass; 
contour length of extended negatively stained nucleocapsids; 
characterisation of the structural repeat along the 
nucleocapsid strand; calculation of nucleocapsid length from 
in situ measurements (Thomas et a l , 1985). An axial channel 
is often seen when the particle is penetrated by stain.
Some controversy exists as to whether the flattened end is 
an artefact caused by the preparative technique and the 
virion is in actual fact bacilliform as are the plant 
rhabdoviruses (Orenstein et a l , 1976).
4. VIRION STRUCTURE AND COMPOSITION
A. Proteins
Wagner et al (1972) introduced a standard nomenclature 
for VSV proteins in order to clarify the confusion which had 
arisen through the use of different classification systems 
in different laboratories. There are five recognised VS 
virion proteins. These are L (large), NS (non-structural),
N (nucleocapsid) which together are associated with the 
genomic RNA and form the internal RNP core; and G 
(glycoprotein) and M (matrix) which are associated with the 
virus outer membrane (Kang and Prevec, 1969; Wagner et a l , 
1969; Cartwright et a l , 1970; Wagner et a l , 1970; Bishop and 
Roy, 1972; Emerson and Wagner, 1972). At present no one has
provided conclusive evidence for the existence of any virus 
coded pr.otein which is present in infected cells but not in 
mature virions (Mudd and Summers, 1970; Wagner et al , 1970; 
Kang and Prevec, 1971; Wagner et a l , 1972; Wunner and 
Pringle, 1972a, 1972b) . However, R. Hermann (personal 
communication, 1985) has suggested that the NS gene encodes 
a second protein.
Thomas et al (1985) used dark field scanning 
transmission electron microscopy to perform mass analysis of 
purified virions of VSV IND, Mudd-Summers strain, 
pronase-treated virions and nucleocapsids. Their results 
are summarised in Table 1.3. M protein is the most abundant 
protein (1,826 copies) in the virion, whereas the G protein 
makes the largest contribution to its mass (Thomas et al , 
1985) .
The L protein of VSV IND serotype, Mudd-Summers strain 
has a molecular weight (mol w t ) of 241,012 (Schubert et a l , 
1984). It is the largest of the VSV proteins but is present 
in only minor amounts in the virion and is located in the 
nucleocapsid (Bishop and Roy, 1972; Emerson and Wagner,
1972; Szilagyi and Uryvayev, 1973). The L protein has been 
shown to form at least part of the transcriptase complex 
(Naito and Ishihama, 1976; Emerson and Wagner, 1972, 1973; 
Emerson and Yu, 1975; Szilagyi, 1975; Mellon and Emerson, 
1978; Kingsford and Emerson, 1980) and recently Ongradi e_t 
al (1985b) suggested that L protein of VSV NJ is the 
transcriptase itself.
The L mRNA is 6,380 nucleotides long (57.13% of the 
genome) (Schubert et al, 1984). Sequence data show there to 
be some short open reading frames in the genome-sense strand
9of the L gene with the longest of these capable of encoding 
a protein of mol wt 10,000. However, there is no evidence 
for other functional transcripts (Schubert et al , 1984).
The G protein is a major virion protein. The G 
protein of
VSV IND, San Juan strain has a mol wt of 75,416 (Rose and 
Gallione, 1981). It is the only glycosylated virus protein 
and constitutes the spikes which project from the virion 
envelope giving rise to type specific neutralising antibody 
(Cartwright and Brown, 1972; Kelley et a l , 1972). The G 
protein appears to be the main target of the antiviral 
immune system because only antibodies to G protein 
neutralise virus infectivity (Kelley et a l , 1972) and 
cytotoxic T cells recognise mainly G proteins on the surface 
of virus infected cells (Zinkernagel et a l , 1978). The G 
protein serves as the virus ligand receptor (Cartwright et_ 
al , 1970), mediates cell to cell fusion in vitro 
(Florkiewicz and Rose, 1984) and B cell mitogenicity 
(Goodman-Smitkoff et a l , 1981).
The G mRNAs of VSV IND and NJ serotypes have both been 
sequenced (Rose and Gallione, 1981; Gallione and Rose,
1983). They are 1,672 and 1,573 nucleotides long 
respectively making G mRNA the second longest VSV mRNA.
The N protein is the second major virion protein. 
Gallione et al (1981) sequenced the N mRNA of VSV IND, San 
Juan strain and calculated a mol wt of 47,355 for the N 
protein. The N mRNA is 1,326 nucleotides long (Gallione et_ 
a l , 1981) .
The N Protein is found closely associated with the 
genomic RNA in virions, and both positive-sense genomic RNA
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(so called replicative intermediate) and mRNAs in infected 
cells (Soria et al , 1974; Grubman and Shafritz, 1977; Rubio 
et a l , 1980; Naeve and Summers, 1980; Adam et a l , 1986). It 
is thought that N protein confers resistance to ribonculease 
digestion on the viral RNA (Cartwright et a l , 1970). The N 
protein has been shown by complement fixation to function as 
the group specific antigen (Cartwright and Brown, 1972).
Thomas et al (1985) using STEM proposed that the N 
protein subunit in the RNP has a wedge-shaped, bilobed 
structure and this property can explain the characteristic 
undulating configuration assumed by the nucleocapsid even 
when the RNA strand is well extended.
The M protein is the third major virion protein. Rose 
and Gallione (1981) sequenced the M mRNA of VSV IND, San 
Juan strain. The M mRNA is 831 nucleotides long and encodes 
a protein of 229 amino acids with a calculated mol wt of
26,064 (Rose and Gallione, 1981).
The M protein is thought to be a peripheral membrane 
protein. It lines the inner surface of the virion envelope 
perhaps interacting with the lipid bilayer, the internal 
portion of G protein and the nucleocapsid core (Wagner, 
1975). In addition to its proposed structural role M 
protein has a role in directing virus budding from infected 
cells (Knipe et al , 1977). There have been reports that M 
protein has a regulatory role in virus directed RNA 
synthesis (Clinton et al , 1978) and functions as an
inhibitor of viral transcription in vitro (Carroll and
Wagner, 1979; Lombard and Printz-Ane, 1979; De et al, 1982; 
Pinney and Emerson, 1982; Wilson and Lenard, 1981). The 
proposed role in RNA synthesis and transcription will be
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discussed in more detail later.
The complete nucleotide sequences of cDNA clones of 
the NS mRNA from VSV IND, San Juan strain and VSV N J , Ogden 
strain have been determined (Gallione et al , 1981; Gill and 
Banerjee, 1985). The NS mRNAs are 822 and 856 nucleotides 
in length respectively and code for proteins of mol wt
25.000 and 31,000. The NS protein runs anomalously on SDS 
polyacrylamide gels with a mol wt ranging between 39,000 and
50.000 (Knipe et al, 1977). It is a phosphorylated protein 
but dephosphorylation decreases the electrophoretic mobility 
and so this is not responsible for the aberrant mobility 
(Gallione et al , 1981). Although there is no direct 
evidence, the likeliest explanation for the aberrant 
mobility is a deficiency in SDS binding caused by the large 
proportion of the negatively charged amino acid residues in 
the NS protein (Gallione et a l , 1981).
The NS protein is found associated with the genomic 
RNA, L and N proteins (Wagner, 1975). It exists in infected 
cells in a variety of phosphorylated forms and it has been 
suggested that the extent of phosphorylation regulates 
transcription (Hsu and Kingsbury, 1980). It is a 
multifunctional protein as evidenced by the variety of 
phenotypes exhibited by the complementation group E mutants 
which have been shown to have t_s lesion(s) in the NS gene 
(Evans et al, 1979). The NS protein is the subject of this 
thesis and so it will be discussed in more detail later.
B . Lipids
The lipid composition of VSV has been shown to consist 
predominantly of phospholipids (61%) and neutral lipids
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(39%) with a cholesterol-to-phospholipid molar ratio of 0.6 
(McSharry and Wagner, 1971). The lipids contribute 21.1% of 
the total mass of the virion (Thomas et al , 1985) . The 
lipids are derived from the host cell and vary according to 
the cell type, reflecting the composition of the host cell 
plasma membrane (McSharry and Wagner, 1971).
C. RNA
The VSV genome consists of one linear, single-stranded 
molecule of negative sense RNA (Wagner, 1975). The RNA is 
responsible for 1.4% of the total mass of the virion (Thomas 
et a l , 1985) and is particularly AU rich. The structure and 
organisation of the genome will be discussed in some detail 
in the next section.
5. VSV GENOME ORGANISATION
A. General
The basic features of the VSV genome are shown in 
Figure 1.2. If the sequences of the leader region (Colonno 
and Banerjee, 1978a,b); L gene of VSV IND, Mudd-Summers
strain (Schubert et a l , 1984); N, NS, G and M mRNAs of VSV
IND, San Juan strain (Gallione et al, 191&; Rose and
Gallione, 1981; Rose et al, 1980) are tahen together with
the sequences of four inter-cistronic junctions (McGeoch, 
1979; Schubert et al, 1980; Rose, 1980) and the terminal 
tail region (Schubert et al, 1980) then some basic facts 
about the organisation of the VSV genome can be established. 
It is unfortunate that Schubert et al (1984) chose the L 
gene of the Mudd-Summers strain of the IND serotype and not
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the San Juan strain since most of the sequence data 
available are from the San Juan strain.
The genome is 11,162 nucleotides in length. Analysis 
reveals a remarkably simple but efficient use of the genome 
- 99.37% of the nucleotides are translated into mRNA; 93.88% 
encodes polypeptide specifying information. The leader RNA 
and the five genes are arranged in a linear array without 
overlaps and with the minimum of untranscribed intervening 
or terminal sequences (McGeoch, 1979; Rowlands, 1979; Keene 
et a l , 1980; Rose, 1980; Schubert et al , 1980). The virion 
associated RNA-dependent RNA polymerase has been shown by 
UV-inactivat ion studies to transcribe the genome in the 
order 3 1-leader-N-NS-M-G-L-5' (Abraham and Banerjee, 1976; 
Ball and White, 1976; Ball and Wertz, 1981). Villarreal et_ 
al (1976) reported that the molar ratios of the mRNA species 
made in infected cells were N :(NS+M):G:L:100:107:36:5.6 and 
the five viral proteins were synthesised in almost identical 
amounts. The partial termination that occurs at or near 
intercistronic boundaries has been termed attenuation 
(Iverson and Rose, 1981). There is no firm evidence for the 
expansion of coding capacity by the use of multiple reading 
frames, and no consensus RNA splicing signals which might 
indicate processing of the mRNA are found in the nucleotide 
sequence.
B . Leader RNA
Plus strand leader RNA is 47-50 nucleotides long and 
transcribed from the precise 3' end of the genome (Banerjee 
et a l , 1977). Plus strand leader RNA has been implicated in
the shut-off of host macromolecular synthesis (Week and
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Wagner, 1978; McGowan and Wagner, 1979; McGowan et al, 1982; 
Grinnell and Wagner, 1983) but its function in viral 
replication is unknown. The full-length plus sense RNA 
synthesised from the genome during VSV replication serves as 
template not only for the synthesis of additional progeny 
minus sense genomes (Wagner, 1975) but also for minus strand 
leader RNA similar in size to the plus strand leader.
Leader RNA, like virion RNA, is neither capped, methylated 
tyor polyadenylated (Colonno and Banerjee, 1976, 1978a,b) .
It has been proposed that plus and minus strand leader 
RNAs may function as decision points in the switch from 
viral transcription to replication (Leppert et a l , 1979).
The precise mechanism of this switch is unknown but it has 
been suggested that replication is mediated by the 
encapsidation of newly replicated viral RNA by N protein 
(Blumberg et al , 1983; Kingsbury, 1974). Blumberg et al 
(1983) proposed that the nascent plus and minus strand 
leader RNAs contain an encapsidation nucleation site which 
could be represented by a five-times-repeated A residue at 
every third base from the 5' end (see Figure 1.3). Thomas 
et al (1985) calculated there were nine nucleotides per N 
monomer in the RNP and this result is in agreement with the 
figure reached by P. Taylor (personal communication) who 
reached the same conclusion by analysing sequence data for 
preferential periodicity of certain bases or types of base.
The plus strand leader RNA can be divided into three 
functional domains shown in Figure 1.4 (Kurfrilla et a l ,
1982). The highly conserved proximal third is thought to 
play a role in initiation of RNA synthesis and in nucleation 
of N protein assembly (see above). The middle third
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contains a TATA-like sequence (Rose and Iverson, 1979) and 
is thought to interact with virion polymerase components 
(Keene et a l , 1981). The 3' proximal third may be involved 
in leader RNA termination and it is this region that has 
been proposed to interact with cellular La protein (Wilusz 
et a l , 1983; Kurilla and Keene, 1983). La protein is a 45KD 
protein which is normally found transiently bound to 
unprocessed cellular RNAs that are products of RNA 
polymerase III (Rinke and Steitz, 1982). The various roles 
of leader RNA will be discussed in greater detail in later 
sect ions.
C. Intercistronic Junctions
The sequence 3'-AUAC(U)7- 5 ' has been described at the 
5' terminus of each of the five genes of VSV (McGeoch, 1979; 
Schubert et al , 1980; Rose, 1980) . It is thought that the 
polyadenylation signal is contained within this sequence 
(McGeoch, 1979; Schubert et a l , 1980; Rose, 1980). The 
sequence is followed by the dinucleotide GA (or CA at the 
NS:M junction) (Rose and Iverson, 1979; Rose, 1980). The 
dinucleotide is untranscribed and marks the intercistronic 
junct ion.
The intercistronic junctions are followed by sequences 
with the general form 5'-AACAGNNAUC-31 (N represents a 
variable nucleotide) which is complementary to the 5' end of 
the mRNA (McGeoch, 1979; 198$). At the intercistronic 
junctions there is no indication of potential secondary 
structure that could account for the phenomenon of 
attenuat ion.
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D. Gene Products
The five mRNAs transcribed from the VSV genome are 
capped and methylated at the 5' terminus and polyadenylated 
at the 3' terminus (Abraham et a l , 1975; Rose, 1975; Rose 
and Knipe, 1975). In this section the processes of capping 
and methylation and polyadenylation will be discussed.
(i ) Capping and Methylation
There is a good deal of evidence indicating the 5' 
capped and methylated structure is not only necessary for 
efficient translation of mRNAs but also confers stability on 
some mRNAs. Both et al (1975) were the first to show this 
for mRNAs of VSV and reovirus. Later it was shown that 
capped mRNAs are more efficient at binding to ribosomes to 
form initiation complexes than their uncapped counterparts 
(Rose and Lodish, 1976; Lodish and Rose, 1977). It is 
possible that the cap structure is involved in, or required 
for, VSV mRNA synthesis because it has been reported that 
VSV mRNAs synthesised in vitro are always capped (Banerjee 
et a l , 1977).
The terminal cap structures in a number of viruses 
have been studied. The cap structure of VSV mRNAs contains 
the phosphate of the penultimate adenosine residue and 
the OC and £ phosphates of GTP, ie. Gpp/^A... and so they 
differ from the Gp/^pN found on the mRNAs of reovirus, 
vaccinia virus and cytoplsmic polyhedrosis virus (Abraham 
a l , 1975; Moss et a l , 1976; Furuichi and Shatkin, 1977; 
Furuichi, 1978). The three phosphate bridge structure of 
VSV mRNAs can arise in two ways. It could be synthesised by 
a mechanism involving Gppp and 5 ,CpA ends from newly
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synthesised mRNA or it might be initiated with pppA ends and 
capping occurs by the removal of the phosphate of 
guanosine and the if phosphates of adenosine (Banerjee,
1980) .
Testa and Banerjee (1977) showed that in vitro the 
methylation of the 5' cap of VSV mRNAs using the methyl 
group donor S-Adenosyl-L-methylmethionine occurs in the 
following manner:
GpppA ---- 1> GpppAm 1> 7mGpppAm to give the dimethyl a ted
product RNA. However, VSV mRNAs isolated from infected 
cells are more extensively methylated, probably by cellular 
enzymes, and so the cap structures are a heterogenous group 
usually in the form 7mGppp(m)Amp(m)A(in)p where (m) indicates 
positions of heterogenous non-obligatory methylation (Rose, 
1975; Moyer and Banerjee, 197^). Although methylation of 
the N7 position has been shown to be essential for efficient 
translation in vitro the function of the other methylations 
is unknown (Both et a l , 1975; Muthukrishnan et al, 1975;
jSu^. cJ i|
Lodish and Rose, 1977). Horikami^(1984) utilised two host 
range mutants of VSV, hrl and h r 8 , which have a mRNA 
methylation defect and direct the synthesis in vitro of 
full-length capped but unmethylated viral mRNAs (Horikami 
and Moyer, 1982), to test the requirements for mRNA function 
in mammalian cells under physiological conditions. 
Methylation of the G residue of the cap was a strict 
requirement for translation in vivo (Horikami et al, 1984).
(i i ) Polyadenylat ion
VSV mRNAs synthesised in vivo and in vitro are 
polyadenylated at their 3' termini with stretches of poly(A)
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residues ranging between 64 and 200 bases in length 
(Banerjee et a l , 1974; Rose and Knipe, 1975). Studies of 
the products of in vitro VSV transcription have shown there 
to be a small fraction of polycistronic viral transcripts - 
two or more m e s s a ^  encoded by adjacent genes connected by 
tracts of 200 polyadenylate residues plus the dinucleotide 
encoded by the intergenic junction (Herman et al , 1978;1980; 
Rose et a l / 1977). A further in vivo study by Schubert and 
Lazzarini (1981) demonstrated that, at the same frequency, 
readthrough even occurs distal to the L gene giving rise to 
L mRNA linked to a 59 base sequence which is complementary 
to the extreme 5' end of the genome.
Examination of sequence data shows that the long 
poly(A) stretches are not encoded by the genome. This has 
led to the proposal that polyadenylation occurs by a 
'chattering' mechanism at a sequence of the seven U residues 
which occur at each intergenic junction (Herman et al, 1980; 
Banerjee et a l , 1974; McGeoch, 1979; Schubert et al, 1980). 
The idea of oligo(U) sequences being used to initiate 
poly(A) synthesis is not without precedent since a 
comparable situation seems to exist with the segmented 
negative strand influenza A viruses (Hay et al , 1977; Skehel 
and Hay, 1978) and paramyxoviruses (Gupta and Kingsbury,
1982) .
Masters and Samuel (1984) detected the in vivo 
synthesis of polycistronic VSV transcripts by RNA blot 
hybridisation. They observed all the possible combinations 
of sequentially linked messages as identified by their 
apparent molecular weights and patterns of hybridisation.
The NS-M dicistronic mRNA was synthesised more frequently
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than the other polycistronic transcripts which were 
synthesised in a roughly uniform distribution (Masters and 
Samuels, 1984). Although analysis of the RNA following 
RNase H treatment in the presence of oligo(dT) indicated 
that in vivo-synthesised poly(A)+ polycistronic species 
NS-M, M-G and N-NS-M had poly(A) tracts at their 3' termini 
but not internally at the intercistronic boundaries (Masters 
and Samuels, 1984) direct sequence analysis is required to 
confirm this observation. If the observation is correct and 
there are no poly(A) tracts internally this represents a 
major difference between in vivo and in vitro transcription.
It is important that the polycistronic transcript 
synthesised in vitro and in vivo be identified as products 
of normal or aberrant transcription if we are to elucidate 
the mechanism of VSV transcription.
6. SEQUENCE INFORMATION
A * Codon Usage
In all of the VSV mRNAs sequenced to date there is 
non-random usage of codons with a deficiency overall in the 
dinucleotide CG. Thus the codon usage for five amino acids 
- serine, proline, threonine, alanine and arginine - is 
affected (Rose and Gallione, 1981). The CG deficiency is 
seen between adjacent codons as well as within codons and so 
it is probably not an adaptation of the virus to a relative 
shortage of cellular tRNAs recognising CG-containing codons. 
The reason for the CG deficiency in viral mRNA and 
vertebrate DNA in general is still unknown (Subak-Sharpe, 
1967, 1969).
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B . Comparative Sequence Analysis
McGeoch et al (1980) compared the terminal sequences 
of the N mRNA of VSV IND (Glasgow strain) and VSV NJ 
(Missouri strain, Hazelhurst subtype) with a view to 
examining the relationship between the two genomes. The two 
sequences were readily aligned showing an overall homology 
of 70.8% at the protein level (McGeoch et a l , 1980). When 
this figure was compared to the 4-20% homology estimated 
from hybridisation experiments between the two serotypes 
(Repik et al, 1974) it was concluded that although the 
overall homology between the genomes of the two serotypes 
was greater than previously estimated there is little exact 
homology over extended regions(McGeoch et a l , 1980).
More recently N, NS and G mRNAs from both serotypes of 
VSV have been sequenced thus allowing more detailed 
comparison of the two genomes (Banerjee et al, 1984;
Gallione and Rose, 1983; Rose and Gallione# 1981; Gallione 
et a l , 1981; Gill and Banerjee, 1985).
Gallione and Rose (1983) determined the sequence of 
the G mRNA of VSV NJ and compared it with their earlier 
sequence of the G mRNA from VSV IND (Rose and Gallione, 
1981). The positions and sizes of the transmembrane 
domains, the signal sequences, and the glycosylation sites 
are identical in both VSV serotypes (Gallione and Rose,
1983). An alignment of the two amino acid sequences shows 
an overall homology of 50.9%. It seems significant that the 
homology between the G proteins was less than that obtained 
for the N proteins (McGeoch et a l , 1980). Since G protein 
is the type specific VSV antigen and N the group specific
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antigen this is what we might have expected. Although the 
signal sequence and transmembrane domains of both G proteins 
are among the least conserved regions they have retained 
their hydrophobic character. This suggests that exact amino 
acid sequence is relatively unimportant as long as 
hydrophobicity is maintained (Gallione and Rose, 1983) .
Banerjee et al (1984) sequenced the N mRNA from VSV NJ 
serotype, Ogden strain and compared it with the 
corresponding sequence of the IND serotype previously 
determined by Gallione et al (1981). The N mRNA from VSV NJ 
is three nucleotides longer than the N mRNA from VSV IND but 
both code for proteins of 422 amino acids (Banerjee et al,
1984). At the nucleotide level 67.7% homology was 
calculated and at the protein level 80% homology was 
calculated when conservative replacements of amino acids 
were considered (Banerjee et al, 1984).
An extensive comparison of NS sequence data from both 
serotypes will be presented in a later section.
Thus analysis of nucleotide sequences, even of small 
regions of the genome, can be an accurate method of 
determining relationships within the family Rhabdoviridae. 
Certainly it is more sensitive and definitive than peptide 
mapping, hybridisation or oligonucleotide fingerprinting 
which have been used previously.
7. VIRION ASSOCIATED ENZYME ACTIVITIES
In addition to the RNA-dependent RNA polymerase 
(Baltimore et a l , 1970) there are two methyltransferase 
activities - 7-methyl G transferase and 2-0 methyl A
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transferase - (Testa and Banerjee, 1977; Banerjee et al ,
1977), a guanylyl transferase activity (Banerjee, 1980) and 
a polyadenylation activity associated with purified virions 
of VSV. It is possible that the polymerase enzyme complex 
carries out all of the enzyme activities involved in virus 
specific RNA synthesis. There have been reports by several 
groups that there is also a protein kinase activity (Imblum 
and Wagner, 1974; Moyer and Summers, 1974; Witt and Summers,
1980). The enzyme was thought to be host derived, but 
Sanchez et al (1985) provided some evidence to indicate that 
the L protein has a kinase activity and is capable of 
phosphorylating NS protein in vitro.
Two other enzyme activities, nucleoside diphosphate 
kinase and nucleoside triphosphatase (Roy and Bishop, 1971), 
are lost on removal of the viral membrane and so it has been 
suggested they are host derived (Hefti et a l , 1975). Other 
virion-associated enzyme activities which may be host 
derived are a proteinase (Holland et al , 1972) and a 
ribonuclease (Szilagyi and Uryvayev, 1973; Kolakofsky and 
Altman, 1978) .
8. VSV REPLICATIVE CYCLE
The processes by which VSV enters the cell and then 
replicates are not fully understood. There are still gaps 
in our understanding of some areas while conflicting results 
in others make them controversial. In studies of the VSV 
replicative cycle the IND serotype has been extensively 
used. It is assumed the NJ serotype is very similar. Much 
of the work has been carried out using in vitro systems and
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very often their relevance to the situation in vivo is open 
to question.
A. Viral Attachment, Penetration and Uncoatinq
Like other enveloped viruses the glycoprotein of VSV 
is the viral component that mediates attachment to the host 
cell. Selective proteolytic removal of the VSV glycoprotein 
reduces viral infectivity by five orders of magnitude 
(Bussereau et a l , 1975) and antibody to the glycoprotein can 
efficiently neutralise the virus (Kelley et al, 1972). The 
oligosaccharide chains on the G protein do not seem to be 
responsible for viral attachment (Gibson et al, 1978). VSV 
grown in the presence of tunicamycin, an antibiotic that 
inhibits glycosylationf has a specific infectivity 
comparable to its glycosylated counterpart (Gibson et a l , 
1978). Vandepol et al (1986) showed in a recent study that 
the sites at which neutralising antibodies attach to the 
glycoprotein correspond to the sites of carbohydrate 
attachment in both the glycoproteins of VSV and rabies 
virus. Thus it could be that alteration of glycosylation 
may be important in escape from antibody recognition and 
this might play an important role in the evolution of 
rhabdoviruses and indeed other viruses (Vandepol et al , 
1986).
VSV cell attachment represents a specific interaction 
between VSV G protein and a limited number (approximately 
4000) of saturable 'receptors' as well as non-saturable 
binding sites (Schlegel et a l , 1982). Schlegel et al (1983) 
solubilised membrane constituents and determined which 
components were able to bind VSV, thus inhibiting virus-cell
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interactions. It was found VSV binds preferentially to the 
acidic phospholipid phosphatidylserine (Schlegel et a l ,
1983) .
A number of studies indicate that VSV enters the cell 
mainly by endocytosis. Electron microscopy has shown that 
cell-bound VSV concentrates in clathrin-coated regions of 
the plasma membrane and appears in cytoplasmic vesicles that 
result from endocytosis of the coated pits (Simpson et a l , 
1969; Dahlberg, 1974). Dansylcadaverine and amantadine both 
inhibit receptor-mediated endocytosis. Although neither 
drug interferes with cell surface binding both were shown to 
greatly decrease internalisation of the virus and RNA 
synthesis (Schlegel et a l , 1982).
It is thought that acidification of the endosomes by 
an ATP-dependent proton pump is responsible for initiating 
the fusion of viral and cellular membranes that leads 
eventually to the release of the viral nucleocapsid into the 
cell cytoplasm (Schlegel and Wade, 1985). Evidence from a 
number of studies indicates that under certain conditions 
VSV G proten is involved in membrane fusion. Mammalian 
cells can be fused by exogenous VSV under acidic conditions 
(White et al , 1981). Cells expressing cloned G protein are 
fusogenic at low pH (Florkiewicz and Rose, 1984; Riedel e_t 
al, 1984). Using fluorescence energy transfer and electron 
microscopy, purified G protein can be shown to affect 
liposome membrane fusion (Eidelman et al, 1984). When 
incorporated into liposomes G protein can haemolyse 
erythrocytes under acidic conditions (Bailey et a l , 1984). 
Schlegel and Wade (1985) showed that peptides corresponding 
to the amino terminus of G protein can also function as a pH
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dependent haemolysin. The haemolytic domain was later 
localised to the six amino-terminal amino acids (Schlegel 
and Wade, 1985). Conservation of the amino terminus of G 
protein from several strains of VSV and the closely related 
rabies virus indicates that the membrane-destabilising 
properties of this domain might be important for 
glycoprotein function (Schlegel and Wade, 1985).
These data support the conclusion that prior to 
initiating RNA synthesis, infectious VSV must pass through 
an endosomal compartment, and so follows a route similar to 
that of the alphavirus Semliki forest virus and the 
influenza virus fowl plague virus (Helenius et al , 1980; 
Marsh et a l , 198$; Matlin et al , 1982).
B. RNA Synthesis
The first step in the infectious cycle of any negative 
strand RNA virus is mRNA synthesis. When the virion 
envelope has been removed the infecting virus initiates 
transcription using the RNA-dependent-RNA polymerase which 
has been packaged in the mature virus particle. Figure 1.5 
is a summary of VSV RNA synthesis. The products of standard 
virus transcription, both in vivo and in vitro, consist of 
five monocistronic RNAs and a leader RNA (Moyer et al ,
1975v; Moyer and Banerjee, 1975; Freeman et al, 1977; Rhodes 
et a l , 1977). Recently, however, Kurath and Leong (1985) 
isolated six viral mRNA species from salmon cells infected 
with the piscine rhabdovirus IHNV. The sixth RNA coded for 
a previously unrecognised viral protein induced in infected 
cells but not present in mature virions. The non-virion 
protein was designated the NV protein (Kurath and Leong,
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1985). It is the first report of a non-virion rhabdovirus 
protein in infected cells. If an analagous protein were 
found in VSV and other rhabdoviruses it could have a general 
role in the rhabdovirus replication cycle. Alternatively, 
the protein might be specific to replication in fish cells 
or replication at colder temperatures. Therefore, it would 
be of interest to see if an NV protein is coded by other 
piscine rhabdoviruses eg. spring viraemia of carp virus, 
pike fry rhabdovirus, or viral hemorrhagic septicaemia virus 
(Pilcher and Fryer, 1978) .
(i ) Viral Polypeptides Involved in VSV Transcription 
Three of the five virus-specified proteins are 
involved in transcription. The G and M proteins can be 
removed from the virion leaving the viral subparticle which 
consists of RNA and L, NS and N proteins. The subparticle 
is both infectious and transcriptionally active (Brown et_ 
al, 1967; Cartwright et al , 1970-.; Bishop and Roy, 1972; 
Emerson and Wagner, 1972; Szilagyi and Uryvayev, 1973).
Dissociation-reconstitut ion experiments in which 
virions are dissociated into the individual proteins and 
then transcriptase activity assayed in vitro after 
reconstitution of various fractions have been performed in 
order to analyse the role of the various proteins in 
transcript ion.
Emerson and Wagner (1972) showed the RNA-N complex was 
essential for transcription. A transcriptionally active 
complex was not formed when L+NS proteins were added to 
deproteinised RNA (Emerson and Wagner, 1972). Further 
evidence of N protein involvement came from the observation
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that antibody directed against the RNA-N complex inhibits
transcription (Carroll and Wagner, 1978).
The dissociation-reconstitution experiments strongly 
suggested that the L protein is at least part of the
transcriptase (Naito and Ishihama, 1976; Emerson and Wagner,
1972, 1973; Emerson and Yu, 1975; Abraham and Banerjee,
1976; Szilagyi, 1975; Mellon and Emerson, 1978; Kingsford 
and Emerson, 1980; Ongradi et a l , 1985a, 1985b). The 
laboratories of both Emerson and Banerjee have provided 
evidence that the L and NS proteins are required for 
transcription - using VSV IND it has been shown that L on 
its own does not synthesise RNA when reconstituted with the 
RNA-N template; however, addition of NS protein leads to RNA 
synthesis (Emerson and Yu, 1975; Banerjee et al , 1974;
Mellon and Emerson, 1978; Kingsford and Emerson, 1980; De 
and Banerjee, 1985). De and Banerjee (1985) using 
dissociation-reconstitution studies concluded that the 
requirements for L and NS proteins were catalytic and 
stoichometric respectively. Their results suggest that NS 
protein is involved in the elongation step of RNA synthesis 
whereas L protein is involved in initiation of the RNA 
chains (De and Banerjee, 1985). However, Szilagyi and his 
coworkers using in vitro reconst i tut ion experiments with _t_s 
mutants of VSV NJ have suggested that L alone is the 
transcriptase while the NS protein exerts some controlling 
role over RNA synthesis by L protein (Ongradi and Szilagyi, 
1981; Ongradi et al, 1985a, 1985b). Direct evidence for the 
involvement of both L and NS proteins in transcription comes 
from the observation that antibody against L and NS proteins 
has the ability to inhibit transcription in vitro by RNps of
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VSV IND (Harmon and Summers, 1982). The conflicting results 
as to the requirement for NS in transcription may represent 
greater differences between the two serotypes than 
previously expected since Szilagyi used VSV NJ in his 
experiments and the other workers used VSV IND.
A major criticism of the in vitro reconstitution 
assays and a factor vital to any meaningful interpretation 
of the results they generate is the lack of characterisation 
of the RNA synthesised in the reactions. The controversy 
over the roles of L and NS proteins in transcription might 
be resolved if the product RNA was characterised by gel 
electrophoresis, hybridisation analysis or direct 
sequencing.
(i i ) Transcript ion
Two models have been proposed to account for 
transcription of the VSV genome and these are summarised in 
Figure 1.6. Dissociation-reconstitution experiments have 
been used to study transcription and so all the work has 
been done in vitro. The interpretation of the results of 
these experiments and their relevance to the situation in 
vivo as well as biological significance of the product of 
the reactions are all open to question. Even today the 
exact mechanism of transcription has not been elucidated and 
different laboratories using slightly different techniques 
still generate conflicting data.
In the multiple initiation model the virion associated 
RNA polymerase initiates transcription at five distinct 
promoter sequences distal to the 3' terminus of the genome 
(Chanda and Banerjee, 1981; Naeve and Summers, 1981). The
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model is based on experiments that demonstrate that 
solubilised virions initiate transcription at internal genes 
in vitro under limiting reaction conditions (Chanda and 
Banerjee/ 1981; Naeve and Summers, 1981). In addition, 
Pinney and Emerson (1982) reported conditions of 
transcription in vitro in which initiations at the N gene 
occur in great molar excess over initiations at the 3' 
leader gene. Thornton et al (1984) reported that^when they
VofC-w*
used a UV irradiated RNA-N/ytemplate reconstituted with L and 
NS proteins full-length mRNA synthesis decreased by 90% 
whereas synthesis of leader RNA and other small initiated 
mRNA sequences continued; this observation, combined with 
the fact that under partial reaction conditions the 
reconstituted complex synthesised polyphosphorylated 
oligonucleotides, some of which corresponded to 5* terminal 
sequences transcribed from leader RNA and genes coding for 
mRNAs, led them to support the multiple entry model.
In two sets of experiments supporting the multiple 
entry model high proportions of additional short 
oligonucleotides, of unknown origin, have bee*1'detected 
(Chanda and Banerjee, 1981; Thornton et al , 1984). These 
oligonucleotides could be merely the products of aberrant 
transcriptive events brought about by the treatment of 
template and/or polymerase. The fact that some correspond 
to the sequences at the 5 1 end of leader RNA and mRNAs could 
be fortuitous. Direct experimental evidence against the 
multiple entry model is the observation by Keene et al 
(1981) that a DI particle, HR-LT2, is unable to trancribe 
its internal genes.
Much of the work supporting the multiple entry model
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assumes that the oligonucleotides synthesised by virions 
under limiting reaction conditions reflect the initial steps 
in transcription. It does not rule out the possibility that 
during viral maturation virions are stopped at various 
stages of transcription and so in the subsequent in vitro 
reactions they are completing rather than beginning 
transcription (Chanda and Banerjee, 1981; Naeve and Summers,
1981). In a reconstitution assay Emerson (1982) recombined 
template completely devoid of enzyme with polymerase so that 
transcription had to start de novo. The data suggest that 
the polymerase begins transcription at the 3' end of the 
genome, and reaches internal genes, only by sequentially 
transcribing the 3' preceeding sequences (Emerson, 1982). 
This led to the formulation of the single initiation model 
of transcription in which the polymerase has a single entry 
site at the 3' terminus of the genome RNA (Emerson, 1982; 
Iverson and Rose, 1982). Iverson and Rose (1981) examined 
the kinetics of synthesis in vitro of the 5' ends of mRNAs. 
From their data they too concluded that there is a single 
polymerase entry site at the 3' end of the genome (Iverson 
and Rose, 1981). For the first time RNA products were 
characterised by sequence analysis - partial sequence 
analysis of two small RNA species whose synthesis was highly 
resistant to UV irradiation showed them to be a 5* capped 
fragment of the N mRNA and a 5 1 fragment of leader RNA 
(Iverson and Rose, 1981).
The single entry promoter model is consistent with the 
generation of monocistronic mRNAs by nuclease cleavage of a 
full-length precursor (Colonno and Banerjee, 1976) or by a 
stop/start mechanism whereby the polymerase moves
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sequentially along the genome and initiates and terminates 
transcription at each gene boundary (Banerjee et al/ 1977). 
The mechanism at present is controversial. Polycistronic 
transcripts have been detected both in vitro (Rose et al , 
1977; Herman et a l , 1980) and in vivo (Masters and Samuel,
1984). However, it is not clear at present if the 
transcripts are the result of aberrant or normal 
transcription. Certainly the transcripts detected in vitro 
and in vivo seem to differ from one another in the extent of 
polyadenylation. Polycistronic transcripts synthesised in 
vitro are polyadenylated internally at intercistronic 
junctions whereas those synthesised in vivo are 
polyadenylated at the 3' molecular termini but not 
internally (Masters and Samuels, 1984). The difference in 
polyadenylation could represent a major difference between 
in vivo and in vitro transcription which would mean that not 
all results from studies in vitro are a true reflection of 
the situation in vivo. Thus new approaches in elucidating 
the mechanisms involved in many aspects of the VSV life 
cycle must be sought if we are to build a clear picture of 
VSV replication.
Transcription by VSV can be divided into primary 
transcription which occurs on release of nucleocapsids into 
the cell cytoplasm and secondary transcription which occurs 
after replication ie. synthesis of full-length genomic RNA.
(iii) Primary Transcription
Flamand and Bishop (1975) estimated that only one out 
of every five virus particles absorbed actually participates 
in primary transcription. Primary transcription gives rise
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to the five species of mRNA (Morrison et a l , 1974; Both et_ 
a l , 1975; Knipe et al , 1975) in addition to the leader RNA 
(Leppert et a l , 1979; Blumberg et a l , 1981; Kurilla et a l ,
1982) and a sequence complementary to the 5' terminal 
ext racistronic region of the virus genomic RNA (Schubert and 
Lazzarini, 1981). It has been reported that primary 
transcription can continue at a linear rate for up to 6 hr 
post infection (at 31-39°C) (Flamand and Bishop, 1973,
1974). At the optimum temperature the maximum activity 
corresponds to one genome mass equivalent copy per 90 
seconds per active genome (Flamand and Bishop, 1974).
(iv) Protein Synthesis
The mRNAs synthesised during primary transcription 
become associated with ribosomes and protein synthesis 
begins. In order for replication, the next stage in RNA 
synthesis, to occur protein must be synthesised (Bishop and 
Smith, 1977). If protein synthesis is inhibited, by use of 
cycloheximide for example, then only primary transcription 
occurs and no genome sized RNA can be detected (Perlman and 
Huang, 1973; Wertz and Levine, 1973). Protein synthesis 
must be continuous because replication ceases if protein 
synthesis is inhibited after its onset (Wertz and Levine, 
1973; Rubio et a l , 1980).
(v) Replication
VSV can be thought to replicate in two stages. The 
negative sense RNP first of all serves as the template for 
the synthesis of full-length complementary RNA (positive 
sense RNA). The positive sense strand RNA complexed with N
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protein is then able to act as the template for the 
synthesis of negative sense virion RNA in the second stage 
of replication (Emerson, 1985). Both postive and negative 
sense RNA complexed with N protein V\«v<3l been detected in 
infected cells (Soria et al , 1974). The problem fundamental 
to an understanding of VSV replication is what controls the 
switch from mRNA to genome RNA synthesis.
Results from a number of studies indicate that the 
viral RNA polymerase, perhaps in conjunction with certain 
host factors, carries out both transcription and replication 
(Emerson and Yu, 1975; Perlman and Huang, 1973; Pringle,
1978). Studies by several workers have led to the proposal 
that the availability of N protein, necessary for the 
encapsidation of genomic RNA, is the switch from 
transcription to replication (Kingsbury, 1974; Blumberg et 
al , 1981; Lazzarini et a l , 1981).
Coupled transcription-translation systems capable of 
synthesising full-length genomic RNA are available and have 
been used to study VSV replication in vitro (Ghosh and 
Ghosh, 1982; Hill et al , 1981; Davis and Wertz, 1982; Patton 
et al , 1983). Patton et al (1984) used a
transcription-translat ion system to test the requirement for 
protein synthesis in replication. In the
transcription-translation system nucleocapsids of a VSV DI 
particle which contained only the 5' 25% of the standard
genome were used as templates so that replication could be 
studied in the absence of mRNA synthesis (Stamminger and 
Lazzarini, 1979). Viral mRNAs purified by hybridisation to 
cDNA clones were used to direct the synthesis of individual 
proteins. Using the system it was demonstrated that the
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synthesis of N protein alone resulted in the replication of 
genome length RNA by both DI intracellular nucleocapsids and 
virion derived nucleocapsids (Patton et al , 1984). Blumberg 
et al (1983) reported that the 5' end of leader RNA may 
serve as a specific binding site for N protein. Thus it is 
conceivable from the studies of Patton and Blumberg that N 
protein binds to the 5' end of nascent leader RNA initiating 
encapsidation of the growing RNA strand. Encapsidation 
might protect the RNA from processing or cause readthrough 
of the transcriptional signals and so lead to the synthesis 
of genome size RNA.
Arnheiter et al (1985) used two monoclonal antibodies 
directed against different epitopes on N protein as 
molecular probes to gain some insight into the mechanisms 
involved in the regulation of RNA synthesis in vivo and in 
vitro. The results of the study indicate that VSV genome 
replication is controlled by the availability of N protein 
even when the polymerase has access to the host factors and 
multiple phosphorylated forms of the NS protein thought to 
be involved in genomic RNA synthesis (Arnheiter et al,
1985).
The two antibodies described by Arnheiter et al (1985) 
are interesting in light of the very different effects they 
have on replication. Antibody 1 binds to nucleocapsids and 
probably the pool of free (unbound) N protein, it inhibits 
transcription and when microinjected into the cell protects 
it against infection by VSV. Antibody 2 only binds poorly 
to nucleocapsids and does not inhibit transcription.
However, when it is microinjected into the cell it binds 
selectively to free N and delays the appearance of progeny
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virus (Arnheiter et al , 1985). The antibodies distinguished 
two distinct pools of N protein - a diffusely staining, 
dynamic pool (N protein not associated with RNA) and a 
punctuate, staining stable pool (N protein assembled into 
nucleocapsids). The existence of a pool of free N protein 
had previously been suspected from pulse-chase experiments 
(Knipe et al , 1977; Hsu et a l , 1979; Rubio et al , 1980).
It seems that the NS protein has a role in replication 
quite apart from its proposed role as part of the 
polymerase. The N protein has a tendency to self-aggregate 
under physiological conditions (Blumberg et a l , 1983;
Sprague et al, 1983). However, N-NS protein complexes have 
been isolated from infected cells (Peluso and Moyer, 1984; 
Bell et al , 1984) and some monoclonal antibodies directed 
against N or NS protein can immunoprecipitate N-NS complexes 
in vitro (Arnheiter et a l , 1985). Thus it is possible that 
one of the roles of replication for NS protein is to complex 
with free N protein in order to prevent N protein 
self-aggregation (Arnheiter et al , 1985).
A number of genetical and biochemical studies have 
estabished that replication of VSV in permissive cells 
requires unidentified host factors (Simpson et al, 1979; 
Morrongiello and Simpson, 1979; Mukherjee and Simpson,
1984). Mukherjee and Simpson (1984) recently used 
non-steroidal anti-inflammatory inhibitors known to 
compromise pros.tcfcglandin biosynthesis, cyclic nucleotides 
and various enzyme systems to demonstrate the dependence of 
VSV replication on pre-existing host factors.
There are differences in the relative amounts of 
positive and negative sense RNA present in infected cells at
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different times during the infectious cycle (Simonsen et al ,
1979). Early in replication the ratio of plus to minus 
strands is 1:1; however, later the minus strands are 
preferentially synthesised (Simonsen et a l , 1979). It seems 
the key to regulating the synthesis of plus and minus 
strands lies in the sequences at the ends of the genome 
because plus and minus strands of DI particles are 
synthesised in roughly equal amounts throughout infection 
(Schubert et a l , 1979). The first 46-48 bases at either end 
of the DI particle genome are highly conserved (Moyer et al , 
1977; Emerson et al, 1977) and are the same as those at the 
3' end of the standard virus genome.
In summary, replication of genome length RNA by VSV is 
dependent upon several, as yet, unidentified host factors. 
One of the main controls over RNA synthesis seems to be the 
availability of N protein. If there is insufficient N or N 
synthesis is restricted in some way then replication is 
restricted and this restiction is presumably accompanied by 
increased transcription. The evidence indicates that during 
N protein deficiency all forms of genome length RNA 
synthesis restricted (Arnheiter et a l , 1985; Patton et_ 
a l , 1984). By including small differences at the end of its 
genome it seems that the virus has developed a means to 
regulate the replication of plus and minus strand RNA.
(v i ) Secondary Transcription
It has been reported that at the time when replication 
occurs there is a very marked rise in the rate of viral mRNA 
synthesis (Flamand and Bishop, 1974). The increased mRNA 
synthesis is due to secondary transcription which uses
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progeny genomic RNA as template. The synthesis of viral 
mRNA switches from a linear to an exponential rate because 
of this secondary transcription although it does eventually 
decrease (Flamand and Bishop, 1974) . There is a limit to 
the amount of viral RNA that can be synthesisied in infected 
cells because there are similar amounts of viral RNA in 
cells infected with high or low multiplicities of infection 
(Flamand and Bishop, 1974). There seems to be a host cell 
involvement in regulation of the infectious cycle because 
the amount of viral RNA synthesised and the yield of virus 
have been shown to be dependent on the host cell type 
(Flamand and Bishop, 1973, 1974).
C. Viral Protein Synthesis and Maturation
VSV mRNAs are \ : efficiently on host cell
ribosomes (Rose, 1980). Rose (1977, 1978) isolated and 
sequenced translation initiation sites from VSV mRNAs and 
the sequences determined from the protected sites from each 
of the five VSV mRNAs are shown in Figure 1.7. Each site 
contains a single AUG initiation codon and the capped 5' end 
of the mRNA only appears in the initiation site when it is 
close to the initiation codon. The sequences do not share 
common features indicating that a variety of structures can 
result in equal translation efficiencies in vivo (Villarreal 
et al , 1976). The significance of the homologies (shown by 
dashed boxes) between the sites ^  unknown. Results from 
several workers indicate all five VSV mRNAs are translated 
with equal efficiency (Villarreal et al , 1976? Lodish and 
Froshauer, 1977). Thus the synthesis of each protein is 
regulated by transcriptional as opposed to translational
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control. The known VSV proteins are structural components 
of the virus and each one may play a role in the final 
assembly process which results in budding and virus release 
(Odenwald et a l , 1986).
The N protein is synthesised as a soluble protein and 
assembled into nucleocapsids that accumulate in the 
cytoplasm (Knipe et al, 1977). As already discussed, the NS 
protein can form a complex with free N protein in the 
cytoplasm of infected cells (Bell et al , 1984; Peluso and 
Moyer, 1984) possibly to prevent the self-aggregation of N 
protein which occurs extensively in the absence of viral 
proteins (Blumberg et a l , 1983; Sprague et al , 1983). The 
nucleocapsids remain in the cytoplasm and serve as templates 
for new negative strand RNA synthesis or take part in 
secondary transcription.
The NS protein of VSV exists in a variety of 
phosphorylated forms in infected cells (Kingsford and 
Emerson, 1980; Hsu and Kingsbury, 1982). Electrophoresis of 
the various forms of NS separates them into two classes (NS1 
and NS2) which differ markedly in their degree of 
phosphorylation and in their degree of transcriptase 
activity in vitro and ability to bind to nucleocapsids 
(Clinton et al , 1979; Kingsford and Emerson, 1980; Kingsbury 
et a l , 1981; Hsu and Kingsbury, 1982). Pulse-chase 
experiments indicate that there is a very large pool of NS 
protein in the cytoplasm of the infected cell (Hsu et a l , 
1979; Rubio et al, 1980). The NS protein has been shown to 
be phosphorylated at multiple serine and threonine residues 
(Clinton and Huang, 1981; Hsu et al , 1982). A number of 
studies which have analysed NS phosphorylation by chemical
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and enzymic cleavage of NS protein support the hypothesis 
that all NS molecules, no matter what their extent of 
phosphorylation, are phosphorylated at a number of specific 
residues which have been termed the 'constitutive' 
phosphorylation sites. The 'constitutive' phosphorylation 
sites, which all seem to lie in the amino half of the 
protein, must be phosphorylated for any basal level of NS 
activity (Hsu and Kingsbury, 1985; Bell and Prevec, 1985). 
Results from Sanchez et al (1985) suggest the L protein may 
be responsible for the phosphorylation of NS protein.
The L protein is not found in a cytoplasmic pool but 
enters RNPs immediately after synthesis (Hsu et al, 1979). 
NS protein is capable of binding directly to the RNA-N 
protein complex; however, binding of L is dependent on the 
presence of NS protein (Mellon and Emerson, 1978). It is 
known that L can bind to NS (Naito and Ishihama, 1976) so L 
may bind indirectly to the RNA-N complex by binding to NS. 
Alternatively, NS binding might expose sites on the RNA 
which allow L to bind (Mellon and Emerson, 1978).
The G protein can be divided into four major domains: 
the N-terminal signal sequence, the main body of the 
protein, the transmembrane domain, and the cytoplasmic 
C-terminal region (Rose and Gallione, 1981). The VSV G 
protein has proved to be an excellent model for studying 
biosynthesis, processing and transport of integral membrane 
proteins (Lodish and Rothman, 1979). Studies carried out 
using VSV infected cells have demonstrated that the nascent 
viral glycoprotein is inserted into the membrane of the 
rough endoplasmic reticulum (ER) and the signal sequence is 
proteolytically removed (Chatis and Morrison, 1979; Irving
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et al , 1979; Lingappa et a l , 1978). As translation proceeds 
the nascent polypeptide is continuously inserted through the 
membrane into the lumen. Glycosylation occurs 
cotranslationally (Kruppa, 1979; Rothman and Lodish, 1977). 
Two identical oligosaccharide chains are linked to the 
peptide chain at asparagine residues (Reading et al , 1978). 
The two glycosylation sites in VSV IND G protein are 
Asn-Ser-Thr at position 178-180 and Asn-Gly-Thr at position 
335-357 (Neuberger et al , 1972; Rose and Gallione, 1981).
The oligosaccharide chains have a high mannose content and 
are preformed on dolicholpyrophosphate molecules (Rothman 
and Lodish, 1977; Toneguzzo and Ghosh, 1978). The 
hydrophobic transmembrane domain is assumed to stop the 
transfer of the growing G protein by anchoring it in the 
lipid bilayer of the ER. The highly charged C-terminal 
region of the G protein remains on the cytoplasmic side of 
the ER membrane (Chatis and Morrison, 1979; Rose et al,
1980; Toneguzzo and Ghosh, 1978). The N linked high-mannose 
oligosaccharides of the G protein are trimmed and modified 
in the Golgi complex (Hubbard and Ivatt, 1981; Bergman et_ 
al, 1981). Specific sugars are removed and new 'terminal 
sugars', usually neuraminic acid, are added (Bergman et a l ,
1978). A fatty acid chain (palmitate) is linked to the 
single cysteine residue in the cytoplasmic domain in VSV IND 
but not in VSV NJ (Magee et a l , 1984; Rose et al, 1984).
The G protein is transported to the plasma membrane and 
normally leaves it as an integral part of budding virus 
particles. The G protein forms spikes, which are probably 
monomeric (Crimmins et a l , 1983) and more than 95% of the 
protein is exposed on the exterior of the virion (Rose and
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Gallione, 1981).
Several workers have described a soluble G protein 
(Gs) present in the culture medium of VSV infected cells 
(Kang and Prevec, 1970; Little and Huang, 1977). It has 
been suggested that Gs arises by proteolytic cleavage of the 
G protein at the cell surface thus causing the protein to be 
shed into the medium (Chatis and Morrison, 1982; Irving and 
Ghosh, 1982; Little and Huang, 1978). Shedding of soluble 
viral proteins is not a phenomenon unique to VSV. It has 
been reported in a number of other systems like rabies virus 
infected cells (Dietzschold et a l , 1983), murine leukaemia 
virus infected cells (Bolognesi et al, 1975) and tumour cell 
lines (Racevski and Sarkar, 1978). Garrais-Wabnitz and 
Kruppa (1984) showed that in BHK cells there is a short form 
of G protein found intracellularly which lacks the 
membrane-anchoring oligopeptide and so is secreted into the 
medium. Graeve et al (1986) extended the observations to 
other cell lines and different VSV isolates. Synthesis of 
Gs in a cell free system combined with kinetic studies 
indicate that Gs is formed during or shortly after the 
translation process rather than at the cell surface by 
proteolytic fragmentation of the membrane-spanning G protein 
(Graeve et al, 1986). The biological role of the soluble 
antigens produced by VSV, rabies virus and different tumour 
viruses remains obscure. It is possible that the soluble 
antigens neutralise antibodies or block cytc^cic immune cells 
thus aiding virus infected cells to escape from the 
immunological defence of the host (Irving and Ghosh, 1982; 
Little and Huang, 1978).
The M protein of VSV is synthesised on free polysomes
and released into the soluble fraction of infected cells 
(Knipe et al , 1977). Although initially a large proportion 
of M protein is non-membrane associated, the protein appears 
to accumulate in the membrane fractions of infected cells as 
the infection proceeds (David, 1973; Knipe et al , 1977). It 
is interesting that in vitro M can accumulate in all classes 
of membranes, including those of uninfected cells, while in 
infected cells, association of M with cellular membranes 
seems to be only transient (Morrison, 1980). It is not 
clear whether there is any direct association of M with the 
lipid bilayer of the plasma membrane. Inspection of the 
predicted M protein sequence does not reveal any long 
hydrophobic or non-polar domains that might be inserted into 
the membrane (Rose and Gallione, 1981).
It has been proposed that the M protein of VSV plays a 
regulatory role in virus-directed RNA synthesis in infected 
cells (Clinton et a l , 1978). Work has suggested that M 
protein serves as an inhibitor in vitro of viral 
transcription (Carroll and Wagner, 1979; Lombard and 
Printz-Ane, 1979; De et al, 1982; Pinney and Emerson, 1982; 
Wilson and Lenard, 1981). The role of M protein in 
regulation of transcription has been studied using 
monoclonal antibodies directed against M protein (Pal et al , 
1985; Ye et a l , 1985). Pal et al (1985) reported that 
monoclonal antibodies directed against three antigenic 
determinants of M protein affected in vitro transcription in 
very different ways. The results indicated that exposure of 
epitope 1 on the surface of M protein is essential for 
inhibiting transcription by VSV (Pal et al , 1985). It has 
also been reported that VSV can induce cell fusion to a
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certain level with G still on the cell surface (Storey and 
Yong-Kang, 1985).
D. Virion Assembly and Virus Budding
Budding of a mature virus particle from the plasma 
membrane of an infected cell is dependent upon the assembly 
of the membrane-associated G protein, the soluble M protein 
and the RNP at a discrete site on the membrane (Knipe et a l , 
1977). The budding process is selective in that only RNPs 
containing negative stranded RNA seem to be recognised (Roy 
et al , 1973; Wagner, 1975). The mechanisms which govern the 
sorting and assembly events are for the most part unknown 
but it seems that the five VSV structural proteins play an 
important part.
The formation of particles lacking the RNP is very 
rare in infections with wild-type virus although they have 
been reported after infection with certain _t£ mutants 
(Schnitzer and Lodish, 1979). The RNP seems to be essential 
in determining the morphology of the budding particle 
(Odenwald et a l , 1986). The amount of G protein 
incorporated into virions varies depending mainly on the 
time of harvest (Lodish and Porter, 1980). It is possible 
that G protein determines the site of budding because in 
polarised cell lines G protein is transported mainly to the 
basolateral membrane and it is from this site that budding 
takes place (Rodriguez-Boulan and Pendergast, 1980;
Rodriguez-Boulan and Sabatini, 1978). However, studies 
using tsQ45, a spontaneous mutant isolated by Flamand (1970) 
which has a block in G protein transport (Bergman et al ,
1981), found that virus particles devoid of G protein bud
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from the cell membrane albeit with low efficiency (Schnitzer 
et a l , 1979).
All the available evidence points to the involvement 
of M protein being crucial to the budding process. A number 
of methods (protease digestion, labelling and cross-linking 
experiments) indicate that M protein is localised on the 
inside of the envelope and may form a bridge between G 
protein and the RNP (Dubovi and Wagner, 1977; Zakowski and 
Wagner, 1980). The M protein may also interact with 
membrane phospholipid (Zakowski et al , 1981). The 
association of M protein with the RNP has been shown by 
experiments with complete virions. Non-ionic detergents, 
eg. Triton-X and octylglucoside, remove G protein and viral 
membranes leaving particles termed skeletons. Newcomb and 
Brown (1981) have shown that in skeletons the M protein 
remains associated with a tightly coiled RNP. If M protein 
is removed from the skeleton by varying salt concentration 
then the RNPs lose their tightly-coiled formation (Newcomb 
et a l , 1982). Addition of M protein to extended RNPs 
converts them to tightly-coiled forms (Thornton et al ,
1982).
Odenwald et al (1986) gained some insight into the 
assembly processes at the cytoplasmic and outer surfaces of 
the plasma membrane by preparing platinum replicas of these 
areas and examining them under the electron microscope 
(Heuser and Evans, 1980; Hirokawa and Heuser, 1982). They 
combined the technique with immunolabelling of the viral N,
M and G proteins in order to view the events involved in 
viral morphogenesis.
The M protein is not present in the membrane and is
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found associated only with tightly coiled RNPs in contrast 
to N protein which is part of the loose and tightly coiled 
RNPs (Odenwald et a l , 1986). It seems that a necessary step 
in the initiation of viral assembly is the interaction 
between the cytoplasmic domain of G protein and the loosely 
coiled RNP. When the contact between the two has been made, 
coiling of the RNP occurs and the particle takes on its 
characteristic morphology. The M protein might function to 
alter the conformation of the RNP such that it is amenable 
to coiling or it might cross-link adjacent turns in the 
tight coil. The two possibilities of M function are not 
mutually exclusive and so it may be involved in both 
processes (Odenwald et al , 1986).
9. THE EFFECT OF VSV INFECTION ON HOST CELL METABOLISM
Infection of many cell types with VSV results in a 
drastic reduction in the ability of the host cell to 
synthesise RNA (Baxt and Bablanian, 1976; Week and Wagner, 
1978, 1979; Yaoi et al, 1970). This effect, in parallel 
with the reduced ability to synthesise DNA (McGowan and 
Wagner, 1981; Yaoi and Amano, 1970) and protein (Baxt and 
Bablanian, 1976; Marcus and Sekellick, 1975; McAllister and 
Wagner, 1976; Wertz and Youngner, 1972) eventually leads to 
cell death (Marcus and Sekellick, 1974; 1975; Marcus et a l ,
1977) .
Cell killing by VSV is a subject on which much work 
has been concentrated. However, it is still not clear 
whether cell death reflects a cumulative effect of viral 
interference with host metabolism or whether there is a
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crucial target. Any understanding of the reasons why VSV 
infected cells die so rapidly is complicated by the facts 
that three different major biosynthetic pathways are 
affected and that different cell lines show different 
degrees of sensitivity to killing. As yet there is no 
integrated picture of how the virus kills cells but details 
of the factors required for shut-off of the individual 
pathways have been obtained. Viral transcription but not 
replication is essential for cell killing and is required 
for shut-off of all three pathways (Marcus and Sekellick, 
1975; Marcus et a l , 1977).
A. RNA Synthesis
The striking effect of VSV infection on host nuclear 
function is surprising in view of the facts that VSV 
replication occurs in the cell cytoplasm and that the virus 
can grow in enucleated cells (Follett et al, 1974).
The rapid and marked inhibition of cellular RNA 
synthesis on infection with VSV does not seem to be due to 
any modification of post-transcriptional events such as 
polyadenylation or transport of RNA (Week and Wagner, 1978). 
Similarly an enhanced degradation of cellular mRNA in 
infected cells has never been observed (Nishioka and 
Silverstein, 1978). The ability of VSV to shut-off cellular 
transcription appears to be at the level of binding of the 
RNA polymerase to its template (Week and Wagner, 1979).
Week and Wagner (1979) carried out reconstitution 
experiments with solubilised RNA polymerases dissociated 
from chromatin of infected and uninfected cells. These 
experiments showed that infection neither altered the
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template capability of the chromatin nor the ability of the 
polymerases to function on endogenous or exogenous 
templates. Measurements of the number of active RNA 
polymerases, however, clearly indicated there was a 
substantial loss in the number of RNA polymerase II (polll) 
molecules engaged in chain elongation. In contrast RNA 
polymerases I and III (poll, polIII) were found to be 
inhibited later in infection.
Primary transcription of the VSV genome has been shown 
to be necessary for the inhibition of cellular RNA synthesis 
(Week and Wagner, 1979a; Wu and Lucas-Lenard, 1980).
However, studies with UV inactivated virus, carried out by 
Week et al (1979), demonstrated that transcription of only a 
small portion at the 3' end of the genome is required for 
inhibition of host RNA synthesis. The only viral product 
they detected was a non-adenylated low molecular weight RNA 
species and so they proposed that leader RNA is the factor 
responsible for shut-off of host cell RNA synthesis. The 
results from several studies support this idea.
McGowan et al (1982) using the in vitro transcription 
system of Manley (1980) demonstrated that although all VSV 
mRNAs could inhibit transcription in vitro at high 
concentrations only the small VSV plus strand leader was 
inhibitory to both polll and polIII at low concentrations. 
Kurilla et al (1982) showed that leader RNA is transiently 
associated with the nucleus early in infection. It is in 
the nucleus that an inhibitor of transcription initiation 
would be expected to act. In addition, Grinnell and Wagner 
(1983) examined the kinetics of leader RNA production in 
cells injected with UV inactivated virus. They showed that
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leader RNA is the only viral product whose level correlated 
with the degree of RNA synthesis inhibition.
The question of how leader RNA shuts off host RNA 
synthesis is unanswered. The leader RNAs of both serotypes 
and five strains of VSV have been sequenced (Colonno and 
Banerjee, 1978a, 1978b; Keene et al , 1980; Giorgi et al ,
1983). In terms of regulatory sequences there are several 
regions of interest. Comparison of the nucleotide sequences 
of the leader RNAs of VSV NJ and VSV IND shows that there is 
an AU-rich region of approximately 16 nucleotides beginning 
18 nucleotides from the 5' end. This region has been 
suggested to resemble the TATA or Goldberg-Hogness box 
(Baker and Ziff, 1981; Gruss et al , 1981; Hu and Manley, 
1981) and is presumably involved in RNA polymerase II 
initiation. There is a purine-rich region at the 3' end of 
the leader RNA and McGowan et al (1982) suggested that it 
resembles the deoxynucleotide sequence implicated in RNA 
polymerase binding (Breathnach et a l , 1978; Jelinek et a l , 
1980). Kurilla and Keene (1983) have found that VSV leader 
RNA can be immunoprecipitated with antisera against the La 
protein. It is a possible polIII transcription factor which 
is bound to polIII precursor RNA (Rinke and Steitz, 1982). 
The association of leader with La protein requires the 
presence of the 3' purine-rich nucleotides.
Grinnell and Wagner (1984) demonstrated the presence 
of an apparent stem-loop structure that contains the AU-rich 
region of VSV leader RNA which appears to be important in 
the efficiency of transcription inhibition. Using a cDNA 
recombinant of the leader RNA and defined synthetic
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oligodeoxynucleotides they showed that the AU-rich region 
alone was capable of inhibiting adenovirus transcription 
directed by both polll and polIII.
Grinnell and Wagner (1983) compared the ability of the 
leader RNAs from VSV NJ and VSV IND to inhibit cellular 
transcription in vivo and in vitro. The leader RNA of VSV 
NJ was found to be significantly more effective in this 
respect. Although the nucleotide sequences from the two 
leader RNAs are very similar (75% homology) most nucleotide 
differences occur in the AU-rich region. It could be that 
the leader RNA of VSV NJ is capable of forming a more stable 
stem-loop structure and so it is more efficient. The 
available evidence all points to this AU-rich region being 
very important.
In summary, inhibition of cellular transcription by 
VSV is caused by decreased initiation by cellular RNA 
polymerases. This effect is mediated by leader RNA which 
appears to be a small nuclear RNA capable of regulating 
transcription in a sequence specific manner.
B • DNA Synthesis
The ability of VSV to inhibit cellular DNA synthesis 
has not been studied in great depth. By measuring the rates
of host DNA, RNA and protein synthesis in the same infected
cells it seems unlikely that inhibition of host DNA 
synthesis is secondary to the other two processes (McGowan 
and Wagner, 1981). Studies reported by McGowan and Wagner 
(1981) and elsewhere (Week et al , 1979; Week and Wagner,
1978, 1979a, 1979b) strongly suggest that the same VSV
function is involved in host DNA and RNA shut-off.
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Experiments with _ts mutants and DI particles suggest that at 
least primary transcription of the VSV genome is required 
for inhibition of host DNA synthesis and UV inactivation 
studies showed that the UV target size of the region on the 
VSV genome responsible for inhibition of host DNA and RNA 
synthesis is very similar (McGowan and Wagner, 1981).
The cellular target for VSV inhibition of DNA 
synthesis has not yet been located. The studies of McGowan 
and Wagner (1981) rule out the possibility of a viral effect 
on nucleoside transport, DNA degradation, inactivation of 
DNA polymerase and thymidine kinase, and premature 
termination of already initiated DNA chains. By exclusion 
they hypothesise that DNA synthesis is inhibited by the 
blocking of DNA replication in a manner similar to VSV 
inhibition of transcription (Week and Wagner, 1979a).
This is an area which requires more work to test if 
indeed the same VSV function inhibits both processes and 
then to identify the specific cellular target involved.
C. Protein Synthesis
Although inhibition of host RNA and DNA synthesis 
might share a common route it is clear that the mechanism of 
host protein synthesis inhibition is different. The UV 
inactivation experiments of Marvaldi et al (1977) showed 
that transcription of the VSV genome as in the other two 
processes, was required for inhibition of host protein 
synthesis. However, similar studies by Marvaldi et al 
(1978) indicated that the region of the VSV genome 
responsible for host protein synthesis inhibition was bigger 
than that required for the other two processes. Marvaldi ejt
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al (1978) showed that newly synthesised N protein (and 
possibly NS) was required for the inhibition of host protein 
synthes i s .
Host protein shut-off must be selective because the 
cellular translational machinery cannot be totally 
abolished. The virus must alter the specificity so that 
viral mRNA is translated in preference to cellular mRNA. It 
has been shown that VSV inhibition of host protein synthesis 
takes place at the level of translation (Lodish and Porter, 
1980). Lodish and Porter (1980) showed that after infection 
cellular mRNA remains intact and fully functional in in 
vitro translation systems. However, it is translated in the 
cell at a decreasing rate. Several different mechanisms 
have been proposed to explain this translational control. 
Nuss et al (1975) suggested that VSV mRNA might be able to 
initiate protein synthesis more efficiently than cellular 
mRNA thus out-competing mRNA for ribosomes. Stanners et al 
(1977) proposed that a specific viral gene product (which 
they termed p) is required for the inhibition. Their 
evidence was that infection of L cells with a mutant of the 
HR (Winnipeg) wild-type isolate of VSV IND did not result in 
the inhibition of protein synthesis as observed with 
wild-type virus (Stanners et a l , 1977).
Lodish and Porter (1980, 1981) concluded that host 
protein synthesis inhibition was due primarily to 
competition for ribosomes by a large excess of viral mRNAs. 
Schnitzlein et al (1985) tested this hypothesis by 
regulating the extent of VSV mRNA synthesis by the use of DI 
particles. The data indicated that competition for cellular 
ribosomes was not the major factor in host protein synthesis
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inhibition. Using the tsG22 mutant (defective in 
replication but not primary transcription) Schnitzlein et al 
(1983) showed that tsG22 inhibits host cell protein 
synthesis to the same extent as wild-type virus even though 
it generates only 30-50% of the amount of viral mRNA of 
wild-type virus.
Recently Adam et al (1986) studied the interaction of 
mRNA with proteins in VSV infected cells by photochemical 
cross-linking in intact cells. Photochemical cross-linking 
and immunoblotting of these proteins showed that in addition 
to host proteins VSV mRNAs also became cross-linked to the N 
protein (Adam et al , 1986). The UV cross-linking data taken 
together with work by Rosen et al (1982) and Grubman and 
Shafritz (1977) who had previously demonstrated that VSV 
mRNAs are associated with N protein, strongly suggest that N 
protein mRNA complexes do exist in the infected cell. The N 
protein associated with VSV mRNA has been shown to inhibit 
protein synthesis in a rabbit reticulocyte lysate and wheat 
germ extract (Rosen et a l , 1984). The inhibition appears to 
be at the first step of protein synthesis, the formation of 
the complex eIF-2.GTP.Met-tRNA (Rosen et al, 1984). The N 
protein may therefore be involved in the shut-off of total 
protein synthesis in VSV infected cells (Adam et al , 1986).
10. PSEUDOTYPES AND PHENOTYPIC MIXING
Double infection of one cell with two different 
viruses often results in the formation of pseudotypes - 
these are viruses which have the genomes of one virus and 
the coat proteins of the other. The phenomenon was first
53
demonstrated for VSV using the IND serotype and the 
paramyxovirus SV5 (Choppin and Compans, 1970). Phenotypic 
mining, in one direction at least, has been recorded 
between VSV and nine out of the ten families of enveloped 
viruses. Pseudotype-like particles have been produced in 
vitro by adding VSV NJ serotype envelope components to 
either bromelain- or pronase-treated VSV IND serotype 
particles (Bishop et al , 1975).
All of the methods for detecting pseudotypes and 
phenotypically mixed particles depend on selective assays 
for genomes and envelopes. Pseudotypes containing the VSV 
genome can be recognised by their resistance to 
neutralisation by anti-VSV serum, sensitivity to antiserum 
specific for the virus donating the envelope antigens, 
complement mediated virolysis, immunoprecipitation, 
acrylamide gel electrophoresis analysis of constituent 
proteins, immunoelectron microscopy and various other tests 
depending on the properties of the envelope proteins 
(Zavada, 1972; Zavada and Rosenbergova, 1972; Zavada et a l , 
1975; Boettiger et a l , 1975; Weiss and Bennett, 1980; Witte 
and Baltimore, 1977; McSharry et a l , 1971; Choppin and 
Compans, 1970; Chan et al, 1978). Pseudotypes containing 
the VSV glycoprotein and the genome of other viruses can be 
analysed by similar means.
Pseudotypes are valuable tools to answer 
experimentally a variety of questions which arise in the 
study of viruses. Indeed the screening for pseudotypes with 
the genome of VSV and the envelope of a heterologous virus 
has proved to be an extremely sensitive method for detecting 
cryptic or latent viruses eg. chick helper factor in avian
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cells (Love and Weiss, 1974); or as a rapid quantitation 
assay for slow or non-cytopathogenic viruses eg. Wild et al 
(1975) demonstrated VSV pseudotype formation in Vero cells 
infected productively or latently with measles virus strains 
isolated from patients suffering subacute sclerosing 
panencephalitis. The sensitivity of the method can be 
increased using immunoprecipitat ion with Staphylococcus 
aureus rather than neutralisation as a detection system 
(Zavada et a l , 1983). Analysis of pseudotype production has 
been used as a quantitative procedure for detection assays 
of bovine leukaemia virus, mouse mammary tumour virus and 
human T lymphotropic virus types I and II (Zavada et a l , 
1979; Bruck et al , 1982; Chan et a l , 1982; Clapham et al , 
1984). Reciprocal formation of pseudotypes between VSV and 
lymphocytic choriomeningitis virus (LCMV) were used to study 
acute and persistent infections of cell cultures and mice 
with LCMV (Bruns and Lehmann-Grube, 1984).
11 * VIRAL PERSISTENCE
Persistent infections by RNA and DNA viruses have been 
implicated as important factors in a number of chronic or 
recurring diseases of man and animals (Stevens et a l , 1978; 
Fields et al , 1980). The mechanisms by which RNA viruses 
are able to establish and maintain persistent infections are 
not understood but a number of factors seem to be important 
eg. the appearance early in such infections of t_s mutants; 
interferon regulation of t_s mutant growth; small plaque 
mutations; DI particles (Preble and Younger, 1973; Fields 
and Raine, 1974; Younger et a l , 1976; Ramseur and Friedman,
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1977; Nishiyama et a l , 1978; Wagner et a l , 1963; Holland and 
Villarreal, 1974; Kawai et al, 1975; Ahmed and Graham, 1977; 
Popescu and Lehmann-Grube, 1977; Elliott and Wilkie, 1986).
Extensive genetic changes occur in VSV maintained in 
persistently infected cells or passaged for a period at high 
multiplicity. Holland and Villarreal (1974) established a 
persistent infection of BHK-21 cells using a bs mutant of 
VSV IND. They analysed the infection by oligonucleotide 
mapping and nucleotide sequencing over a number of years 
(Holland et a l , 1979; Rowlands et a l , 1980; Semler and 
Holland, 1979). They found that the highly mutated virus 
clones they isolated following years of persistence 
exhibited considerable genome stability upon repeated lytic 
passages in cell culture or in vivo in mice (Holland et a l , 
1979; Rowlands et al , 1980). There are other virus-host 
cell systems which have been shown to involve the evolution 
of viruses eg. VSV in L cells (Youngner et al, 1978) and 
Semliki forest virus in L cells (Meinkoth and Kennedy,
1980).
Spindler et al (1982) demonstrated that rapid genome 
evolution of VSV clones can occur equally well during lytic 
high-multiplicity passages as during long term persistence. 
They also demonstrated that this genome evolution is random 
and not determined by selective pressures.
A number of interesting and potentially useful mutants 
have been isolated from persistent infections. Virus stocks 
isolated from two persistently infected mouse L cell lines 
expressed an altered phenotype of RNA synthesis (rt“ ) from 
the viruses used to initiate the infection (rt+ ) (Fray and 
Youngner, 1982). At 34QC and 37oc in L cells productively
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infected with the stocks derived from the two cell lines, 
mRNA transcription was significantly reduced whereas 
replication of genomic RNA was enhanced compared to the 
viruses used to initiate the infection. The results from 
further analysis of these persistent infections demonstrated 
that a specific viral phenotype (ts~, rt” ) evolved and was 
stable over a period of at least three years, which was the 
longest period tested (Frey and Youngner, 1984).
Reid et al (1979) isolated a mutant of VSV (VSV-P) 
from a persistent infection of tumour cells in nude mice. 
BHK-21 cells infected with VSV-P are resistant to natural 
killer (NK) cells in vitro and form tumours in nude mice, 
while BHK-21 cells persistently infected with wild-type VSV 
are sensitive to NK cells in vitro and do not form tumours 
in nude mice (Minato et al, 1979). oligonucleotide maps
showed that VSV-P underwent extensive mutation during its 
selection in vivo in persistently infected BHK-21 cells, and 
subsequent nude mouse passaging of BHK-21 cells persistently 
infected with VSV-P revealed continuing rapid evolution of 
VSV-P in vivo (Jones et al, 1980; Spindler et al , 1982). 
There has been extensive nucleotide sequence analysis of 
antibody-selected variants of a variety of RNA viruses and 
these have shown that the mutations are associated with 
antibody-binding epitopes in the viral glycoproteins (Wiley 
et a l , 1981; Seif et a l , 1985; Skehel et al , 1984; 
Dietzschold et a l , 1983; Hovenac and Air, 1985). Vandepol 
and Holland (1986) sequenced the RNA of three independently 
derived VSV-P mutants. The results show that these NK cell 
resistant mutants selected in vivo accumulated extensive 
mutations in the surface G protein but only relatively few
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changes in the M and NS proteins. This suggests, but does 
not prove, that G protein plays an important role in NK cell 
lysis .
A problem in the study of persistent viral infections 
in vivo when _ts viruses are involved has been the 
development of procedures for reisolating viruses after 
infection. However, Hughes et al (1985) isolated t£ mutants 
of VSV after passage of the mutant tsG31 by a series of 
intracerebral inoculations in mice by inducing hypothermia 
in the animals. They injected the neuropeptide bombasin to 
unbalance the normally stable thermoregulatory system of the 
animal. If this procedure proves useful for the isolation 
of other viruses then it could provide a valuable and quite 
unique method for studying various aspects of persistence.
12• VSV AND INTERFERON
Rhabdoviruses are very sensitive to the action of 
interferon. They rank close to the highly sensitive 
togaviruses and are on par with vaccinia virus in many test 
systems (Lockart, 1973). VSV is often used as the test 
agent in biological assays of interferon (Finter, 1973). 
Indeed, this sensitivity of VSV to interferon action, its 
broad host range and the knowledge of certain aspects of its 
molecular biology have made it an excellent model for the 
study of interferon mediated interference.
In cells pretreated with interferon there is no 
detectable accumulation of primary transcripts. In these 
same cells neither amplified RNA synthesis nor virus protein 
synthesis can be detected (Marcus and Sekellick, 1978;
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Thacore, 1978; Marcus, 1980). The virus transcripts found 
in interferon-treated cells are equal in size and have the 
same half-life as in untreated cells which suggest that once 
transcription is initiated in interferon-treated cells it is 
completed as normal (Marcus and Sekellick, 1978). It has 
been reported that the host cell might influence sensitivity 
to interferon. Wagner et al (1963) demonstrated that two 
strains of VSV were inhibited to different degrees by 
interferon acting in mouse L cells but showed the same 
sensitivity in chicken cells. Thacore (1978) came to 
similar conclusions from his experiments in which he used 
different interferons and cell types.
VSV is not considered to be a very efficient inducer 
of interferon. It could be that an interferon inducing 
factor is not produced in sufficient quantities as to be 
sensed by the cell or the characteristic efficient shut-off 
of cellular macromolecular synthesis precludes interferon 
mRNA transcription and/or translation (Wertz and Youngner, 
1970; Wagner and Huang, 1966; Yamazaki and Wagner, 1970;
Week and Wagner, 1978; Marvaldi et al , 1977, 1978; Stanners 
et a l , 1977). Studies using DI particles and J^ s mutants 
have shown that under non-replicating conditions when 
inhibition of cellular protein synthesis and cell killing 
are delayed or prevented, VSV is an excellent inducer of 
interferon (Marcus and Sekellick, 1977; Marcus, 1980). Work 
by Sekellick and Marcus (1979) has indicated that 
transcription of a small part of the genome is required for 
interferon induction. This is presumably required to form 
double-stranded RNA complexes.
Interferon action is the singularly most effective
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means of preventing cell killing by viruses and recent work 
has implicated interferon induction as a means of cell 
sparing in persistent infection with VSV (Marcus, 1980).
13. DEFECTIVE INTERFERING PARTICLES
Defective interfering (DI) particles of VSV are 
deletion mutants which contain only a portion of the 
parental genome and interfere specifically with standard 
virus replication (Huang and Baltimore, 1970). They are not 
capable of self-replication in host cells but require 
coinfection with competent helper virus which supplies the 
missing gene products. Under these conditions the 
replication of helper virus is greatly suppressed - this 
phenomenon is termed autointerference or the von Magnus 
phenomenon (von Magnus, 1954). Available evidence strongly 
suggests that DI particles interfere with replication of 
helper virus by favourably competing for the limited amount 
of polymerase or nucleocapsid protein supplied by the helper 
vi rus .
Four classes of DI particle genome can be 
distinguished and these are shown in Figure 1.8. The four 
classes have been designated fusion, panhandle, snapback and 
compound (Lazzarini et al, 1981; Perrault, 1981). The four 
types share certain features - variable portions of the L 
gene are deleted; the 5 ’ terminal regions of the deleted 
genomes are identical in sense and sequence to the 5' 
terminus of the minus strand of the complete genome; the 3' 
terminal regions are identical to the 5 ‘ terminus of either 
the minus or plus strand region of the complete genome.
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(i ) Fusion
The fusion DI particles are simple deletion mutants. 
The best characterised example of this type of DI particle 
in VSV contains the genetic information from the 3' half of 
the parental genome (Leamnson and Reichmann, 1974;
Stamminger and Lazzarini, 1974). The DI particle appears to 
be a true deletion mutant in which most of the L gene has 
been deleted. Hybridisation studies and direct sequencing 
have established the presence of both parental viral RNA 
termini on this DI particle RNA (Perrault and Semler, 1979; 
Epstein et a l , 1980). Because the parental 3' terminus is 
preserved the viral polymerase can transcribe the DI 
particle genome yielding four functional mRNAs (Colonno et_ 
al, 1977; Johnson et a l , 1979). The ability to transcribe 
its genome is unique amongst DI particles and may confer on 
it special biological properties (Prevec and Kang, 1970; 
Marcus et al , 1977).
(ii) Panhandle
The genome of the panhandle DI particle contains 
information from the 5' half of the parental VSV genome but 
terminates at the 3 ‘ end with a short complementary 
sequence. The first evidence for this type of configuration 
came from electron microscope studies which showed that the 
major class of VSV and Sendai virus DI particle appeared as 
unit length circles suggesting that the RNA had 
complementary termini (Kolakofsky, 1976; Perrault and 
Leavitt, 1977). Hybridisation studies subsequently showed 
that the parental 5' terminus was preserved in this class of
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DI particle RNA indicating that the 3 ‘ terminus of the DI 
particle was different from that of the parent virus 
(Leppert et a l , 1977; Perrault et a l , 1978). RNA sequencing 
studies confirmed not only the presence of a complementary 
sequence at the 3' end but also the structure (Keene et a l , 
1978; Schubert et a l , 1978; 1979; Semler et a l , 1978).
(iii) Snapback
Like the panhandle class of DI particle the genome of 
the snapback class contains information from the 5' half of 
the parental genome but instead of terminating in a short 
complementary sequence at its 3' terminus it is linked to an 
exact complement so that every base has the potential of 
entering into a duplex. The prototype of this class of 
molecule is the VSV DI-1011 (Lazzarini et a l , 1975). When 
the molecule is deproteinised the RNA has been shown to snap 
into a perfect duplex (Schubert and Lazzarini, 1981). The 
snapback class of DI particle has frequently been found 
among the progeny of VSV infections (Lazzarini et al , 1975; 
Perrault, 1976; Perrault and Leavitt, 1977; Gillies and 
Stollar, 1980).
(iv) Compound
The genome of the compound class of DI particle 
contains multiple initiation sites at the 3' terminus of its 
RNA. The prototype of this class is again a VSV DI particle 
- DI-LT2 . DI-LT2 was discovered in the original seed stocks 
of the fusion DI particle, DI-LT. Evidence has suggested 
that DI-LT2 was derived from DI-LT (Epstein et al, 1980; 
Perrault and Semler, 1979). Keene et al (1981) determined
the 3' terminal base sequence of the DI-LT2 RNA. They found 
that the 3' end of the RNA was the exact complement of the 
5' end of the VSV RNA for 70 nucleotides. After base 71 
they found the 3' end of the non-defective genome was 
present. The non-defective sequence includes the entire 
leader gene# the intervening sequence and the beginning of 
the N gene. Although sequencing data do not extend beyond 
this point hybridisation studies indicate that the DI-LT2 
RNA contains most, if not all, of the genetic information 
from the 3' half of the VSV genome (Epstein et al , 1980; 
Perrault and Semler, 1979). Unlike its presumed parent, 
DI-LT2 is not transcriptionally active and the internal 
leader gene is muted (Keene et al , 1981). The difference in 
transcriptional abilities between DI-LT and DI-LT2 is 
paralleled by a difference in their ability to interfere 
with wild-type VSV (Perrault and Semler, 1979).
There are a number of factors which affect the 
generation of DI particles. Most important amongst these is 
the nature of the host cell, time of harvest and 
multiplicity of infection. Holland et al (1976) showed that 
some cell types produce more DI particles than others. When 
they infected cells with a mixed population of DI particles 
they found that the predominant type in the progeny varied 
between cell types. The biochemical basis for the host 
effect is unknown but a number of studies, as already 
mentioned, have pointed to the involvement of host factors 
in VSV replication (Nowakowski et al , 1973; Obijeski and 
Simpson, 1974; Szilagyi et al, 1977; Szilagyi and Pringle,
1978) .
DI particles are released from cells at a slower rate
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than standard virus and so harvesting early after infection 
selects against DI particles (Khan and Lazzarini, 1977). 
This slow release of DI particles does not appear to result 
from restricted replication of the RNA since DI 
nucleocapsids are abundantly present in cells infected with 
a mixture of viruses. It suggests, however, that the 
assembly of the DI particle might be the limiting factor.
Generally it is true that infecting at high 
multiplicity favours DI particle generation. DI particles 
are most often observed in virus stocks that have been 
passaged at high multiplicity. Faulkner and Lazzarini 
(1980) reported that infecting at multiplicities below 
lpfu/cell usually selects against DI particles.
The exact mechanism by which DI particles interfere 
with the replication of standard virus is unclear. Data 
suggest that the presence of DI particles does not affect 
viral transcription and translation directly but rather 
interferes with the synthesis of nucleocapsid template for 
secondary transcription (Perrault and Holland, 1972; Khan 
and Lazzarini, 1977; Stamminger and Lazzarini, 1977). It 
was found that although the total amount of intracellular 
nucleocapsid RNA was almost unaffected by autointerference, 
the composition of the nucleocapsid material changed 
dramatically with increased levels of autointerference. 
Higher proportions of DI nucleocapsids were found in cells 
exhibiting high levels of autointerference (Khan and 
Lazzarini, 1977; Stamminger and Lazzarini, 1977).
Although the study of DI particles has limited the 
number of possible mechanisms of autointerference it has 
not, as yet, pointed to a particular mechanism. It is
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possible that all the mechanisms contribute in varying 
degrees to autointerference (Huang, 1982). The copy choice 
model for the generation of DI particles in VSV suggests 
that during replication the polymerase prematurely 
terminates, moves with the nascent daughter strand to 
another site on the same or different template molecule, and 
resumes elongation of the nascent strand (Lazzarini et a l ,
1981). Meier et al (1984) analysed the sites where 
premature termination or resumption of replication had 
occured during the generation of representatives from the 
fusion, snapback and panhandle classes of DI particle. The 
sequence of the relevant regions of the DI particle RNAs 
were compared with that of the VSV L gene (Schubert et a l , 
1984) in order to identify the sites of recombination. 
Although homology between these sites was not detected 
(ruling out the existence of a general terminator or 
promoter sequence involved in copy-choice replication) it 
was found that in many cases premature termination or 
resumption of RNA replication might be favoured by specific 
sequences. It has been proposed that specific sequences 
modulate DI particle generation in a quantitative way and 
favour the generation of certain types of DI particle genome 
eg. those of the panhandle type.
In general DI particles can efficiently interfere with 
the replication of virions of the homologous serotype but 
are incapable of heterotypic interference (Schnitzlein and 
Reichmann, 1977). However, Prevec and Kang (1980) reported 
that the HR-DI particle of VSV IND serotype (which contains 
sequences from the 3' terminus of the parental genome) can 
interfere as efficiently heterotypically as homotypically.
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The study of the structure and origin of DI particles 
is important not only because of their proposed importance 
in the establishment and maintenance of persistent infection 
(Holland et a l / 1980; Holland and Villarreal, 1974;
Horodyski and Holland, 1984) but also because they arise 
from aberrant replicative events. Their study might 
therefore reveal some much needed details on the mechanism 
of replication.
14. VSV GENETICS
In the study of virus growth and development the 
isolation of mutants has proved an invaluable tool. Much of 
the study on rhabdoviruses has concentrated on this area 
with the result that there are now hundreds of mutants 
available for study. However, the field of VSV genetics has 
become both confused and confusing and since much has 
already been written (reviews by Flamand, 1980; Pringle,
1975, 1977, 1982, 1985; Pringle and Szilagyi, 1980) I intend 
to write only briefly on the subject concentrating mainly on 
the characterised mutants of VSV NJ serotype (see Table 
1.4) .
Pringle (1977) divided the known mutants of VSV into 
two broad categories: those with specific phenotypes and
conditional lethal mutants where a common phenotype embraces 
many if not all indispensable genome functions. The _t_l 
mutants of VSV IND where the phenotype is due to the 
thermosensitivity of the virion envelope (Zavada, 1972) or 
the Rif + mutants where the drug rifampicin appears to 
directly inhibit transcriptase activity (Moreau, 1974) are
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examples of the former. The conditional lethal mutants of 
rhabdoviruses are either temperature sensitive (t_s) , host 
restrictive (hr) or temperature dependent host range (tdCE) 
mutants. The majority of the conditional lethal mutants of 
VSV appear to arise from 'missense' mutations. However, 
recently a new class of mutant, the supressor sensitive 
'nonsense' mutants have been is o|a ted (B. White, unpublished 
results). Wild-type VSV IND serotype was mutagenised using 
the base analogue 5-fluorouraci1 (5-FU) and 'nonsense' 
mutants were detected by assaying growth on suppressing and 
non-suppressing cell lines.
Due to the ease by which they can be assayed the _ts 
mutants have been extensively used in the study of many 
aspects of the rhabdovirus lifecycle.
With the exception of 71 spontaneous _ts mutants 
isolated from VSV IND by Flamand (1970) the t_s mutants of 
VSV have been derived using one of several mutagens - 5-FU, 
5-azacytidine and ethylmethane sulphonate. 5-FU was the 
most efficient mutagen producing 105 of the 175 t_s mutants. 
The 436 mutants of VSV IND are classified into six 
complementation groups I-VI. Unambiguous gene assignments 
have been completed for five of the complementation groups 
and each of the five viral proteins is represented (Pringle 
and Szilagyi, 1980). It is thought that the sixth 
complementation group, which comprises mutants isolated by 
Flamand (1980) and Rettenmier et al (1975), probably 
represent intragenic complementation (Pringle and Szilagyi, 
1980) .
The 48 t_s mutants isolated from VSV NJ, Hazelhurst 
subtype have been classified into six non-overlapping
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complementat ion groups designated A-F. The sixth 
complementation group has been postulated to represent a 
sixth, non-structural, virus encoded protein involved in 
replication (Lesnaw and Reichmann/ 1975). However/ analysis 
of the functional properties of tjs mutants from three 
rhabdoviruses (Chandipura virus, VSV IND and N J ) and the 
complete sequencing of the genome of VSV IND has borne out 
the prediction by Gadkari and Pringle (1980) that the 
presence of a sixth complementation group does not imply the 
existence of a sixth genome product.
Analysis of the functions of representative mutants of 
VSV NJ has suggested the mutants classified in 
complementation groups B and F are L protein mutants 
(Ongradi et al , 1985b). The four remaining viral proteins 
can be assigned to complementation groups A, C, D and E. 
Conclusive gene assignments have been made using techniques 
such as gel electrophoresis of virion proteins, partial 
proteolysis, tryptic peptide mapping, in vitro dissociation 
and reconstitution of transcriptase assay, and heteroduplex 
mapping.
A. Complementation Groups of the VSV NJ Mutants 
(i ) Group A
The _t£ lesion in complementation group A has been 
assigned to the N protein. The assignment was made on the 
basis of the thermolability of the template activity of the 
Al N-RNA complex in in vitro transcription reactions and the 
covariance of the phenotype with the _t_s phenotype in a 
spontaneous Al revertant (Marks et a l , 1985).
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(i i ) Groups B and F
The mutation in complementation groups B and F was 
thought to be in the L gene (Bell-Isle and Emerson, 1980; 
Szilagyi and Pringle, 1979; Pringle and Szilagyi, 1980). 
Conclusive proof that the mutation was in the L gene was 
provided by Ongradi et al (1985b). Ongradi et al (1985b) 
used reconstitution assays to positively identify the L gene 
as the location of the mutation.
Since the gene encoding the L protein occupies 
approximately half of the VSV genome it is not surprising 
that in both the IND and NJ serotypes the complementation 
group with the largest number of members are those with 
mutations in this protein.
(iii) Group C
Initially the mutation in complementation group C was 
tentatively assigned to the M protein on the basis of the 
similar cytopathology of the mutants to the complementation 
group III mutants (lesion in M gene) of VSV IND (Unger and 
Reichmann, 1973). Positive identification of the gene in 
which the mutation lay was made by analysis of in vivo 
degradation and peptide mapping (Kennedy-Morrow and Lesnaw,
1984).
(iv) Group D
There is, as yet, no positive assignment made for 
complementation group D. Pringle et al (1981) observed that 
one member of the group, tsDl, exhibited an enhanced 
mutability whereby clones showed a variety of phenotypes
Assignment of the complementation group D mutants to the G 
gene (Table 1.4) is based on exclusion only.
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involving N, G and NS proteins. When tsDl is incubated at 
the restrictive temperature an absence of nucleocapsid 
assembly and an abnormally high ratio of genome length to 
mRNA is observed (Pringle et a l , 1981). Because the two 
processes appear to be coupled the major phenotypic changes 
could be accounted for by mutations in the L or N genes.
(v ) Group E
The mutations affecting mutants of complementation 
group E have been shown to be located on the NS gene by gel 
electrophoresis of virion proteins (Evans et al, 1979;
Lesnaw et a l , 1979); in vitro reconstitution studies 
(Ongradi and Szilagyi, 1981; Ongradi et al, 1985a); and 
tryptic peptide mapping data (Maack and Penhoet, 1980).
There are three mutants in this group (t sEl, t sE2, t sE3) and-^«- 
are of interest not only because of their aberrant migration 
on SDS polyacrylamide gels but also because of their very 
different phenotypes. They will be discussed in more detail 
in later sections.
B . Mapping of Mutations
The efficient techniques for cDNA cloning of viral RNA 
and the methods of rapid sequencing of DNA now available 
have made more definitive studies of the well characterised 
mutants possible. The mutant tsQ45, a spontaneous mutant 
isolated by Flamand (1970), is probably the best 
characterised mutant of the complementation group V of VSV 
IND and one which has been extensively used in the study of 
the viral glycoprotein. The mutant has a reversible block 
in transport of the G protein from the rough ER to the Golgi
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apparatus (Bergman et al , 1981). By firstly sequencing cDNA 
clones, then recombining them in vitro and expressing the 
recombinants in COS-1 cells, Gallione and Rose (1985) were 
able to localise the critical lesion in tsQ45 to a single 
substitution of a polar amino acid (serine) for a 
hydrophobic amino acid (phenylalanine) in a hydrophobic 
domain. It is important that the analysis be extended to 
other mutants so that the lesions can be localised and the 
functional domains of the proteins identified.
15. RECOMBINANT DNA TECHNOLOGY AND RNA VIROLOGY
The bulk of our current knowledge of the molecular 
biology of RNA viruses has come from the application of 
recombinant DNA technology in their study. Techniques such 
as cDNA cloning, sequence determination and the ability to 
express the cDNA clones in eukaryotic and prokaryotic cells 
have allowed workers to make detailed studies on such 
diverse topics as genome evolution and protein function.
The discovery of the retroviral enzyme, reverse 
transcriptase, capable of synthesising DNA (copy DNA or 
cDNA) from an RNA template (Baltimore, 1970; Temin and 
Mizutani, 1970) and the steady advances in sequence 
technology over the last 15-20 years (Sanger et al, 1983; 
Maxam and Gilbert, 1980) have led to the generation of the 
great amount of sequence data now available. Table 1.5 
lists some of the genomes that have been completely 
sequenced. The sequence data alone have proved invaluable 
in the analysis of many aspects of the virus lifecycle.
Sequence data have highlighted the heterogenous nature
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of the RNA virus genome. Schubert et al (1984) found a 
number of variants in cDNA clones of the VSV L gene derived 
from plaque-purified virus. Variants were also detected in 
a cDNA library derived from the tobacco mosaic virus (TMV) 
RNA, indeed variants were detected in related TMV stocks 
obtained from different laboratories (Goelet et al, 1982). 
Recently, Buonogurio et al (1986) used sequence analysis to 
study the evolution over a 50 year period of the NS gene of 
influenza A virus.
The first report of an RNA virus using overlapping 
reading frames was made with influenza virus (Lamb and Lai, 
1980; Lamb et a l , 1981). The phenomenon has since been 
shown to occur in Sendai virus (Giorgio et al, 1983); 
bunyaviruses (Cabradilla et al , 1983) and arenaviruses 
(Akashi and Bishop, 1983). Members of the family 
Arenaviridae and the Phlebovirus genus of the Bunyaviridae 
have been shown to possess 1ambisense' RNA ie. genes are 
encoded in both negative and positive senses (Auperin et a l , 
1984; Romanowski et al, 1985; Ihara et al , 1985).
A number of glycoprotein genes have been sequenced and 
the data have been useful in identifying regions important 
to transport and surface expression. Lees et al (1986) 
sequenced Bunyamwera virus M RNA which encodes the virion 
glycoproteins and a non-structural protein. They found a 
single open reading frame sufficient to encode a 
polyprotein. Comparison of the sequence with the M RNA of 
snowshoe hare virus (Eshita and Bishop, 1984) revealed quite 
marked sequence and structural similarities between the 
genes and gene products of these related but antigenically 
distinct bunyaviruses (Lees et al , 1986). Satake et al
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(1985) calculated a mol wt of 32,588 from their sequence 
data on the G protein of respiratory syncytial virus. The 
previously estimated mol wt of 90,000 from the proteins 
mobility on gels can be at t r ibut ed -te> the fact that it is 
heavily glycosylated with a number of the sugars attached by 
O-glycosylations.
In many cases sequence data serve to emphasise the 
differences between viruses even in the same family. The 
fish rhabdovirus, IHNV, was recently shown to encode six 
mRNAs as opposed to five mRNAs as in the prototype 
rhabdovirus, VSV (Kurath and Leong, 1985; Leong et al ,
1985). Four viruses which cause acquired immune deficiency 
syndrome (AIDS) have now been completely sequenced (Muesing 
et a l , 1985; Ratner et al, 1985; Sanchez-Pescador et a l , 
1985; Wain-Hobson et al , 1985). Analysis of the sequence 
data not only emphasises the variability between related 
viruses but has also led to the proposal that AIDS virus be 
reclassified as a lentivirus due to its similarity to visna 
virus, the prototype member of the family Lentiviridae 
(Sonigo et a l , 1985).
The genome of yellow fever virus (YFV) was recently 
sequenced (Rice et al, 1985). This was the first report of 
the complete nucleotide sequence of a member of the family 
Flaviviridae. Flavivirus transcription/translation was an 
area of some controversy. Two models had been proposed - 
one involving protein processing; the other multiple 
initiation of mRNAs. The sequence data strongly support the 
idea that the RNA is translated as a large polyprotein which 
is subsequently cleaved (Rice et a l , 1985).
The Picornaviridae is a large family of viruses which
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includes human hepatitis A, many enteroviruses and foot and 
mouth disease virus. The 3-dimensional (3-D) structure of 
two viruses from this group [poliovirus, type 1, Mahoney 
strain and human rhinovirus, type 14 (Hogle et al, 1985; 
Rossmann et a l , 1985)] have now been determined. The large 
amount of sequence data available on these two viruses and 
their mutants will now enable workers to relate nucleotide 
changes to alterations in structure. These types of 
analyses were first employed when the 3-D structure of the 
influenza virus haemagglutinin was elucidated (Wilson et al , 
1981) eg. Daniels et al (1985) were able to relate the 
nucleotide sequence changes in the haemagglutinins of 
amantadine-resistant mutants of influenza virus to 
structural changes in the haemagglutinin of the wild-type 
protein.
From the few examples quoted here it is quite clear 
that the use of recombinant DNA technology has been 
invaluable in the study of RNA viruses. However, there have 
also been practical benefits from its application eg. Hu et^  
al (1986) expressed the envelope (env) gene of one of the 
AIDS viruses in recombinant vaccinia virus in the search for 
a vaccine. They reported that the recombinant viruses 
elicit antibodies that specifically recognise AIDS virus env 
proteins. Denniston et al (1986) reported that a cloned 
cDNA fragment of hepatitis delta virus (HDV) had been used 
as a sensitive radioactive probe for the detection of HDV 
RNA in the serum of patients with either acute or chronic 
HDV infections.
It is quite apparent that recombinant DNA technology 
will become increasingly important in the study of RNA
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viruses as the problems encountered in their study become 
more complex.
75
AIMS OF THIS PROJECT
The complementation group E mutants of VSV NJ, strain 
Missouri have been shown to have a lesion in the NS gene. 
They are of interest because of the different phenotypes 
they possess and the fact that on SDS-polyacrylamide gels 
their NS proteins exhibit a differential migration pattern 
both in relation to wild-type virus and one another. 
Recombinant DNA technology was applied to the analysis of 
the NS genes of wild-type virus and complementation group E 
mutants. The aims of this project were:
(a) to obtain full-length cDNA copies of the NS mRNAs of 
wild-type, complementation group E mutant and revertant 
vi ruses
(b) to determine the nucleotide sequence of the cDNAs
(c) to map exactly the position of the mutation(s) in tsEl, 
tsE2 and tsE3
U P II
A MODEL OF THE VSV STRUCTURE
A
.pi um.
Figure 1.1
(A) Electron micrograph of negatively stained VSV particles 
(magnification 180,000).
(B) Schematic model of the VSV structure. The spiral
ribonucleocapsid is enclosed within the lipid envelope. 
Spikes consisting of G protein project from the 
envelope.
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Figure 1.2
Physical map showing the basic organisation of the VSV 
genome. The size in nucleotides of the 3' and 5' terminal 
regions together with the five genes is indicated. The 
numbers in parenthesis represent the number of nucleotides 
not found in the transcription products (not drawn to 
scale).
(From Pringle, 1986 using data of McGeoch, 1979; Rose, 1980; 
Schubert et a l , 1984; Gallione et a l , 1981; Rose and 
Gallione, 1981).
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Figure 1.3
Examination of sequence data from five plus and minus 
strand leader RNAs revealed that 14 of the first 18 bases 
were conserved and the consensus sequence is shown opposite. 
There is a five times repeated A residue every three bases 
shown opposite. It was suggested that this pattern of A 
residues is important to encapsidation.
(Blumberg, 1983).
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Figure 1.4
Functional domains of the leader region. The leader 
sequence is divided approximately into thirds by three 
sequences - the polymerase initiation and N protein 
sequence, the polymerase contact sequence and the region 
which is homologous to cellular 7S and Alu sequences.
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Figure 1.5
Schematic diagram of the VSV replication cycle 
(Emerson, 1985).
Rhabdovirus replication occurs in two stages. The negative 
sense genomic RNA is transcribed (primary transcription) 
from the extreme 3' end to generate the five viral mRNAs 
which are subsequently translated. When viral protein 
synthesis decreases and full length, plus sense RNA is 
synthesised. The plus sense RNA then acts as template for 
synthesis of full length negative strand RNA which is 
packaged into budding virions or used as template for 
subsequent mRNA synthesis (secondary transcription).
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Figure 1.6
Models of VSV mRNA synthesis. Two models have been 
proposed to explain the monocistronic and sequential 
transcription of the mRNAs. In the multiple entry model 
individual promoters and polymerase entry sites are 
postulated for each gene.
The single promoter model proposes that polymerase 
enters the genome only at the 3' end. Monocistronic mRNAs 
are then generated by cleavage of a full-length precursor or 
by a stop/start mechanism which requires the polymerase to 
initiate and terminate transcription at gene boundaries. 
(Based on Banerjee, 1980).
0
<
<
o
ZD
0
<
o
<
3
3
0
3
O
3
0
%
<
<
O
3
<
<g!<i
$
E
<
E
*ia.aIO
0.N"
E
0 
<  
<  
<  
< 
O 
< 
o
3
0 
3 
< 
< 3 
<! 
0! 
0 
3 
<1
5
<
j 0 i 
I <1 
I Ol 
1 <1
i I ]
I m .
*
• Q  
* QI io I
i0 | 
1 C=‘
I E l
1
I <|
0
3
3
3
<
0
O
<
o
o3
0
<
» < i
^0 ,
0
3
< JO
3
$
i o |
I < 1
i<!il!
I
' n 1 I l, j
!- 
! B
0
0
0
o3
O
3
3
<
0
<
<
0
<
<
<
3
3
O
O
33
0
<
0
3
<
'S'
3
3
<
O
O
3
<
<
O
O
o
3
<
3
3
0
o
UJ 0
<
3
3
O
<
3
0
33
3
3
O
O
0
3
0
<
<
[0]
3
<
3
O
<
0
3
3
O
O
3
33
a
z COz 0
Figure 1.7
The complete sequences of the ribosome recognition 
sites from the five VSV mRNAs. Regions of homology are 
indicated by dashed boxes.

Figure 1.8
Physical maps of VSV genomic RNA and the four classes 
of DI particle RNA.
A = VSV genome RNA 
B = a simple deletion DI particle 
C = panhandle DI particle 
D = compound DI particle 
E = snap-back DI particle 
X and Y' = 3' ends
Y = 5 ' end
Y, Y' and Z, Z' = regions complementary to each other 
N, NS, M, G and L = the 5 VSV mRNAs
The four classes of DI particle are shown in relation 
to the parental virus genome. The VSV genome is not drawn 
to scale. (Based on Lazzarini et al, 1981).
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Table 1.3 Protein Composition of the VS Virion
Protein Mass of Protein 
Present in Virion 
(Megadaltons)
Number of Molecules/ 
Virion
G 75.2 1205
N 59.6 1258
*L 12.1 50
NS* 11.7 466
M* 47.6 1826
Calibration relative to N protein 
Thomas et al (1985)
Table 1.4 Gene Assignments of the Complementation
Groups of VSV Indiana and New Jersey 
Serotypes
Virus Complementat ion 
Group
Assignment
VSV IND I L
II NS
III M
IV N
V G
VI (NS)
VSV NJ A N
B L
C M
D (G)
E NS
F L
( ) indicates that positive gene assignment 
has not been made
Pringle (1986)
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MATERIALS AND METHODS
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1. MATERIALS
A. Chemicals, Reagents and Enzymes
Agarose, Dithiothreitol (DTT), Bovine serum albumin 
(BSA), Tris [hydroxymethyl]-aminoethane (Tris), 
tetracycline, chloramphenicol, lysozyme, 5-chloro-4-bromo-3- 
indolyl-^ -D-galactose (>K£u.j ) , isopropyl-D-thiogalactoside 
were all obtained from Sigma Chemical Company.
Caesium chloride, boric acid and sodium hydroxide were 
purchased from Koch-Light Laboratories.
Formamide was purchased from Fluka AG.
Deoxyribonucleoside triphosphates, dideoxyribonucleoside 
triphosphates, E.coli DNA ligase were obtained from 
Pharmacia P-L Biochemicals.
Sephadex G-50 was purchased from Pharmacia Fine 
Chemicals A-B.
Ammonium persulphate and TEMED were supplied by 
Bio-Rad Laboratories.
Pstl-cleaved G-tailed pBR322 DNA, RNase H, DNA 
polymerase 1, BSA (for use in cDNA synthesis) were supplied 
by Bethesda Research Laboratories.
Terminal transferase was obtained from Amersham.
RNasin was purchased from Anglian Biotechnology. Reverse 
transcriptase was supplied by NBL enzymes. Ampicillin was 
purchased from Beecham Research Laboratories. Ethanol was 
supplied by James Burroughs Ltd. Nitrocellulose was 
supplied by Schleicher and Schuell GmbH.
All tissue culture reagents were supplied by 
Gibco-Biocult except calf serum which was prepared in the 
Institute of Virology.
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All other reagents were of analytical grade and were 
obtained from BDH Chemicals LTd (Acrylamide and 
Methylenebisacrylamide were 'Electran' grade).
B. Solutions
The following solutions were used in the various 
experimental procedures:
NTE lOOmM NaCl, lOmM Tris-HCl pH7.5, ImM EDTA 
PBS 170mM NaCl/ 3.4mM K C1, ImM Na 2HP04 pH7.2 
(Dulbecco and Vogt, 1954)
SSC 150mM NaCl, 15mM tri-sodium citrate
TBE 90mM Tris-HCl, 90mM boric acid, ImM EDTA
TE lOmM Tris-HCl pH7.5, ImM EDTA
50 x Denhardt 1% Ficoll, 1% polyvinylpyrolidine,
1% BSA in 3xSSC
Agarose Gel Buffers: 0.5M Sorenson's citrate buffer (A) 0.5M 
disodium citrate; 40g NaOH, 105g citric acid for 1,000ml (B) 
0.5N HC1.
To make 1,000ml 0.5M Sorenson's citrate buffer pH3.4, 
combine 460ml solution A and 540ml solution B when this 0.5M 
solution is diluted to 0.025M it renders a solution of 
pH3.5 .
Running Buffer: 0.025M citrate buffer pH3.5.
Sample Buffer: 0.025M citrate buffer pH3.5, 6M urea, 20% 
(w/v) sucrose, bromophenol blue.
10M urea stock solution heated, deionised using Amberlite 
MB-1 resin and filtered immediately before use.
[35s]-methionine (specific activity 900Ci/mmol)
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C. Radiochemicals
All radioisotopes were obtained from Amersham 
International Ltd. The specific activities of those used 
were:
[If-32 P] ATP 5, OOOCi / mmol
[<X_32p] dATP 2,000-3,OOOCi/ mmol
dCTP 2,000-3,OOOCi/mmol
dGTP 2,000-3,OOOCi/mmol
dTTP 2,000-3,OOOCi/mmol
[32p]-inorganic orthophosphate (carrier free) was 
supplied by the Western Infirmary, Glasgow.
D. Plasmid Vector and Bacteria
The vector used in all experiments was pBR322 an 
Escherichia coli (E .coli) plasmid which carries genes 
conferring resistance to tetracycline and ampicillin 
(Sutcliffe, 1978).
The host bacteria used for plasmid propagation were
E .coli strain MC1061 (araD,-*3 (ara, leu) 7697, galV", galK” , 
h^v", hsm+ , strA) (Casadaban and Cohen, 1980).
E. Bacterial Culture Medium
Bacteria were propagated in L-broth. This comprises 
177mM NaCl, lOg/l bacto-peptone and 5g/l yeast extract pH7.5 
(pre-sterilisation). Bacterial culture plates were L-broth 
containing 1.5% (w/v) agar. Both liquid media and agar were 
supplemented with ampicillin (50ug/ml) or tetracycline 
(15ug/ml) where appropriate.
79
2. METHODS
A. Growth of Cells and Virus
BHK-C13 cells are a continuous cell line derived from 
baby hamster kidneys (MacPherson and Stoker, 1962) and were 
supplied by the Cytology Department, Institute of Virology, 
Glasgow. The cells were grown in the Glasgow modification 
of minimal essential medium (MEM; Stoker and MacPherson, 
1961) which was supplied as a lOx liquid concentrate. The 
concentrate was diluted in distilled water and supplemented 
with lOOunits/ml penicillin, lOOunits/ml streptomycin, 5mM 
L-glutamine and 2.75g/l NaHC0 3 . Foetal calf serum was added 
to a final concentration of 1 0 %.
MEM deficient in phosphate was supplied by the Media 
Department, Institute of Virology, Glasgow.
Vesicular stomatitis virus (VSV), New Jersey serotype 
(NJ) Missouri strain was first isolated from swine in 1943. 
Seed stocks were obtained from Dr J.F. Szilagyi. Virus 
stocks were grown in 2 litre burler bottles (1-2x1 0 ® cells).
Monolayers were infected at low multiplicity with a 
10ml inoculum of MEM containing 2.5% calf serum. The virus 
was allowed to absorb for 1 hr at 31°C when a further 25ml 
of MEM, containing --- 2.5% calf serum, was added.
Incubation was continued until a well advanced cytopathic 
effect was observed. This was usually 24 hr post-infection.
The three complementation group E mutants tsEl, t sE2 
and tsE3 were originally isolated from wt VSV NJ strain 
Missouri after exposure to the base analogue mutagen 
5-fluorouraci1 (5-FU) (Pringle et al , 1971). Stocks of 
these viruses as well as the revertant viruses tsElRl
80
(Szilagyi and Pringle, 1979) and tsE3Rl (Evans et al , 1979) 
were also obtained from Dr J.F. Szilagyi.
B. Virus Purification
The medium from infected cells was decanted and 
clarified by centrifugation for 30 min at 2,500rpm in a 
Sorval RC-5B centrifuge using a GSA rotor. The virus was 
pelleted from the clarified medium through a 9ml glycerol 
cushion consisting of 30% (v/v) glycerol, 20mM Tris-HCl 
pH8.0, ImM EDTA and lOOmM NaCl. Centrifugation was for 90 
min at 21,000rpm using the Du Pont 10x100 rotor in the 
Sorval OTD-50 ultracentrifuge. All centrifugation steps 
were carried out at 4°C. The virus pellets were resuspended 
in an appropriate volume of 20mM Tris-HCl pH8.0, ImM EDTA,
0.1m NaCl. The virus was aliquoted and stored at -70°C.
The virus stocks were titrated using standard 
procedures. Monolayers of BHK-C13 cells in 50mm tissue 
culture dishes were inoculated with serial dilutions of 
virus in MEM containing 10% calf serum. Absorption was 
carried out at 31°C for 1 hr. The inoculum was removed and 
5ml of an agar overlay (310ml Eagle's A, 60ml Eagle's B 
without phenol red, 125ml 3.6% Difco agar, 7ml calf serum). 
The plates were incubated for 2 days at 31°C. The agar 
overlay was removed and the cells fixed with 1 0 % cidex for 2 
hr. Clear plaques were counted after staining with Giemsa 
for 1 hr and the concentration of the virus calculated.
The titre of the stock of wt VSV NJ used in this work 
was 3xl0pfu/ml.
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C. Purification of Genomic RNA
VSV genomic RNA was purified using a modification of 
the method described by Palese and Schulman (1976) for 
influenza virus RNA. A suspension of VSV was incubated for 
15 min at 56°C in lOmM Tris-HCl pH7.4, lOmM KC1, 1.5mM MgCl2 
(RSB), 0.2% SDS and 500ug/ml proteinase K. The solution was 
then made up to a final concentration of 0.5% (w/v) SDS, 
140mM LiCl, lOmM Na-acetate pH4.9 and an equal volume of 
phenol equi1ibriated with RSB was added and incubated at 
56°C for 5 min with continual mixing. The mixture was 
vigorously shaken for 15 min after the addition of an equal 
volume of chloroform and then centrifuged for 15 min at 
3,000rpm in an MSE Coolspin centrifuge. The aqueous phase 
was removed and the phenol-chloroform extraction repeated. 
The RNA in the aqueous phase was precipitated with 2.5 
volumes of ethanol. The RNA was recovered by centrifugation 
at 10,000rpm for 15 min in a Sorval SS34 rotor and the 
pellet, which formed a film on the side of the tube, 
resuspended in 0.4ml 0.3M Na-acetate. The RNA was 
reprecipitated with ethanol in a 1.5ml Isppendorf tube, 
centrifuged at 12,000g for 10 min in an Eppendorf centrifuge 
and the pellet washed with 70% (w/v) ethanol. The RNA was 
lyophylised and stored at -70°C.
D. Extraction of Total Cellular ®NA
Monolayers of cells grown in 2 litre burler bottles 
were infected with virus as previously described. However, 
the medium contained lOug/ml Actinomycin D. At 6 hr 
post—absorption the cells were removed from the burlers by 
trypsin treatment and centrifuged at 3 ,0 0 0 rpm for 5 min at
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4°C. A modification of the method first described by 
Chirgwin et al (1979) was used to extract total cellular 
RNA. The cell pellet was resuspended in cold PBS and 
pelleted at 3,000rpm for 5 min at 4°C. The cell pellet was 
lysed in 5 volumes of 6 M guanidinium isothiocyanate, 5mM 
Na-citrate pH7.0, lOOmM -mercaptoethanol, 0.5% sarcosyl. 
One gram caesium chloride was added to each 2.5ml of cell 
lysate. The mixture was layered onto a 1.2ml cushion of 
5.7M caesium chloride in lOOmM EDTA and centrifuged at 
35,000rpm for 12 hr at 20°C in a Beckman SW50.1 rotor. The 
supernatant was discarded and the RNA, which formed a 
pellet, resuspended in lOmM Tris-HCl pH7.4, 5mM EDTA, 1% 
(v/v) SDS and extracted once with an equal volume of a 4:1 
mixture of chloroform and 1-butanol. The organic phase was 
re-extracted once more with an equal volume of the 
Tris/EDTA/SDS buffer. The aqueous phases were then combined 
and the RNA precipitated in the presence of 0.3M Na-acetate 
and 2.5 volumes of ethanol. After centrifugation for 10 min 
at 12,OOOg the RNA was resuspended in water and 
reprecipitated with ethanol. The RNA was stored at -70°C.
E. cDNA Synthesis
cDNA was synthesised using a method based on that of 
Gubler and Hoffman (1983). Synthesis of first strand cDNA 
was carried out in a reaction volume of 40ul containing 50mM 
Tris-HCl pH8.3, lOmM MgCl2 , 10mM DTT* 20mM dNTPs, lOuCi 
[ oi.—  32p] dNTPs, lug oligo (dT)^2 —ig, 5Qug RNA and 40 units 
reverse transcriptase. The reaction was incubated at 42°C 
for 60 min. Prior to being added to the reaction the RNA 
and primer were boiled together for 90 sec and then chilled
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on ice in order to denature the RNA. The reaction was 
stopped by the addition of EDTA to 20mM. The products were 
extracted with phenol/chloroform and twice precipitated with 
ethanol out of 2M ammonium acetate as described by Okayama 
and Berg (1982). This procedure removes most of the 
unincorporated triphosphate. Half of the single stranded 
cDNA was used in the second strand reaction. At this stage 
the single strand cDNA existed in the form of a cDNA:RNA 
hybrid. In the second strand reaction RNase H, which has a 
specificity for RNA that is part of an RNA:DNA hybrid, was 
used to digest the RNA. RNase digestion leaves small 
fragments which can be used by DNA polymerase I as primers 
for second strand cDNA synthesis. DNA ligase was included 
in this reaction but is has been reported that it is not 
absolutely necessary (Gubler and Hoffman, 1983). The second 
strand reaction consisted of half of the product of first 
strand synthesis, 20mM Tris-HCl pH7.5, 5mM MgCl2 / lOmM 
(NH4 )2 S04 , lOOmM KC1, 0.15mM £-NAD, 50ug/ml BSA, 40uM 
dNTPs, 8.5 units/ml of E .coli RNase H, 230 units/ml DNA 
polymerase I and 0.4ug/l00ul E .coli DNA ligase. Incubations 
were sequentially 60 min at 12°C and 60 min at room 
temperature. EDTA was again added to 20mM in order to stop 
the reaction. The product was extracted with 
phenol/chloroform and precipitated twice from ammonium 
acetate as previously described.
F. Insertion of cDNA into pBR322
The double stranded cDNA was tailed with dC residues 
and then annealed to G-tailed Pst1-cut pBR322. The 
conditions for the C-tailing reaction had been established
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by Dr Richard M. Elliott such that the particular batch of 
terminal transferase used would add 20-25 dc residues. The 
C-tailing reaction was carried out at 37°C for 1 hr in a 
50ul volume containing 5 x terminal transferase buffer 
(BRL), lOmM dCTP and 30 units terminal transferase. The 
reaction was terminated by heating at 70°C for 10 min. The 
G-tailed pBR322 was commercially produced (BRL) and had an 
average of 24 G-residues per 3' end (Lot Number 41111).
In order to find the maximum number of clones 
obtainable from the input cDNA, a series of 50ul reactions 
were set up in which varying amounts of C-tailed cDNA were 
annealed to 25ng G-tailed vector in 150mM NaCl, lOmM 
Tris-HCl pH7.5, ImM EDTA for 90 min at 53°C. The annealing 
mixtures were each used to transform E .coli MC1061 cells 
directly and the number of tetracycline resistant colonies 
was noted. The remaining cDNA was annealed under optimal 
condi t ions.
G. Transformation of Bacterial Cells with Plasmid DNA
Competent cells were produced by the method of Dagent 
and Ehrlich (1979). Fifty millilitres of L-broth was seeded 
with 0.5ml of an overnight culture of E .coli MC1061 and 
grown at 37°C with vigorous shaking until the OD590 reached 
a value of 0.2 (usually 2 hr). The cells were chilled on 
ice for 10 min, pelleted at 3 ,0 0 0 rpm for 10 min and 
resuspended in 25ml ice cold lOOmM CaCl2 - The cell 
suspension was incubated on ice for 1 hr and the cells 
centrifuged as above. The resultant pellet was resuspended 
in 0.5ml lOOmM CaCl2 and stored at 4°C overnight before use. 
The number of transformants decrease with time due to the
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decrease in cell viability (Dagent and Ehrlich, 1979).
The plasmid DNA (in a maximum volume of 50ul in TE) 
was mixed with lOOul of competent cells, stored on ice for 
30 min and then heat shocked at 42°C for 2 min; typically 
400ul L-broth was added to the DNA/cell suspension and the 
mixture incubated at 37°C for 1 hr. It was then plated onto 
agar containing tetracycline (15ug/ml). The plates were 
incubated at 37°C overnight.
H. Preparation of Plasmid DNA
Plasmid DNA was isolated using the alkali lysis method 
described by Ish-Horowicz and Burke (1981). Bacterial cells 
were harvested by centrifugation at 6 ,OOOrpm for 10 min at 
4°C in a Sorval GSA rotor. In order to disrupt the cell 
walls the pellet obtained from 500ml of culture was 
resuspended in 10ml 50mM glucose, 25mM Tris-HCl pH8.0, lOmM 
EDTA, 5mg/ml lysozyme, and incubated at room temperature for 
5 min. The cells were then lysed with 20ml 0.2N NaOH, 1% 
(w/v) SDSjwhich was added with gentle mixing. The samples 
were placed on ice for 10 min. Fifteen millilitres of 
pre-cooled 5M K-acetate pH4.8 then added, the samples
mixed vigorously and incubated for a further 10 min on ice 
(5M K-acetate pH4.8 had a final concentration of 3M 
K-acetate plus 2M acetic acid; Ish-Horowicz and Burke, 1981; 
Maniatis et al, 1982). The crude lysate was centrifuged at 
18,OOOrpm for 20 min at 4°C in a Sorval SS34 rotor to pellet 
chromosomal DNA and cell debris. Plasmid DNA was 
precipitated from the supernatant by the addition of 0.6  
volumes of isopropanol for 15 min at room temperature and 
recovered by centrifugation at 18,OOOrpm in a Sorval SS34
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rotor for 30 min at 15°C. The resulting pellet was washed 
with 70% (v/v) ethanol and dried in a vacuum dessicator.
Supercoiled plasmid DNA was purified away from RNA, 
host cell DNA, linear and open forms of plasmid DNA by 
isopycnic banding in caesium chloride gradients* “tine 
plasmid DNA pellet was resuspended in 8 ml TE buffer to which 
was added 8 g solid caesium chloride and 0 .8 ml ethidium 
bromide solution (lOmg/ml in water). Centrifugation was 
carried out at 45,000rpm for 36 hr at 15°C in a Beckman Ti50 
rotor. The lower band, as visualised under long wave 
(365nm) UV illumination, containing the supercoiled plasmid 
DNA was removed and the ethidium bromide extracted with 
isopropanol saturated aqueous 5M NaCl, lOmM Tris-HCl pH8.0, 
ImM EDTA. Caesium chloride was removed from the preparation 
by dialysis against TE buffer and DNA recovered by ethanol 
precipitation out of 0.3M Na-acetate. Plasmid DNA was 
resuspended in sterile distilled water as appropriate.
I. Analytical DNA Extraction ('Miniprep')
Analytical DNA extractions were carried out as 
described by Ish-Horowicz and Burke (1981): 1.5ml of an 
overnight culture was harvested by centrifugation for 1 min 
at 1 2,OOOg in a microfuge tube. The pellet was resuspended 
in lOOul (cold) 50mM glucose, 25mM Tris-HCl pH8.0 EDTA, 
4mg/ml lysozyme and incubated for 5 min at room temperature. 
Two hundred microlitres 0.2N NaOH, 1% (w/v)SDS was added, 
mixed gently and the sample placed on ice for 5 min. One 
hundred and fifty microlitres of 5M K-acetate pH4.8 was then 
added, the sample mixed thoroughly and incubated on ice for 
a further 5 min. After centrifugation at 12,OOOg for 5 min
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the supernatant, containing the plasmid DNA, was extracted 
with an equal volume phenol/chloroform (1:1 v/v). The DNA 
was precipitated with ethanol for 2-5 min at room 
temperature and centrifuged at 12,OOOg for 5 min. The DNA 
pellet was washed with 70% (v/v) ethanol, dried and 
resuspended in 50ul TE buffer containing RNase A (20ug/ml): 
lOul aliquots were subsequently digested with restriction 
endonucleases and analysed by gel electrophoresis.
J. Bacterial Cell Culture 
(i ) Seed Stocks
Seed stocks of bacteria were prepared from 10ml 
cultures which had been inoculated with a single bacterial 
colony and grown overnight at 37°c with shaking to 
saturation density. One millilitre of the overnight culture 
was removed, diluted with an equal volume of 80% (v/v) 
glycerol and stored at -20°C.
(ii) Growth of Large Scale Cultures
The following method was used to propagate one litre 
cultures of plasmid carrying bacteria: 1 0-2 0ul of glycerol 
stock was inoculated into 10ml L-broth containing 
tetracycline (15ug/ml) and grown overnight with shaking.
Five millilitres of this culture was inoculated into 
one litre of tetracycline containing L-broth (15ug/ml) and 
the bacteria grown at 37°C with shaking for 24 hr.
Usually after 9 hr chloramphenicol was added (170ug/ml 
final concentration) to promote amplification of the plasmid 
(Clewell, 1972).
88
K. DNA Sequencing
DNA was sequenced using the chain terminator/dideoxy 
method (Sanger et al , 1977, 1980). There have been many 
improvements made in the last 5 years in this field so that 
now the main rate limiting step to the amount of sequence 
data generated in one day is the number of gels which can be 
run. Because the cDNA to be sequenced was relatively short 
(less than 900 bases) restriction enzyme cleavage was used 
to generate DNA fragments. It must be stated that this 
method gives an uneven distribution of fragments for cloning 
and sequencing and that DNase digestion (Anderson, 1981) or 
more recently sonication (Deininger, 1983) are more 
efficient methods for generating the random DNA fragments 
required for this method.
The various steps involved in this method of 
sequencing are outlined below.
(i ) Ligation
The replicative form of M13mp9 or M13mpl8 (Messing and 
Vieira, 1982; Yanisch-Perron et al , 1985) was used in all 
cloning experiments. Linearised vector (20ng) was incubated 
with various concentrations of DNA insert (10-30ng) in a 
final volume of lOul at 15°C overnight in lOmM Tris-HCl 
pH7.5, lOmM MgCl2 » 10mM DTT, ImM ATP. For ligations 
involving flush or complementary ends 2 units of T4 DNA 
ligase were used. M13mp9 and M13mpl8 were linearised with 
Smal and dephosphorylated using calf intestinal alkaline 
phosphatase (BRL).
Purified DNA insert was digested with an appropriate 
restriction enzyme. When ligating insert fragments into
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vector without complementary ends the digest was made 
flush-ended by incubating the fragments with 0.4mM dNTPs, 
33mM Tris-acetate pH7.5, 6 6mM K-acetate, lOmM Mg-acetate, 
0.5mM DTT and one unit of T4 DNA polymerase at 37°C for 1 
h r .
(i i) Transfect ion
The transfection method was essentially that of Cohen 
et al (1972). E .coli JM101 (Messing et al, 1977) grown to 
an optical density (OD) of 0.3 at 630nm was centrifuged at 
6,000rpm for 10 min at 4°C. The pellet was resuspended in 
0.5 volumes 75mM CaCl2 and the cells left in ice for 30 min. 
The cells were again centrifuged at 6,000rpm for 10 min at 
4°C. They were then resuspended in 0.1 volumes 75mM CaCl2 * 
Aliquots of 0.2ml CaCl2 treated cells were added to the 
ligation mix and left on ice for 40 min. The suspension was 
then incubated at 42°C for 2 min and added to 3ml top agar 
at a similar temperature containing 20ul lOOmM 1PTG and 20ul 
2.5% XGal (dissolved in dimethyl formamide). The mixture 
was added directly to 90mm L-broth agar plates, the top agar 
allowed to set and the plates incubated overnight at 37°C.
(iii) Growth of Recombinant M13 Clones for Sequencing
The bacteriophage M13 has been genetically engineered 
to provide a variety of restriction enzyme sites for cloning 
and also to provide a detection marker for identifying phage 
with inserted DNA. The M13 intergenic region contains part 
of the -galactosidase (Z) gene and its operator and 
promoter. The Z gene fragment contains the coding region 
for the first 145 amino acids of ^-galactosidase
interrupted, in frame, by the insertion of synthetic DNA 
containing restriction enzyme cloning sites. Induction with 
1PTG causes the peptide produced to complement the defective 
gene on the F episome of the E .coli JM101. XGal is a 
lactose substrate analogue and, once added, it is hydrolysed 
by the functional ^ -galactosidase to the blue compound 
bromochloroindolt e which confers a blue colour to the 
perimeter of the phage plaques. However, if the peptide 
coding region is interrupted, by clonift^L DNA fragments into 
the restriction enzyme sites then a functional 
f> -galactosidase is not produced and the plaques are 
colourless. Thus plaques containing inserts can easily be 
identified and grown up.
One millilitre of a standing culture of E .coli JM101 
was added to 100ml 2YT broth (for 1 litre add lOg Bacto 
tryptone, lOg yeast extract and 5g NaCl). This was 
dispensed in 1.5ml aliquots into 20ml universal bottles. 
White plaques were picked using a toothpick into these 
bottles and incubated at 37°C for 5-6 hr with shaking. The 
broth was transferred to 1.5ml fppendorf tubes and cells 
pelleted by centrifugation at 12,OOOg for 5 min. The 
supernatant was poured into another 1.5ml tube and 150ul of 
2.5m NaCl, 20% PEG 6,000 added to precipitate the phage. 
After incubating the mixture at 12, OOOg for 5 min. The 
supernatant was completely removed. The pellet was 
resuspended in lOOul TE buffer and extracted with 0.5 volume 
of phenol/chloroform and ethanol precipitated. The pellet 
was resuspended in 20ul TE buffer and stored at -20°C.
91
(iv) Sequence Analysis of M13 Clones
Three microlitres of the single stranded DNA template 
was annealed to 2.5ng of a commercial oligonucleotide primer 
(GTAAAACGACGGCCAGT; Collaborative Research) in lOmM Tris-HCl 
pH8.5, lOmM MgCl2 in a final volume of lOul at 37°C for 30 
min. One unit of the large fragments of DNA polymerase I 
(Klenow polymerase) was added to each clone (the 
concentrated Klenow polymerase stock was diluted in ImM 
Tris-HCl pH8 .5, ImM Mg C ^ )  and the DNA aliquoted in 2ul 
amounts into four 1.5ml eppendorf tubes corresponding to the 
specific A, G, C and T reactions of each clone. An equal 
volume of nucleotide mix (Figure 2.1) was added and the 
reaction continued for 20 min at room temperature. The 
reaction was chased by the addition of 2ul of 11.5uM dATP 
for 45 min at room temperature. The reaction was stopped by 
the addition of formamide dyes and the samples 
electrophoresed on the same day. Prior to loading on the 
gel, all samples were boiled for 1 min.
(v) Sequence Gel Electrophoresis
The in vitro synthesised complementary strands formed 
during the sequence reactions have a common 5' DNA sequence 
(the synthetic oligonucleotide primer). After denaturation 
from the parent template strand they can be separated by 
virtue of their differing chain length by polyacrylamide gel 
electrophoresis.
Two types of gel were used to electrophorese samples — 
single strength and buffer gradient gels. The single 
strength gels were run for 2 hr or 4 hr and were used to 
clearly resolve bases which ran near the bottom of the gel.
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Approximately 100-150 bases could be read from these single 
strength gels whereas 150-200 could routinely be read from 
the buffer gradient gels.
High resolution sequencing gels were used as outlined 
by Sanger and Coulsen (1978). Electrophoresis was carried 
out in vertical gels of 40x20x0.3cm. Spacers and gel combs 
were cut from Plastikard. The teeth were 2.5mm wide, 1.5mm 
apart and 3mm deep. Later sharks-tooth combs (obtained from 
BRL) were used. Plastikard was initially washed in mild 
detergent to prevent inhibition of polymerisation of the 
gel. The notched plate was treated with siliconising agent 
(2% dimethylide chlorosilane in 1,1,1-trichloroethane). The 
plain plate was treated with 0.05% siliconising agent 
(Wackersilicone) and 0.3% acetic acid in ethanol (Garoff and 
Ansorge, 1981). This treatment encourages sticking of the 
gel to only one plate when dismantling on completion of 
electrophoresis.
The gel contained 9M urea, 6 % (w/v) acrylamide 
crosslinked with bis-acrylamide in the ratio 20:1. Gels 
were polymerised in the presence of 0.25% (w/v) ammonium 
persulphate, 0.01% (v/v) TEMED and electrophoresed in either 
0.5X or lxTBE (pH8.3 or 8 .8 ) at a constant power of 40 watts 
for 2-4 hr.
TBE gradient gel electrophoresis was essentially as 
outlined by Biggin et al (1983). A gradient of 0.5% to 2.5% 
TBE was used. The top mix was 0.5xTBE, 6 % acrylamide, 9M 
urea and the bottom mix was 2.5xTBE, 6 % acrylamide, 9M urea, 
5% sucrose (w/v) and 0.1% bromophenol blue (w/v). When 
preparing the gel 7ml of bottom mix and 50ml of top mix were 
polymerised in the presence of ammonium persulphate and
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TEMED as described. Six millilitres of bottom mix were 
taken up in a 10ml pipette followed by 6ml of top mix. A 
gradient was prepared by allowing the introduction of air 
bubbles into the mixture. The gradient was allowed to 
settle in the gel sandwich and the remainder of the top gel 
mix added. The gel was electrophoresed at a constant power 
of 40 watts.
(vi) Autoradiography
After electrophoresis the urea was removed from the 
gel and the DNA fixed in the gel by soaking in 10% acetic 
acid for 30 min. The gel was then dried down on the plain 
plate by heating at 125°C for 1.5 hr. Autoradiography was 
carried out against dried down sequencing gels using X-Omat 
S-film at room temperature typically overnight. The 
autoradiographs were developed automatically using a Kodak 
X-Omat Processor Model ME-1.
L . Visualisation of Nucleic Acid
A number of techniques were used for the visualisation 
of unlabelled nucleic acid.
(i ) Ethidium Bromide Staining
Because ethidium bromide intercalates with DNA the DNA 
can be visualised by transmitted UV light (long wave 365nm 
or short wave 280nm). Short wave illumination although more 
sensitive (2ng double stranded DNA can be detected as 
opposed to lOng with long wave) results in cleavage of DNA 
molecules and can therefore be used solely for analytical 
procedures. Polyacrylamide gels were soaked in a solution
94
of ethidium bromide (0.5ug/ml) for 30-60 min after 
electrophoresis. Gels were photographed on a Polaroid 
camera through a red filter.
(ii) Silver Staining
The method of Whitton et al (1983) was used for the 
silver staining of RNA. A polyacrylamide gel prepared on a 
sand-blasted plate was soaked for 30 min (minimum time) in 
10% (v/v) acetic acid, 25% (v/v) ethanol and for a further 
30 min (minimum) in 0.5% (v/v) acetic acid, 10% (v/v) 
ethanol. The gel was placed in a solution of lOmM silver 
nitrate for 2 hr then washed three times in deionised water. 
The gel was then soaked in 0.75M NaOH containing 0.3% (v/v) 
formaldehyde and 87.5mg/l sodium borohydride (reducing 
solution) until the DNA bands were stained. The silver ions 
are reduced to their elemental form and bind to the nucleic 
acid. The reducing reaction was stopped before the 
background became too dark by placing the gel in 5% (v/v) 
acetic acid.
M. Recovery of DNA from Gel Slices
(i ) Agarose
DNA fragments were recovered from agarose by 
electroelution. The gel slice was placed in a dialysis bag 
with 800ul lxTBE and electroeluted for 2-3 hr at lOOv or 
overnight at 50v in lxTBE. The polarity was then reversed 
for 2 min to release DNA from the wall of the dialysis 
tubing and the buffer removed. The eluate was passed 
through a disposable cellulose acetate filter (Schleicher 
and Schuell, BA85) to remove any fragments of agarose. The
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DNA was ethanol precipitated. The pellet was resuspended in 
sterile distilled water and extracted once with 
phenol/chloroform, twice with an excess of diethylether 
before being precipitated with 0.1 volume 3M Na-acetate and 
2.5 volumes ethanol.
(ii) Polyacrylamide
DNA was purified from polyacrylamide gels by the 
crush-soak method: a hole was punched in the bottom of a 
0.75ml microfuge tube using a syringe needle and the gel 
slice placed inside the vial which was in turn placed inside 
an intact 1.5ml microfuge tube. The tubes were centrifuged 
at 12,OOOg for 10 sec and the gel slice exuded through the 
hole to form a slurry at the base of the 1.5ml tube. The 
slurry was resuspended in 400ul of elution buffer (500mM 
NH4 -acetate, ImM EDTA) and incubated at 37°C overnight. 
Residual polyacrylamide fragments were removed by passing 
the eluent through a siliconised glass wool plug at the base 
of a 1ml pipette tip. The DNA was recovered by ethanol 
precipitation and purified by extraction once with 
phenol/chloroform and twice with diethylether before being 
precipitated with ethanol.
N. Identification of Recombinant Plasmids with Viral 
Specific Inserts
The plasmid vector pBR322 contains two antibiotic 
resistance genes, ampicillin (ampR ) and tetracycline (tetR ) 
(Sutcliffe, 1978). The Pstl cleavage site is located within 
the ampicillin resistance gene and therefore an Amp^, TetR 
phenotype is indicative of a DNA insert in pBR322 at that
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site. Colonies were replica-plated onto ampicillin and 
tetracycline containing agar to screen for those with 
recombinant plasmids.
Identification of viral specific recombinant plasmids 
was by in situ colony hybridisation (Grunstein and Hogness, 
1975) using [oC_32p] labelled, alkali-treated, genomic RNA 
as a probe. In later experiments gene specific inserts from 
recombinant plasmids were used as hybridisation probes.
Colonies with Amps, Tet^ phenotype were replica-plated 
onto agar plates containing the appropriate antibiotic, 
grown at 37°C overnight and transferred to a nitrocellulose 
membrane filter (Schleicher and Schuell, BA85) by placing 
the filter onto the plate and peeling back gently. The 
bacteria were prepared for colony hybridisation in the 
following way:
(a) the filter was placed (colony side up) in turn onto two 
layers of Whatman 3MM paper saturated with 0.5M NaOH (10 
min), 1M Tris-HCl pH8 .0 (10 min, repeated twice) and 
lOxSSC (10 min), to lyse the cells and denature the DNA.
(b) the filter was air dried, submerged in chloroform 
(twice), air dried, washed in lOxSSC and baked at 80°C 
for 2 hr in a vaccum oven.
Prehybridisation was performed at 42°C for at least 2 
hr in 20ml/3 filters of 5xSSC, lxDenhardt 0.02% (w/v)
Ficoll, 0.02% (w/v) BSA, 0.02% polyvinylpyrolidone, 50% 
formamide, lOOug/ml sheared herring sperm DNA. The solution 
was removed and hybridisation to an appropriate 32p_iat)en ed 
probe carried out in 5ml/3 filters of 50% (v/v) formamide, 
5xSSC, 1 x Denhardt, lOOug/ml sheared herring sperm DNA.
The DNA probes were heat denatured at 100oc for 5 min and
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quick-chilled prior to hybridisation. Non-specifically 
bound radioactivity was removed from the filter by washing 
sequentially in 100ml 3xSSC at 42°C for 1 hr and lxSSC, 0.1% 
(w/v) SDS for 1 hr at room temperature. The filter was 
dried and colonies containing plasmids with viral inserts 
detected by autoradiography. Appropriate controls were 
included on each filter.
Genomic RNA extracted from VSV was incubated in 0.1M 
NaOH for 1 hr on ice after which the alkali was neutralised 
with 0.1 volume of 1M acetic acid. The RNA was recovered by 
ethanol precipitation in the presence of 0.3M Na-acetate and 
the RNA 5 '-end labelled in a 20ul reaction containing 60mM 
Tris-HCl pH 7.5, lOmM MgCl2 / 15mM DTT, ImM spermidine, 
400ug/ml BSA, 30uCi [ cx32p] ^ P  and 2 units 
T4-polynucleotide kinase. The reaction mixture was 
incubated at 37°c for 1 hr and the unincorporated [<=<32p]
ATP separated from the labelled RNA by Sephadex G-50 
chromatography.
O. Northern Blot Analysis of Intracellular RNA
(i) Gel Electrophoresis of Total Cellular RNA
Unfractionated RNA from infected and uninfected cells 
was separated on 1.5% agarose horizontal slab gels 
containing 6M urea and 0.025M citrate buffer pH3.5 adapted 
from the method of Wertz and Davis (1979).
Each gel consisted of 3g agarose, 70ml distilled 
water, 10ml 0.5M citrate buffer pH3.5 and 120ml 10M urea and 
was prepared by melting the agarose in the water in a 
microwave oven, then adding the citrate buffer and finally 
the urea which had been heated, deionised and filtered
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immediately prior to use. Gels were poured at 4°C on
26.5x16.5cm glass plates in a "horizontal slab gel apparatus
and left to solidify for 1 hr.
Samples were made up to 50ul with buffer. 
Electrophoresis was for 18 hr in the cold at lOOv with rapid 
recirculation 1 ■ of the running buffer.
Urea was removed from the gel by three 30 min washes 
in running water at room temperature with gentle agitation.
(ii) Transfer of RNA to Nitrocellulose
Transfer of RNA to nitrocellulose was essentially by
the method described by Thomas (1980). After washing, the 
gel was soaked in 20xSSC for 30 min and placed onto two
sheets of Whatman 3MM paper saturated with lOxSSC. The gel
was then covered with a sheet of nitrocellulose (Schleicher 
and Schuell, BA85) which had been equilibriated with 20xSSC, 
followed by two sheets of Whatman 3MM paper, a 10cm stack of 
paper towels and a 1kg weight. Transfer was complete in 12 
hr. The nitrocellulose filter was washed in 6 xSSC and baked 
at 80°C for 2 hr in a vacuum oven.
(iii) Hybridisation to Nick-translated 32p-jabelled DNA 
The filter was cut into strips as required and 
pre-hybridised for at least 3 hr in 100ml solution of 50% 
formamide, 5 x Denhardt buffer, 5xSSC. Hybridisation to an 
appropriate 32p_^abelled nick-translated probe was performed 
in 5ml 50% formamide, 5 x Denhardt, 5xSSC. The strips were 
washed in 100ml 3xSSC, 0.1% (w/v) SDS at 42°C for 1 hr, then 
lxSSC, 0.1% (w/v) SDS at room temperature. The filters were 
dried and autoradiographed.
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(iv) In vivo synthesis of 3 2 P-labelled RNA
3 2P-labelled RNA synthesised in vivo was used as 
marker. BHK-C13 cells grown in 80cm2 tissue culture flasks 
(approximately lxl0 7cells/flask) were infected at a 
multiplicity of lOpfu/cell at 4°C and allowed to adsorb at 
this temperature for 1 hr. The medium contained lOug/ml 
actinomycin D (actinomycin D remained at this concentration 
throughout the experiment). The medium was removed and 
replaced with phosphate deficient medium containing lmCi 
[3 ^p]-orthophosphate. Incubation at 31°C was continued for 
6 hr. The cells were harvested by the method of Collins e_t 
al (1978): after removal of the radioactive solution the 
cell monolayers were washed once with ice cold 0.1M NaCl, 
0.01M Tris-HCl pH8 .8 , and lysed by adding 1ml cold 
solubilising buffer (0.1M NaCl, 0.01M Tris-HCl pH8 .8 , 2mM 
EDTA, 1% Triton X100, 0.5% sodium deoxycholate, 1%
-mercaptoethanol) . The cell extract was removed, 
centrifuged at 15,000rpm for 5 min at 4°C to remove nuclei 
and cell debris. The supernatant was adjusted to 0.4M NaCl, 
0.5% SDS. An equal volume phenol/chloroform was added, 
vortexed for 1 min and centrifuged at 3,000rpm for 10 min at 
20°C. The aqueous phase was removed and precipitated with 
0.1 volume 3M Na-acetate and 2.5 volumes ethanol.
P. mRNA Selection and In Vitro Translation
mRNA selection and in vitro translation was carried 
out using the method of Elliott (1985).
Approximately 20ug of plasmid DNA was dissolved in 
2 0ul of water and heated at 100oc for 10 min, followed by
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chilling on ice. An equal volume of 1M sodium hydroxide was 
added and the mixture incubated at room temperature for 20 
min. The DNA sample was neutralised by adding 0.5 volume of 
a solution of 1M NaCl, 0.3M Na citrate, 0.5M Tris-HCl pH8.0 
and 1M HC1. The sample was mixed and immediately chilled on 
ice. The DNA was spotted 5ul at a time onto a 
nitrocellulose disc (Schleicher and Schuell, BA85). The 
discs were allowed to air dry and then baked for 2 hr at 
80°C in a vacuum oven.
Four hundred micrograms of RNA extracted from virus 
infected BHK-C13 cells were added to the hybridisation 
solution (lOmM 1,4-piperazinediethanesulfonic acid [PIPES 
pH6.4], 400mM NaCl, 4mM EDTA, 50% formamide) and incubated 
at 45°C overnight. The hybridisation solution was removed 
by aspiration and the discs washed 10 times with wash 
solution (lOmM Tris-HCl pH7.6, 0.15M NaCl, ImM EDTA, 0.5%
$DS) and twice with wash solution without SDS. The wash 
solutions were preheated to 65°C and maintained at 65°C 
during the wash procedure.
The discs were transferred to individual tubes 
containing 300ul of water and 500ng calf liver tRNA. The 
tubes were boiled for 1 min and then snap frozen in a 
dry-ice/ethanol bath. The samples were thawed on the bench. 
The RNA was extracted with an equal volume of
phenol/chloroform and precipitated with ethanol in the usual 
way. The RNA was washed with 70% ethanol, dried and 
resuspended in 5ul sterile water. It was used to programme 
an in vitro translation system (New England Nuclear Company) 
and the translation products analysed by polyacrylamide gel 
electrophoresis.
Preparation of Radiolabelled VS Virion Proteins
BHK C13 cells were grown in 30mm petri dishes until 
confluent and infected at a multiplicity of 4-5pfu/cell. 
After allowing virus to absorb for 1 hr at 31°C, 2ml of 
medium containing 30uCi, [33S]-methionine was added. The 
cells were incubated overnight at 31°C. The medium was 
decanted and centrifuged at 3,000rpm for 5 min. The 
supernatant was then poured into a 15ml Beckman quick seal 
tube and centrifuged at 40,000rpm for 1 hr in a Sorval Ti65 
rotor. The supernatant was poured off and the pellet 
resuspended in lOOul protein dissociation mix (0.125M Tris 
HCl pH6.8r 10% ^f-mercaptoethanol, 2 0% glycerol, 0.1% 
bromophenol blue). After boiling for 2 min the sample was 
stored at -20oc.
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The in vitro translation reactions were assembled on 
ice and initiated by transfer to 37°C where incubation was 
continued for 1 hr. A typical reaction comprised: 2ul RNA, 
2.5ul [35s ]-methionine, 5ul rabbit reticulocyte lysate,
2.75ul in vitro translation cocktail, lul K-acetate, 0.25ul 
Mg-acetate. The reaction was terminated by adding 15ul 
protein dissociation mix (0.125M Tris-HCl pH6.8, 4% SDS, 10% 
-mercaptoethanol, 20% glycerol, 0.1% bromophenol blue). 
Samples were boiled for 2 min and stored at -20°C. Before 
loading on the gel, samples were boiled for 5 min.
Proteins were fractionated on polyacrylamide gels in 
the presence of 0.1% SDS using the discontinuous buffer 
system of Laemmli (1970). The ratio of acrylamide to 
bisacrylamide was 75:1. Separating gels contained 10%, 12% 
or 15% acrylamide and stacking gels contained 3% acrylamid^. 
Electrophoresis was at 30mA at 4°C until the bromophenol 
blue was 10mm from the bottom of the separating gel.
To increase the sensitivity of detection of 
[35s ]-labelled proteins the gels were fixed in 45% methanol, 
5% acetic acid overnight. They were then soaked in En3Hance 
(New England Nuclear) for 1 hr and washed in water for 1 hr, 
before being dried down under vacuum using a Bio-Rad gel 
drier. They were exposed against X-Omat S film and stored 
at -70°C.
Q. Nick Translation of DNA
Nucleic acid hybridisation is one of the most powerful 
techniques for detecting and quantitating specific RNA and 
DNA sequences. There are a variety of ways by which 
complementary strands can form duplex structures. However,
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no matter what annealing procedure is used and no matter 
what means are used to quantitate the hybridisation one of 
the strands of nucleic acid must be ? labelled.
The concept of radiolabelling DNA molecules internally in 
vitro to a high specific activity was first introduced by 
Rigby et al (1977).
DNA was labelled in a 50ul reaction containing 50mM 
Tris-HCl pH7.5, lOmM MgS04 , O.lmM DTT, 50ug/ml BSA, 5uM of 
each of the unlabelled dNTPs and 10uci of each [oC -32p] 
dNTPs, 0.004ug/ml DNasel and 2 units DNA polymerase. After 
incubation at room temperature for 1 hr unincorporated 
[c>C-32p] dNTPs were removed from the DNA preparation by 
passage over a Sephadex G-50 column.
R. Quantitation of Nucleic Acid
In order to determine the concentration of nucleic 
acid DNA or RNA in a particular preparation optical density 
measurements were read at 260nm and 280nm. Quartz 
microcuvettes and a Cecil 595 double beam digital UV 
spectrophotometer were used. The pathlength of the light 
was 1cm and it was assumed that 1 OD unit was equivalent to 
50ug/ml of nucleic acid.
S. Restriction Endonuclease Cleavage
All restriction endonuclease digests were performed in 
Tris-acetate buffer (33mM Tris-acetate pH7.9, 66mM 
K-acetate, lOmM Mg-acetate, 0.5mM DTT, lOOug/ml BSA) at 
37°c. Smal digests were performed in 15mM Tris-HCl pH8.0, 
6mM MgCl2 , 15mM KC1, at 37°C. Various concentrations of DNA
were digested using the simple rule that 1 unit of a
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restriction enzyme would digest lOug of DNA in 1 h r . The 
concentration of enzyme in the reaction never exceeded 10% 
due to the inhibitory effects of glycerol in the enzyme 
storage buffer. Typically reaction volumes were between 
20ul and 60ul.
T. Digestion of DNA with Nuclease BAL31
Bal31 is an enzyme which has two activities (Lau and 
Gray, 1979): (a) it is a highly specific, single stranded 
deoxyribonuclease and exonuclease that catalyses the removal 
of small oligonucleotides or mononucleotides from both 5' 
and 3 ‘ termini of double stranded DNA. Both strands of DNA 
are degraded at the same rate; (b) it is a single stranded 
specific endonuclease similar to nuclease SI.
Bal31 was used because of its ability to degrade the 
3' and 5' strands of DNA in order to remove the C-tails from 
insert DNA. One unit of Bal31 was added to a 30ul reaction 
containing 0.5ug DNA, 12mM MgCl2 » 12mM CaCl2 » 20mM Tris-HCl 
pH8.0, ImM EDTA, 200mM NaCl. The rate at which Bal31 
removes nucleotides from the 5' and 3 ‘ termini of duplex DNA 
is variable and depends on a number of factors eg. batch of 
enzyme. Therefore, reactions were usually about 30 sec in 
duration at 37°C with lOul aliquots removed at 10 sec 
intervals. The aliquots were frozen on dry ice to stop the 
reaction or EGTA was added to a final concentration of 20mM. 
Bal31 activity is completely dependent on calcium and so it 
can be inactivated by EGTA which binds calcium ions.
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U . Comput ing
The nucleotide and amino acid sequences were stored, 
manipulated, and analysed on a PDP 11/44 computer using the 
following programs:
(a) TRANS - This program allows the user to translate a
DNA sequence in any or all reading frames (Pustell and
Kafatos, 1982a).
(b) PROFIL - Evaluates the hydrophilicity and 
hydrophobicity of an amino acid sequence using the SOAP 
algorithm of Kyte and Doolittle (1982). The result of 
the prediction is illustrated in graphical form where 
peaks represent hydrophobic regions.
(c) CINTHOM - This is a dot-matrix plot which aligns two 
sequences, whether nucleic acid or amino acid, on the X 
and Y axis of a 2D co-ordinate system. The user 
defines the parameters of homology (Pustell and 
Kafatos, 1982b).
(d) HOMOL - This aligns two sequences such that their 
homology is maximised. The program works by inserting 
gaps to minimise mismatch (Taylor, 1984).
(e) CHOU and FASMAN - A program which allows the 
prediction of protein secondary structure (Chou and 
Fasman, 1978).
The results were graphically displayed using the 
PLOTCHOU program contained in the University of Wisconsin 
Genetics Computer Group software package and outputted to a 
Hewlett-Packard model 7475A plotter.
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Figure 2.1
Diagram showing the composition of the nucleotide mix. 
2ul [32p]_dATP was added to 9ul dATP mix. 2.5ul of this 
mixture was then added to 18ul of the G, A, T and C mixes.
Table 2.1 dNTP Mixes
dG mix dA mix dT mix dC mix
0.5mM dT 200 200 10 200
0.5mM dC 200 200 200 10
0.5mM dG 10 200 200 200
dNTP-*-mix buffer 50 50 50 50
Table 2.2 ddNTP Mix
0. 2mM 
<\dGTP
70uM
ddATP
0. 3mM 
ddATP
70uM
ddCTP
5mM ddG 40 — —
5mM ddA - 14 - -
5mM ddT - - 60 -
5mM ddC - - - 14
h 2o 960 986 940 986
Table of Protein Gel Mixes 2..^,
10% 12% 15%
acryl:bis 75:1 8.00 10.30 12.75
1M Tris pH8.8 12.30 12.30 12.30
h 2o 11.70 10.00 7.55
10% SDS 0.33 0.33 0.33
10% AP 0.33 0.33 0.33
TEMED 30ul 30ul 30ul
Stacking Gel acrylsbis 1.00
1M Tris pH6.8 0.625
h 20 8.00
10% SDS 0.10
10% AP 0.10
TEMED 5ul
Table 2.3 dNTP: ddNTP Mix
Sequencing Mix dNTP ddNTP h 2o
G 400 300 100
A 400 150 250
T 400 400 -
C 400 400 -
dNTP-*-mix buffer = 0.05m Tris-HCl pH8.0
ImM EDTA
Chapter 3
CLONING AND IDENTIFICATION OF THE WILD-TYPE, 
MUTANT AND REVERTANT VIRUS NS mRNAS
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1. RNA PRODUCTION AND cDNA SYNTHESIS
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Actinomycin D-treated BHK C13 cells were infected with 
each of the viruses at low multiplicity (lpfu/cell). Six 
hours post-adsorbtion the cells were harvested and total 
cellular RNA was extracted using the guanidinium/CsCl method 
of Chirgwin et al (1979). Solutions of guanidinium chloride 
and guanidinium isothiocyanate are potent chaotropic agents 
which readily dissolve proteins (Cox, 1968). Cellular 
structures disintegrate and nucleoproteins dissociate 
rapidly from nucleic acid as ordered secondary structure is 
lost. Even RNase, an enzyme which is resistant to many 
forms of physical abuse, eg. boiling, is completely inactive 
in the presence of 4M guanidinium isothiocyanate and 
reducing agents like -mercaptoethanol (Sela et al, 1957). 
This combination of reagents as used in the method of 
Chirgwin et al (1979) allows the efficient recovery of large 
quantities of intact, pure RNA from even those cells which 
are rich in RNase eg. the pancreatic cells.
Total cellular RNA extracted from infected cells was 
used as template for cDNA synthesis without being poly (A) 
or size selected. cDNA was synthesised using oligo 
(^T)12-18 Primer and the protocol of Gubler and Hoffman 
(1983) as outlined in Figure 3.1.
All of the recombinant plasmids had the general form 
shown in Figure 3.2. Double-stranded cDNA was C-tailed and 
annealed to Pst1 digested G-tailed pBR322. The unique Pst1 
site in pBR322 is located in the ampicillin resistance gene 
and so cDNA inserted at this site inactivates the gene. 
Therefore recombinant plasmids have a tetracycline 
resistant, ampicillin sensitive phenotype.
2. IDENTIFICATION OF WILD-TYPE NS GENE-SPECIFIC
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r e c o m b i n a n t  p l a s m i d s
The procedure used to identify firstly virus-specific 
recombinant plasmids and then those containing NS 
gene-derived inserts is outlined in Figure 3.3.
Recombinant plasmids containing virus-specific inserts 
were identified by colony hybridisation using 
partially alkali digested, VSV genomic RNA as a probe. VSV 
genomic RNA was extracted from purified virions using a 
modification of the method described by Palese and Schulman 
(1976) for influenza virus RNA. After partial hydrolysis 
with alkali (to increase the number of free 5' ends) the RNA 
was 5' end labelled using T4-polynucleotide kinase.
It was calculated that 15% of the recombinant plasmids 
contained virus-derived inserts. Because the template RNA 
for the cloning reactions was unselected this high 
proportion probably reflects both the inhibitory action of 
actinomycin D and VSV infection on cellular mRNA synthesis 
and the efficient production of VSV mRNAs, combined with the 
efficiency of the cloning method.
NS gene-specific recombinant plasmids were identified 
using a combination of Northern blot analysis and mRNA 
selection/in vitro translation.
For the Northern blot (Figure 3.4) RNA was extracted 
from infected cells, separated by agarose gel
C\.
electrophoresis and blotted onto^Biodyne membrane. The 
Biodyne membrane was then probed with nick translated 
recombinant plasmid D N A . VSV mRNAs, 32_labelled in__yivo and 
electrophoresed on the same gel, were used as markers.
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The gel system did not resolve the M and NS mRNAs and 
so when they were transferred to the Biodyne membrane the NS 
and M mRNAs appeared as a single band (Figure 3.4). In 
order to positively identify NS gene-specific recombinant 
plasmids, those hybridising in the NS/M mRNA position on 
Northern blots were used in mRNA selection/in vitro 
translation experiments (Figure 3.5).
Recombinant plasmids were bound to nitrocellulose and 
then hybridised with RNA extracted from infected cells.
After a stringent wash procedure, bound RNA was eluted and 
used to program an in vitro translation system. 
Electrophoresis clearly resolved the M and NS proteins thus 
allowing the positive identification of NS gene-specific 
recombinant plasmids. For the sake of comparison a 
wild-type N-gene-specific recombinant plasmid has been 
included in Figures 3.4 and 3.5.
Using the procedure outlined in Figure 3.3 several 
recombinant plasmids were identified as containing NS 
gene-specific inserts. In the library the frequency of 
plasmids containing inserts derived from the NS mRNA was 
calculated to be 0.7%.
3. CHARACTERISATION OF THE WILD-TYPE NS GENE-SPECIFIC 
RECOMBINANT PLASMIDS
Digestion of the NS gene-specific recombinant plasmids 
with Pst1 was performed in order to excise the insert and 
size it. All of the NS gene-specific recombinant plasmids 
identified contained a characteristic internal Pst1 site 
(Figure 3.6). The recombinant plasmid digested with Ps1 1 in
108
Figure 3.6 has an insert of approximately 900 bases and this 
was thought to be about the size of a full-length copy of 
the NS mRNA. This recombinant plasmid was designated pNJNSl 
and was used for sequence determination.
4. IDENTIFICATION OF RECOMBINANT PLASMIDS CONTAINING 
MUTANT AND REVERTANT VIRUS NS-SPECIFIC INSERTS
The insert from pNJNSl was purified from an agarose 
gel, 32p_iabelled by nick translation and used as a specific 
probe in colony hybridisation experiments to detect 
NS-specific recombinant plasmids derived from the three 
complementation group E mutants (tsEl, tsE2 and tsE3) and 
the two revertant viruses (tsEl/Rl and tsE3/Rl).
Figure 3.7 shows a typical result of a colony 
hybridisation experiment. The frequency of NS gene-specific 
recombinant plasmids had been calculated to be 0.7% and so 
low density screening was possible.
NS gene-specific recombinant plasmids from the three 
complementation group E mutants and the two revertant 
viruses were sized by Pst1 digestion and agarose gel 
electrophoresis. Figure 3.8 shows a Pst1 digest of pNJNSl 
electrophoresed with Pstl digests of the three recombinant 
plasmids which were used for sequence determination of the 
complementation group E mutants. Since they seemed to be 
approximately the same size as pNJNSl (Figure 3.8) it was 
assumed that they contained full-length copies of the NS 
mRNA. The plasmids were designated pNJNSEl, pNJNSE2 and 
PNJNSE3.
C L O N I N G  S T R A T E G Y
AAAAAr R N A
First strand synthesis
Reverse transcriptase, 
oligo dT primer
TTTTT—
AAAAA—
TTTTT-
AAAAA— ■
DNA:RNA hybrid
RNase H, polymerase I
C-tail
terminal transferase, dCMP
TT----------------------------------CCCCC
CCCAA---------------------------------
Anneal to G-tailed pBR322
gggtt-------------------------------- eeccc-
•CCCAA      -. GGGGG*
Transform
E .coli
Figure 3.1
A schematic representation of the method used to clone 
cDNA copies of the VSV mRNAs. The RNAsDNA hybrid produced 
after the first strand cDNA synthesis reaction was treated 
with RNase H and DNA polymerase 1. Rnase H specifically 
digests RNA which is part of an RNA:DNA hybrid. Thus 
RNase H treatment leaves small RNA fragments which can be 
used as primers by the DNA polymerase 1 to make 
double-stranded cDNA. The double-stranded cDNA was C-tailed 
and annealed to Pst1 cut, dG-tailed pBR322. The recombinant 
plasmids were used to transform competent E.coli MC1061 
cells.
cD
NA
pBR322
Diagramatic representation of the general form of the 
recombinant plasmids. cDNA was inserted into the unique 
pst1 site of pBR322.
IDENTIFICATION PROCEDURES
Colony hybridisation with 32p_iab en ea VSV genomic RNA 
partially hydrolysed with alkali
>15% of colonies contained 
viral specific inserts
Northern blot analysis of viral specific plasmids
Confirm ID with mRNA selection/in vitro translation
0.7% of colonies in the library 
contained NS-specific inserts "V.
Figure 3.3
An outline of the procedure used to detect 
gene-specific recombinant plasmids.
<NS,M
Figure 3.4
Northern blot analysis: total cellular RNA was 
extracted from VSV infected cells, separated by agarose gel 
electrophoresis and blotted onto Biodyne membrane. The 
filter was then hybridised with recombinant plasmid DNAs 
32p-iabelled by nick translation.
(1) pNJNl (a cDNA clone of the N gene of wild-type VSV N J f
Missouri strain) reacting with the N mRNA.
(2) pNJNSl, reacting with either the NS or M mRNA.
(3) A marker track of VSV mRNAs 22p_ia]3en e<j in vivo,
separated by gel electrophoresis and blotted onto 
Biodyne membrane.

Message selection/in vitro translation: recombinant 
plasmid DNA was bound to nitrocellulose filters and 
hybridised with total cellular RNA extracted from VSV 
infected cells. Bound RNA was eluted and used to program a 
rabbit reticulocyte in vitro translation system. The 
translation products were analysed by polyacrylamide gel 
electrophores is.
(1 ) Proteins translated from mRNA selected with pBR3 22.
(2 ) Proteins translated from mRNA selected with pNJN) .
(3) Proteins translated from mRNA selected with pNJN*» I
(4) Translat ion products of total infected cell RNA.
(5) Marker track of [35g] methionine-labelled VSV proteins.
VSV proteins are indicated at the right. pG is the in 
vitro equivalent of G which has a greater electrophoretic 
mobility because it is unglycosylated. The solid arrowheads 
indicate the translation products of the selected mRNAs. A 
minor band comigrating with the M protein consistently 
appeared among the proteins translated from mRNA selected 
using either pNJNSl or pNJNl.
<pBR
< n2
<in3
Figure 3.6
Agarose gel electrophoresis of a partial Pst1 digest 
of pNJNSl.
(1) HindiII-digested A  DNA markers from top to bottom 
23.1, 9.4, 6 .6 ., 4.4. 2.3., 2.0 and 0.56 Kb.
(2) Partial Pst1 digest of pNJNSl showing the intact insert 
in 1 (approximately 900 bases) and the complete Pst1 
digestion products in 2 (550 bases), and in 3 (350 
bases). pBR is the pBR322 vector DNA.

Figure 3.7
Examples of in situ colony hybridisation to detect 
mutant NS gene-specific recombinant plasmids. Nick 
translated insert from pNJNSl was used as a probe.
^  indicates mutant NS gene-specific recombinant plasmids 
E> indicates control colony of pNJNSl containing E .coli
The control is more intense in each case probably due 
to the fact that the colony was grown from a glycerol stock 
and the bacteria may have had a higher plasmid copy number.
wt E 1 E2 E3
vector
cDNA
Figure 3.8
Agarose gel electrophoresis of Pstl digest of pNJNSl, 
pNJNSEl, pNJNSE2 and pNJNSE3. All inserts are approximat ely 
the same size and contain the characteristic internal Pst1 
site.
Chapter 4
THE SEQUENCE OF THE NS mRNA OF WILD-TYPE VSV NJ
MISSOURI STRAIN
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The precise role of the NS protein in the VSV 
infectious cycle is not known. It has been shown that NS 
protein is involved in transcription, replication and virion 
maturation (Emerson and Yu, 1975; Evans et al, 1979; Isaac 
and Keene, 1982; Keene et al, 1981; Kingsford and Emerson, 
1980; Mellon and Emerson, 1978; reviewed by Pringle, 1986). 
Kinetic studies of VSV protein synthesis have shown that 75% 
of newly synthesised NS protein enters a soluble pool in the 
cell cytoplasm; the remaining 25% bypasses the soluble pool 
and enters nucleocapsids directly (Hsu et al, 1979). The 
results of the kinetic studies indicate that VSV RNP 
assembly in vivo is a stepwise process analagous to the 
stepwise assembly of Sendai virus nucleocapsids (Kingsbury 
et al , 1978).
Evidence suggests that the balance between 
phosphorylation and dephosphorylation of proteins is a 
fundamental method of controlling certain processes in viral 
infection (Clinton et al, 1978; Kamata and Watanabe, 1977; 
Mellon and Emerson, 1978; Sen et al; 1977; Smith et al,
1979; Sokol and Clark, 1973). For example, the degree of 
phosphorylation of the pl2 protein of mouse mammary tumour 
virus determines the extent of its binding to homologous 
viral RNA (Privalsky and Penhoet, 1977) and viral 
transcription is stimulated by phosphorylation of the 
influenza virus nucleocapsid protein (Kamata and Watanabe, 
1977). The NS protein of VSV is the major phosphoprotein 
present in infected cells and an integral component of the 
viral transcriptional complex (Moyer and Summers, 1974;
Naito and Ishihama, 1976; Privalsky and Penhoet, 1977; 
Watanabe et al, 1974). Much work has been concentrated on
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finding how phosphorylation affects NS protein activity.
It has been reported that NS phosphorylation is 
required for in vitro transcription (Hsu et al, 1982). The 
degree of phosphorylation of NS protein in vivo has been 
correlated with its ability to bind to nucleocapsids 
(Clinton et al, 1978) and its ability to function as part of 
the transcriptase (Kingsford and Emerson, 1980). In the 
infected cell NS protein exists in a variety of 
phosphorylated forms (Kingsford and Emerson, 1980; Hsu and 
Kingsbury, 1982) which have been separated on the basis of 
electrophoretic mobility into two classes, NS1 and NS2.
These two classes differ markedly in their degree of 
phosphorylation and in their abilities to activate 
transcription (Clinton et al, 1979; Kingsford and Emerson, 
1980; Kingsbury et al, 1981; Hsu and Kingsbury, 1982). The 
NS1 class has the lower electrophoretic mobility and 
phosphate concentration. NS1 molecules are found in the 
intracellular soluble pool of NS protein and intracellular 
or virion nucleocapsids. In contrast NS2 molecules are more 
highly phosphorylated and are found mainly in virions (Hsu 
et a l , 1982).
There are at least three kinase activities associated 
with the VS virion. Imblum and Wagner (1974) identified a 
virion protein kinase that they concluded was associated 
with the viral envelope and probably acquired from the 
cellular membrane during the budding process. A protein 
kinase precipitable with anti-c-src antibody has also been 
identified. This protein is again thought to be acquired as 
a consequence of budding (Clinton et al, 1982). The NS 
protein is extensively phosphorylated at serine and
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threonine residues? howpvor o v a t, ,' nowever, c-src is known to be a tyrosine
specific kinase (Clinton and Huang, 1981).
Evidence for the involvement of a third type of kinase 
m  the infectious process has accumulated over a number of 
years. Imblum and Wagner (1974) observed that although 
their virion kinase activity was sensitive to actinomycin D 
the level of phosphorylation of intracellular NS was 
unaffected. Hsu et al (1979) showed that dephosphorylated 
NS, inactive in rn vitro transcription assays, could not be 
reactivated by phosphorylation with virion-bound kinases. 
Sinacore and Lucas-Lenard (1982) demonstrated that the 
virion—bound protein kinases may not be essential for 
transcriptional activity in vitro. Evidence that the L 
protein is capable of specifically phosphorylating NS 
protein has recently been presented (Sanchez et al, 1985) .
The L fraction of purified nucleocapsids was shown to be 
capable of phosphorylating exogenous phosphate acceptor 
proteins like phosvitin and casein. However, an excess of 
phosvitin was unable to compete with phosphorylation of NS 
protein by L indicating that the protein kinase activity has 
an affinity for NS protein (Sanchez et al, 1985).
In this chapter sequence data from the NS mRNA of 
wild-type VSV New Jersey, strain Missouri is presented and 
di scussed.
1. SEQUENCE ANALYSIS OF THE NS MRNA OF WILD-TYPE 
VSV NJ, MISSOURI STRAIN
The nucleotide sequence of the insert of pNJNSl was 
det ermined by the dideoxy chain terminator method of Sanger
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e -^ (1977, 1980). Approximately 75% of the sequence was
determined on both strands though each base was sequenced an 
average of five times. Figure 4.1 shows a restriction map 
of the insert from pNJNSl with the sites of the restriction 
enzymes used in the sequence analysis shown* Because the 
DNA was relatively short (approximately 900bp) restriction 
enzyme cleavage was used to generate DNA fragments as 
opposed to DNase digestion (Anderson, 1981) or sonication 
(Deininger, 1983).
The sequence spanning the internal Pst 1 site was 
obtained by digesting intact pNJNSl with HpalI, purifying 
the appropriate fragment (approximately 175bp) from a 
polyacrylamide gel and ligating the fragment into M13mpl8 
DNA.
Due to the method used to clone the double-stranded 
cDNA into pBR322 there were 20-25 dC or dG residues at 
either end of the insert fragment when it was excised from 
the plasmid by Pst1 digestion. It has been reported that 
DNA polymerase finds certain sequences, like stretches of dC 
or dG residues, difficult to copy (Smith, 1980) resulting in 
unreadable sequence tracks after the polymerase has 
encountered the homopolymer tracts. Two methods were used 
with varying success to overcome the problem. Firstly,
Bal31 nuclease digestion of purified insert from pNJNSl 
removed bases from either end of the DNA molecules.
However, due to variation in the enzyme preparations it was 
difficult to remove the same number of bases consistently. 
Alternatively, pNJNSl was digested with Haelll and 
electrophoresed with HaeIll-digested pBR322. The 
appropriate fragment was then purified from the gel and
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ligated into HaeIII—digested Ml3mpl8. In this way sequence 
was read from the Haelll site in the vector towards the 
tails.
Figure 4.2 shows the nucleotide and predicted protein 
sequence of the NS mRNA of wild-type VSV NJ, Missouri 
strain. The NS mRNA is 856 nucleotides long (excluding 
polyadenylic acid) and codes for a protein of 274 amino 
acids (mol wt 31,M,0). The protein initiates at AUG 
(position 11-13) and terminates at UAA (position 833-835). 
Thus there is very efficient utilisation of the mRNA with 
only the minimum untranslated region.
The sequence shows that pNJNSl contains a full-length 
cDNA copy of the NS mRNA because (a) at the 5' end there is 
the sequence AACAGAGATC which corresponds with the consensus 
sequence (5 ' ) AACAGNNAUC (3' ) reported to be at the 5' end of 
all VSV mRNAs (McGeoch, 1979; Rose, 1980; Franze-Fernandez 
and Banerjee, 1978) and (b) at the 3' end there is the 
sequence . . .UA'jtfG (A ~f  )Cn . It has been reported that the 
sequence ...UAUG(U7 ) occurs at the mRNA-poly(A ) junction in 
each mRNA (Rose, 1980). The presence of the 12 A residues 
at the 3 ' end arises from the oligo(dT)12-18 used to prime 
cDNA synthesis and the C residues from the 'tailing' 
react ions.
Klapper (1977) examined the frequency of amino acid 
pairs in proteins and from this work calculated the 
composition of an 'average' protein. Compared to the 
'average' protein of Klapper (1977) the NS protein is 
relatively rich in aspartic and methionine but deficient in 
alanine and glycine (Table 4.1).
Figure 4.3 shows a translation of the NS protein with
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N-chlorosuccinimide (NCS) cleaves protein molecules at 
tryptophan residues. The efficiency of the cleavage is 
dependant upon the local amino acid environment.
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acidic and basic amino acids highlighted. The NS protein is 
highly acidic especially in the amino-terminal half. If we 
assume the values for the charge of amino acids shown in 
Table 4.2 then at pH7.0 the NS protein has an overall charge 
of -18.5.
The acidity is probably the reason for the aberrant 
mobility of the NS protein on SDS-polyacrylamide gels.
Early estimates of the mol wt of NS protein determined from 
its relative mobility on these gels were usually too large, 
being between 40-60,000 (Kang and Prevec, 1971; Knipe et a l , 
1975; Mudd and Summers, 1970; Obijeski et al, 1974). The 
high concentration of acidic residues especially in the 
amino-terminal half might be responsible for a deficiency in 
SDS binding which results in the low electrophoretic 
mobility of the NS protein. Bell and Prevec (1985) by 
cleavage of NS protein with N-chlorosuccinimide (NCS), 
showed that the region responsible for the anomalous 
migration of NS protein on SDS polyacrylamide gels does 
reside in the amino-terminal half of the protein.
The aberrant migration of the NS protein on SDS gels 
has previously been attributed to the fact the NS is a 
phosphoprotein; however, dephosphorylation of NS protein by 
alkaline phosphatase results in decreased mobility (Hsu and 
Kingsbury, 1980) . A number of workers have proposed that NS 
protein has an unusual monomeric structure or it migrates as 
a dimer (Evans et al, 1979; Gallione et al, 1981). Bell and 
Prevec (1985) showed that incomplete NCS cleavage of NS 
protein produces no more than four cleavage products. Since 
even the simplest dimer of NS protein ie. one cross-linked 
in the carboxy-terminal fragment, would be expected to
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generate eight new partial cleavage products when subjected 
to incomplete NCS cleavage, the dimer theory must be ruled 
out .
Figure 4.4 shows there are 46 potential phosphorylated 
amino acids (ie. serine or threonine) in the NS protein of 
VSV NJ, strain Missouri: 13 threonines and 33 serines. The 
majority of the potential phosphorylated amino acids lie in 
the amino half of the molecule. These data support the work 
of Bell and Prevec (1985) who showed that most of the 
phosphate groups are located on residues in the 
amino-terminal the molecule in the New Jersey and
Indiana serotypes of VSV and Piry virus. This consistency 
supports the idea that phosphorylation in the amino-terminal 
half of the protein is structurally significant to the 
molecule.
Figure 4.5 shows a hydropathic plot (Kyte and 
Doolittle, 1982) of the NS protein. The program of Kyte and 
Doolittle (1982) uses a hydropathy scale in which each amino 
acid has been assigned a value reflecting its relative 
hydrophilicity and hydrophobicity. The program moves along 
a sequence from the amino to the carboxy terminus 
calculating, as it does, the average hydropathy. In Figure 
4.5 the residues above the line are hydrophobic and those 
below the line are hydrophilic. As one would expect from 
such a highly charged protein it is predominantly 
hydrophilic. The most hydrophilic portions lie in the 
amino-terminal half of the molecule.
The sequence data of the NS mRNA of wild-type VSV NJ, 
Missouri strain combined with the results of physical 
studies on the NS protein of other strains of VSV all point
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to the amino-terminal half of the protein being important to 
its function. Comparison of the sequence of the NS mRNA of 
the Missouri strain with that of other strains of VSV 
combined with the comparison of the proteins they encode 
might now be useful in trying to define the precise areas of 
the protein that are important to its function.
2. COMPARISON OF THE NS GENES AND PROTEINS
The NS genes of four strains of VSV have now been 
fully sequenced. The four strains represent two subtypes 
from each of the two serotypes of VSV. Table 4.3 is a 
comparison of the four strains at the nucleotide and amino 
acid levels.
Table 4.3 shows that viruses from the same serotype 
have the same length of mRNA and code for proteins of the 
same size. There is high homology between viruses of the 
same serotype both at the nucleotide and amino acid level.
If nucleotide homology is taken as a measure of the 
relatedness of two viruses then the two viruses from the IND 
subtype (9 7 %) are more closely related than the two viruses 
from the NJ serotype (85%).
The two strains of the NJ serotype were isolated six 
years apart. The Ogden strain representing the Concan 
subtype was isolated from cattle in Utah in 1949; the 
Missouri strain representing the Hazelhurst subtype from 
swine in 1943 (C.R. Pringle, personal communication). I 
have not been able to find any information on the origin of 
the two IND strains but the greater sequence divergence in 
the NJ serotype is probably due to the fact that one of the
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strains belongs to the Hazelhurst subtype. The Hazelhurst 
subtype is regarded as an unrepresentative form of the NJ 
serotype due to its apparently limited host range 
(Schnitzlein and Reichmann, 1985). Until 1982 when it was 
isolated from horses and black flies (Simuliidae) in an 
outbreak near Loveland, Colorado, the Hazelhurst subtype had 
only been isolated from swine (Schnitzlein and Reichmann,
1985) .
Figure 4.6 shows the nucleotide sequences of the NS 
mRNAs of the Ogden and Missouri strains of the NJ serotype 
aligned for maximum homology using the HOMOL program of 
Taylor (1984) . The majority of the differences occur in the 
3' half of the mRNA. A limited comparison of 151 bases at 
the 5 1 end and 208 bases at the 3 1 end of the N mRNA of the 
Missouri and Ogden strains shows a similar degree of 
homology (D.J. McGeoch, personal communication; Pringle,
1986) .
Figure 4.7 shows that there are 27 amino acid 
differences between the two NS proteins of the Ogden and 
Missouri strains. In particular, there are six contiguous 
mismatched residues at position 200-205. However, 13 of the 
27 amino acid differences are the result of conservative 
changes and so one can say that there is only 5% difference 
in the amino acid content of the two proteins. On 
SDS-polyacrylamide gels the difference in amino acid 
composition manifests itself as a difference in the 
electrophoretic mobility of the NS proteins (Schnitzlein and 
Reichmann, 1985). Gopalkrishna and Lenard compared the M 
genes of three strains of VSV IND (San Juan, Glasgow, Orsay) 
and reported 1 .8 % nucleotide and 2 .6% amino acid differences
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between the three strains. The values for the nucleotide 
and amino acid differences between the NS genes of the San 
Juan and Mudd-Summers strain of VSV IND (3% and 5% 
respectively) are approximately double those obtained for 
the M gene by Gopalkrishna and Lenard (1985). Thus it seems 
that the M gene is more highly conserved than the NS gene.
Between serotypes there is approximately 50% 
nucleotide homology and 33% amino acid homology (Table 4.3). 
In Figure 4.8 the distribution of homology between the NS 
genes of the IND and NJ serotypes at the amino acid and 
nucleotide level is shown as a computer generated dot 
matrix. The computer compares sequences of a certain size 
and, depending on the degree of homology, prints a dot of 
variable intensity. Thus regions of homology are denoted by 
a diagonal line and the level of homology by the thickness 
of the line. At the nucleotide level the homology is quite 
scattered; however, at the amino acid level it is apparent 
that the two proteins are related.
When one examines the amino acid composition of the 
four NS proteins (See Table 4.4) it can be seen that overall 
their composition is very similar. However, the serotypes 
do differ in the relative amounts of val ine,/\ alanine and 
cysteine. The overall similarity in amino acid composition 
is reflected in the hydropathicity profiles of the proteins. 
Figure 4 . 9 is a comparison of the hydropathic plots of the 
four NS proteins. The profiles are very similar, the four 
proteins being predominantly hydrophilic especially in the
amino-terminal half.
Figure 4.10 shows the predicted secondary structure of
VSV NJ, Missouri strain and VSV IND, San Juan strain. The
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secondary structures were predicted following the method of 
Chou and Fasman (1978). It can be seen from Figure 4.10 
that the proteins share a number of features in their 
predicted secondary structures. The degree of secondary 
structure predicted for the first 190 amino acids of each 
protein is very similar. The majority of the potential 
phosphorylated residues lie in this region. It is unclear 
how the areas of complex secondary structure and 
phosphorylation are related to one another. The shaded 
areas are regions of hydrophobicty. Predictions show that 
the areas of hydrophi1 icity are predominantly in the 
amino-terminal half of the proteins.
As mentioned earlier comparisons of related proteins 
can give some insight into structurally important regions.
If a region is conserved between related proteins then that 
region is likely to be functionally important. Likewise a 
rapidly changing region is probably not important to 
function (Dover and Flavell, 1984). Figure 4.11 is a 
comparison of the four NS proteins aligned for maximum 
homology using the HOMOL program of Taylor (1984). The 
overall homology between the four NS proteins is 33%. If 
conservative changes are considered then the homology is 
increased to 52% (see Table 4.5).
In Figure 4.11 there are ■jouv'' domains designated I, 
III \\/
Domains I^Jand III are regions of high conservation and 
so might be important to the function of NS protein. In 
these areas there is approximately double the overall 
homology. When conservative changes are taken into 
consideration the homologies are considerably greater being
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over 90% for domain III (see Table 4.5).
Domain I i s  the area where there is the most 
difference between the two NS proteins of the NJ serotype 
and the area where a deletion has been made in the NS
protein sequences of the IND serotypes in order to align the
proteins. This suggests that this domain is a non-essential 
or dispensable portion of the protein.
There are 18 potential phosphorylated residues 
conserved between the four NS proteins and these are 
highlighted in Figure 4.12. The Mudd-Summers strain of VSV 
has the least number of serine and threonine residues (38)
and of those 48% are conserved between the four proteins.
Interestingly, none of the conserved serine or threonine 
residues appear in the highly conserved carboxy-terminal 
region (domain III).
Kingsbury and co-workers have studied NS protein 
phosphorylation by examining the products of chemical or 
enzymic cleavage of the NS protein of VSV IND. The NS1 
class of molecules are phosphorylated in two relatively 
acidic clusters of chymotryptic peptides and molecules of 
the NS2 class are phosphorylated at several additional 
peptides (Hsu et al, 1982). Hsu and Kingsbury (1985) 
proposed that every molecule of NS protein was 
phosphorylated at a set of common residues they termed the 
constitutive phophorylation sites. In their hypothesis 
phosphorylation of the constitutive sites was essential for 
a basal level of NS protein activity (Hsu and Kingsbury,
1985) .
Further analysis of the NS protein by chemical and 
enzymic means localised the constitutive sites to a peptide
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between amino acids 38 and 75 (Hsu and Kingsbury, 1985).
Bell and Prevec (1985) observed the same major 
phosphorylation patterns in all forms of cytoplasmic NS 
protein (whether the NS proteins were derived from the 
soluble cytoplasmic pool or attached to nucleocapsids) and 
so their results support the hypothesis of Hsu and Kingsbury 
(1985) that a common set of residues are phosphorylated in 
all forms of NS protein.
Inspection of the deduced amino acid sequence of the 
NS protein of the IND serotype (Gallione et al, 1981, with 
corrections by J.K. Rose, 1985) reveals there are five 
residues in the peptide between amino acids 38 and 75 with 
the ability to accept a phosphate group. Hsu and Kingsbury 
(1985) proposed these five residues were the constitutively 
phosphorylated residues.
Figure 4.12 shows that the five residues identified by 
Hsu and Kingsbury (1985) as being the constitutively 
phosphorylated residues in the NS protein of VSV IND are 
conserved between the four NS proteins. These data in 
addition to those of other workers (Hsu and Kingsbury, 1985; 
Bell and Prevec, 1985) points to the five residues 
highlighted in Figure 4.12 being important in NS protein 
act ivi ty .
The overall conclusion to be drawn from the comparison 
of the NS proteins of the four different strains of VSV is 
that structurally the proteins are very similar although 
there is only limited sequence homology.
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Figure 4.1
Restriction enzyme map of the insert from pNJNSl 
showing the cloning and sequencing strategy. The insert of 
pNJNSl represents a full-length cDNA copy of the NS mRNA of 
VSV NJ, Missouri strain. g /C at the ends indicate Pst1 
sites generated by the G/C cloning procedure. The scale 
measures distances from the 5' end of the NS mRNA in 
hundreds of nucleotides. Restriction enzyme fragments used 
to derive the sequences are shown in the lower part of the 
figure and the arrows represent the limits of the sequence 
data from each fragment.
A = Hpall 
B = Hinfl 
C = Haelll 
D = Pstl
Met Asp Ser lie Asp Arg Leu Lys Thr Tyr Leu Ala Thr Tyr Asp Asn 
AACAGAGATC ATG GAC AGT ATT GAT CGG CTC AAA ACT TAC TTG GCT ACT TAT GAT AAT
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Leu
TTG
Asp
GAT
Ser
TCT
Ala
GCC
Leu
TTG
Gin
CAG
Asp
GAT
Ala
GCA
Asn
AAT
Glu
GAG
Leu
CTC
Gin
CAA
Asp
GAC
Leu
CTC
Phe
TTC
lie
ATC
Glu
GAA
Asp
GAT
Gin
CAA
Gly
GGA
Glu
GAA
Glu
GAA
Glu
GAA
Ser
TCG
Ser
TCA
Asp
GAT
Ser
TCA
Asp
GAT
Thr
ACT
Asp
GAC
Ser
TCG
Pro
CCG
Asp
GAT
Glu
GAA
Arg
AGA
lie
ATA
Asp
GAC
Lys
AAA
Trp
TGG
Glu
GAA
Asp
GAT
Asp
GAT
Asp
GAT
H e
ATA
Pro
CCA
Val
GTA
Thr
ACT
Phe
TTT
Ser
TCT
Asp
GAC
Gly
GGA
Gly
GGG
Glu
GAG
Lys
AAA
Ser
TCA
Leu
CTA
Ser
TCT
Leu
CTG
Phe
TTT
Pro
CCT
Asp
GAC
Gin
CAA
Trp
TGG
Arg
AGG
Lys
AAG
Thr
ACA
lie
ATT
Glu
GAG
Ala
GCA
Val
GTC
Ser
TCA
Glu
GAA
Cys
TGT
Gin
CAG
lie
ATT
Met
ATG
Asn
AAC
Ser
TCA
Glu
GAA
Asp
GAT
Thr
ACT
Pro
CCT
Asp
GAC
Cys
TGC
Ser
AGT
Ser
TCA
Ser
TCA
lie
ATC
Lys
AAA
Ser
TCT
Leu
CTC
Ser
TCC
Ser
TCC
Ser
TCG
His
CAT
Ser
TCA
Pro
CCC
Gly
GGT
Pro
CCA
Ala
GCA
Trp
TGG
Asp
GAT
Ser
TCA
Lys
AAA
Ser
TCA
Thr
ACA
Glu
GAA
Val
GTA
Gin
CAA
Leu
CTG
Met
ATG
Met
ATG
Val
GTG
Lys
AAA
Leu
TTG
Thr
ACA
Asp
GAC
Phe
TTT
Phe
TTT
Gly
GGA
Pro
CCA
Glu
GAA
Gly
GGG
Ala
GCC
Pro
CCA
Asp
GAT
Leu
TTG
Met
ATG
Gly
GGA
Ala
GCA
Ser
TCT
Glu
GAA
Glu
GAA
Arg
AGA
Arg
AGA
Glu
GAG
Asp
GAT
Lys
AAA
Tyr
TAT
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Asp
GAT
Lys
AAA
Pro
CCA
Thr
ACT
Pro
CCG
Ser
TCA
Tyr
TAT
Tyr
TAT
Gin
CAG
54
172
Tyr
TAT
Asn
AAT
Ala
GCT
Glu
GAA
His
CAT
Leu
CTT
Thr
ACG
Met
ATG
Leu
TTG
73
229
Glu
GAA
Asp
GAT
Leu
TTG
Pro
CCC
Glu
GAA
Leu
TTG
Glu
GAA
Lys
AAG
lie
ATT
92
286
Trp
TGG
Thr
ACA
Gin
CAA
Pro
CCT
Val
GTA
Met
ATG
Lys
AAG
Glu
GAA
Asn
AAC
111
343
Pro
CCG
Val
GTT
Gly
GGA
Leu
TTA
Thr
ACA
Lys
AAA
Val
GTT
Gin
CAG
Thr
ACA
130
400
Cys
TGT
Glu
GAG
Ser
AGC
Ser
TCT
Lys
AAA
Tyr
TAT
Trp
TGG
Asn
AAT
Leu
TTG
149
457
Arg
CGT
Leu
CTT
lie
ATC
Leu
CTC
Lys
AAA
Gly
GGC
Arg
CGA
lie
ATT
Met
ATG
168
514
Gin
CAG
Asn
AAC
Ser
TCC
lie
ATA
Gin
CAG
Ser
AGT
Ser
TCC
Glu
GAA
Ser
TCT
187
571
Pro
CCA
Lys
AAG
Ser
TCA
Arg
CGG
Asn
AAT
Gin
CAA
Leu
CTA
Gly
GGT
Leu
CTA
206
628
lie
ATC
Ser
TCG
Lys
AAG
Arg
AGG
Ala
GCC
Gly
GGA
Val
GTG
Lys
AAG
Asp
GAC
225
685
Ser
AGT
Glu
GAA
Glu
GAG
Glu
GAA
Tyr
TAT
Tyr
TAT
Ser
TCA
Val
GTA
Cys
TGC
244
742
lie
ATC
lie
ATC
Met
ATG
Gly
GGA
Leu
CTA
Lys
AAA
His
CAT
Lys
AAA
Lys
AAG
263
799
Leu Phe Asn Gin Ala Arg Met Lys Tyr Arg lie --
CTT TTT AAC CAA GCA AGA ATG AAG TAT CGT ATC TAA TTAATTCCGATGATCAA^ATG
274
856
Figure 4.2
Nucleotide sequence and deduced amino acid sequence of 
the NS mRNA of VSV NJ, Missouri strain. The 5' terminal 
methylated cap structure and 3' terminal poly(A) tail are 
not shown. The 5' and 3' consensus sequences are 
highlighted. The NS mRNA is 856 nucleotides long and codes 
for a protein of 274 amino acids (mol wt 31,000).
Met
AACAGAGATC ATG
Asp Ser lie Asp Arg Leu Lys Thr Tyr Leu Ala Thr Tyr Asp Asn 16
GAC AGT ATT GAT CGG CTC AAA ACT TAC TTG GCT ACT TAT GAT AAT 58
Leu
TTG
Asp
GAT
Ser Ala Leu Gin 
TCT GCC TTG CAG
Asp
GAT
Ala Asn 
GCA AAT
Glu
GAG
Ser
TCT
Glu Glu 
GAA GAA
Arg Arg 
AGA AGA
Glu Asp 
GAG GAT
Lys
AAA
Tyr
TAT
Leu Gin 
CTC CAA
Glu Glu Glu
GAA GAA GAA
Ser Ser 
TCG TCA
Asp
GAT
Ser Asp" 
TCA GAT
Ser Pro 
TCG CCG
Asp Glu 
GAT GAA
Arg
AGA
H e
ATA
Asp
GAC
Lys
AAA
Thr
ACT
Trp
TGG
Asp
GAC
Tyr Asn Ala 
TAT AAT GCT
Glu
GAA
His
CAT
Leu Thr Met Leu 
CTT ACG ATG TTG
Glu Glu Asp 
GAA GAA GAT
Leu Pro 
TTG CCC
Glu
GAA
Leu
TTG
Asp Asp Asp lie Pro Val Thr Phe Ser Asp
GAT GAT GAT ATA CCA GTA ACT TTT TCT GAC
Trp Thr Gin pro Val Met 
TGG ACA CAA CCT GTA ATG
Glu
GAA
Lys
AAG
Lys
AAG
Glu
GAA
lie
ATT
Asn
AAC
Gly Gly Glu Lys Ser Leu Ser Leu Phe Pro Pro Val Gly Leu Thr Lys
GGA GGG GAG AAA TCA CTA TCT CTG TTT CCT CCG GTT GGA TTA ACA AAA
Val Gin Thr 
GTT CAG ACA
Asp
GAC
Gin Trp 
CAA TGG
Arg Lys 
AGG AAG
Thr lie 
ACA ATT
Glu
GAG
Ala Val Cys 
GCA GTC TGT
Glu
GAG
Ser Ser 
AGC TCT
Lys
AAA
Tyr Trp Asn Leu 
TAT TGG AAT TTG
Ser
TCA
Glu
GAA
Cys Gin lie Met Asn Ser 
TGT CAG ATT ATG AAC TCA
Glu Asp 
GAA GAT
Arg Leu lie Leu 
CGT I CTT ATC CTC
Lys Gly 
AAAI GGC
Arg
CGA
lie Met 
ATT ATG
Thr Pro Asp Cys Ser Ser Ser lie Lys Ser Gin Asn Ser lie Gin Ser Ser Glu
ACT CCT GAC TGC AGT TCA TCA ATC AAA TCT CAG AAC TCC ATA CAG AGT TCC GAA
Ser
TCT
Leu Ser Ser Ser
CTC TCC TCC TCG
Trp Asp Ser Lys
TGG GAT TCA AAA
Met Met Val Lys
ATG ATG GTG AAA
Pro Glu Gly Ala
CCA GAA! GGG GCC
Leu Phe Asn Gin
CTT TTT AAC CAA
His
CAT
Ser Thr 
TCA ACA
Leu Thr 
TTG ACA
Glu Val Gin Leu lie Ser 
GAA GTA CAA CTG ATC TCG
Lys ArgjAla Gly Val 
AAG AGG GCC GGA GTG
Lys
AAG
Asp
GAC
Asp
GAC
Phe Phe Gly Ser 
TTT TTT GGA AGT
Lys Tyr Arg
AAG TAT CGT
H e --
ATC TAA TTAATTCCGATGATCAATATG
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Asp Leu Phe lie Glu Asp Gin Gly Asp Lys Pro Thr Pro Ser Tyr Tyr Gin 54
GAC CTC TTC ATC GAA GAT CAA GGA GAT AAA CCA ACT CCG TCA TAT TAT CAG 172
73
229
92
286
111
343
130
400
149
457
168
514
187
571
Ser Pro Gly Pro Ala Pro Lys Ser Arq Asn Gin Leu Gly Leu 206
TCA CCC GGT CCA GCA CCA AAG TCA CGG AAT CAA CTA GGT CTA 628
225
685
Glu Glu Glu Tyr Tyr Ser Val Cys 244
GAA GAG GAA TAT TAT TCA GTA TGC 742
|Lys His Lys Lys 263
1 AAA CAT AAA AAG 799
274
856
Figure 4.3
Nucleotide and predicted amino acid sequence of the NS 
mRNA of VSV NJ , Missouri strain. The acidic ( ) and
basic ( £  ) amino acids are highlighted. The NS protein
is highly acidic especially in the amino terminal half.
Met Asp 
AACAGAGATC ATG GAC
Ser
AGT
lie Asp Arg Leu Lys 
ATT GAT CGG CTC AAA
Thr
ACT
Tyr Leu Ala 
TAC TTG GCT
Thr
ACT
Tyr Asp Asn 16
TAT GAT AAT 58
Leu Asp Ser Ala Leu Gin Asp Ala Asn Glu Ser
TTG GAT TCT GCC TTG CAG GAT GCA AAT GAG TCT
Leu Gin Asp Leu Phe H e Glu Asp Gin Gly Asp
CTC CAA GAC CTC TTC ATC GAA GAT CAA GGA GAT
Glu Glu Glu Ser Ser Asp Ser Asp Thr ASp Tyr
GAA GAA GAA TCG TCA GAT TCA GAT ACT GAC TAT
Ser Pro Asp Glu Arg lie Asp Lys Trp Glu Glu
TCG CCG GAT GAA AGA ATA GAC AAA TGG GAA GAA
Arg Arg
AGA AGA
Thr Pro
ACT CCG
Glu His
GAA CAT
Pro Glu
CCC GAA
Ser
TCA
Tyr
TAT
Leu
CTT
Thr
ACG
Met Leu 
ATG TTG
35
115
54
172
73
229
92
286
Asp Asp Asp lie Pro Val Thr Phe Ser Asp Trp Thr
GAT GAT GAT ATA CCA GTA ACT TTT TCT GAC TGG ACA
Gly Gly Glu Lys 
GGA GGG GAG AAA
Ser Leu
TCA CTA
Ser
TCT
Asp Gin Trp Arg Lys 
GAC CAA TGG AGG AAG
Thr
ACA
lie Glu Ala Val Cys Glu 
ATT GAG GCA GTC TGT GAG
Gin Pro Val
CAA CCT GTA
Gly Leu Thr
GGA TTA ACA
Ser Ser Lys
AGC TCT AAA
Lys Val Gin 
AAA GTT CAG
Thr
ACA
Ser Glu Cys Gin H e Met Asn Ser Glu Asp Arg Leu lie Leu Lys Gly Arg lie Met
TCA GAA TGT CAG ATT ATG AAC TCA GAA GAT CGT CTT ATC CTC AAA GGC CGA ATT ATG
Thr Pro Asp Cys Ser Ser Seri lie Lys Ser! Gin Asn Ser H e Gin Ser Ser Glu Ser
ACT CCT GAC TGC AGT TCA t c a IATC AAA TCTj CAG AAC TCC ATA CAG AGT TCC GAA TCT
111
343
130
400
149
457
168
514
187
571
Leu
CTC
Ser Ser Ser His Ser Pro Gly Pro Ala Pro Lys Ser Arg Asn Gin Leu Gly Leu 206
TCC TCC TCG CAT TCA CCC GGT CCA GCA CCA AAG TCA CGG AAT CAA CTA GGT CTA 628
Trp Asp
TGG GAT
Ser Lys 
TCA] AAA
Ser Thr Glu Val Gin Leu H e Ser Lys Arg Ala Gly Val Lys Asp 225
TCA ACA GAA GTA CAA CTG ATC TCG AAG AGG GCC GGA GTG AAG GAC 685
Met Met Val Lys Leu Thr ASp Phe Phe Gly Ser Glu Glu Glu Tyr Tyr Ser Val Cys 244
ATG ATG GTG AAA TTG ACA GAC TTT TTT GGA AGT GAA GAG GAA TAT TAT TCA GTA TGC 742
Pro Glu Gly Ala Pro Asp Leu Met Gly Al a lie lie Met Gly Leu Lys His Lys Lys 263
CCA GAA GGG GCC CCA GAT TTG ATG GGA GCA ATC ATC ATG GGA CTA AAA CAT AAA AAG 799
Leu Phe Asn Gin Ala Arg Met Lys Tyr Arg lie  
CTT TTT AAC CAA GCA AGA ATG AAG TAT CGT ATC TAA TTAATTCCGATGATCAATATG
274
856
Figure 4.4
Nucleotide and predicted amino acid sequence of the NS 
mRNA of VSV NJ, Missouri strain with the potential 
phosphorylated residues (ie. serines and threonines) 
highlighted. There are 46 potential phosphorylation sites 
in the protein: 13 threonines, 33 serines.
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Figure 4.5
Hydropathy plot of the NS protein of VSV NJ , Missouri 
strain using the program of Kyte and Doolittle (1982). The 
degree of hydrophobicity increases with the distance above 
the horizontal line; hydrophilicity increases with distance 
below the horizontal line. The letters below the plot refer 
to the amino acid residues. The NS protein is predominantly 
a hydrophilic protein.
Parameters used were: group length = 9
shift = 1
spacing between plotted points = 2
A window size of nine amino acids was used in the plot and 
so the letters below the plot refer to each ninth amino 
acid.
First sequence: NJNS.RAE
Second sequence: NJNS.BAN
1 AACAGAGATCATGGACAGTATTGATCGGCTCAAAACTTACTTGGCTACTTATGATAATTTGGATTCTGCCTTGC 
* * * * * *  * * * * * * * * * * * *  * * * * *  * * * * * * *  * * * * * * * *  * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * *
1 AACAGATATCATGGACAGTGTTGATAGGCTCAAGACTTACTTAGCCACTTATGATAATTTGGATTCTGCCTTGC
75 AGGATGCAAATGAGTCTGAAGAAAGAAGAGAGGATAAATATCTCCAAGACCTCTTCATCGAAGATCAAGGAGAT 
* * * * * * *  * * * * *  * * * * *  * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
75 AGGATGCCAATGAATCTGAGGAAAGACGAGAGGATAAATATCTCCAAGACCTCTTCATCGAAGATCAAGGAGAT
149 AAACCAACTCCGTCATATTATCAGGAAGAAGAATCGTCAGATTCAGATACTGACTATAATGCTGAACATCTTAC 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * *
149 AAACCAACTCCGTCATATTATCAGGAAGAAGAATCGTCAGATTCAGATACTGATTATAATGCTGAACATCTTAC
223 GATGTTGTCGCCGGATGAAAGAATAGACAAATGGGAAGAAGATTTGCCCGAATTGGAAAAGATTGATGATGATA 
* * * *  * * * *  * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * *  * * * * *  * * * * * * * * * * * * * * * * * * *
223 GATGCTGTCACCGGATGAAAGAATAGACAAGTGGGAAGAAGATTTGCCTGAATTAGAAAAGATTGATGATGATA
297 TACCAGTAACTTTTTCTGACTGGACACAACCTGTAATGAAGGAAAACGGAGGGGAGAAATCACTATCTCTGTTT 
* * * *  * *  * *  * * * * * * * *  * * * * * * * *  * * * * * * * * * * * * * * * * *  * *  * *  * * * * * * * * *  * * * * * * * * *
297 TACCGGTGACCTTTTCTGATTGGACACAGCCTGTAATGAAGGAAAATGGGGGAGAGAAATCATTGTCTCTGTTC
371 CCTCCGGTTGGATTAACAAAAGTTCAGACAGACCAATGGAGGAAGACAATTGAGGCAGTCTGTGAGAGCTCTAA 
* * * * *  * *  * *  * * * * * * * *  * * * *  * * * * *  * * * * * * *  * *  * *  * * * * * * * *  * *  * * * * * * * *  * *  **
371 CCTCCAGTCGGGTTAACAAAGATTCAAACAGAACAATGGAAAAAAACCATTGAGGCGGTTTGTGAGAGTTCAAA
445 ATATTGGAATTTGTCAGAATGTCAGATTATGAACTCAGAAGATCGTCTTATCCTCAAAGGCCGAATTATGACTC 
************ ******** ** *** * **** ***** ★ ** * ************ * *******
445 ATATTGGAATTTATCAGAATGCCAAATTCTTAACTTGGAAGACAGCCTCACTCTCAAAGGCCGATTGATGACTC
519 CTGACTGCAGTTCATCAATCAAATCTCAGAACTCCATACAGAGTTCCGAATCTCTCTCCTCCTCGCATTCACCC 
* * * *  * *  * * * * *  * * *  * * * * * * * * *  * *  * *  * * * * *  * *  * * *  * * * * * *  * * * * * *  * * * * *  * *
519 CTGATTGTAGTTCTTCAGTAAAATCTCAAAATTCTGTCCGGAGGTCAGAACCTCTCTACTCCTCTCATTCTCCA
593 GGTCCAGCAC CAAAGTCACGGAATCAACTAGGTCTATGGGATTCAAAATCAACAGAAGTACAACTGATCTCGA 
* * * * *  * * *  * * *  * *  * * * * * * *  * * * * * * * * * *  * * *  * *  * *  * * * * * * * * *  * * * * * * *  *
593 GGTCCCCCACTCAAGGTATCAGAGTCCA TCAATTTATGGGATTTAAAGTCCACTGAAGTACAATTGATCTCCA
666 AGAGGGCCGGAGTGAAGGACATGATGGTGAAATTGACAGACTTTTTTGGAAGTGAAGAGGAATATTATTCAGTA 
* * * *  * * * * * * * *  * * * * * * * * * *  * *  * * * * * * * * * * * * * *  * * * * * * * * * * *  * *  * *  * * * * * * * * * * * *
666 AGAGAGCCGGAGTTAAGGACATGACAGTCAAATTGACAGACTTCTTTGGAAGTGAGGAAGAGTATTATTCAGTA
740 TGCCCAGAAGGGGCCCCAGATTTGATGGGAGCAATCATCATGGGACTAAAACATAAAAAGCTTTTTAACCAAGC 
* * * * * * * * * * * * * *  * * * * *  * * * * * * * * * * *  * * * * * * * * * * * * * *  * *  * * *  * *  * *  * *  * *  * *  **
740 TGCCCAGAAGGGGCGCCAGACTTGATGGGAGCTATCATCATGGGACTGAAGTACAAGAAACTCTTCAATCAGGC
814 AAGAATGAAGTATCGTATCTAATTAATTCCGATGATCAATATG 
* * * * * * * * *  * * * * * *  * * * * * *  * *  * * * * * * * * * * * *
814 AAGAATGAAATATCGTCTTTAATTCCTTTTCATGATCAATATG
Matched = 732 out of 857 percent 85
Mutation weight = 5 Gap weights = 3k + 7, k up to 2000
Evolutionary distance = 635
Figure 4.6
Comparison of the nucleotide sequences of the NS mRNAs 
of the Ogden and Missouri strains of VSV N J . The sequences 
are aligned for maximum homology by the program of Taylor 
(1984) .
NJNS.RAE = sequence of NS mRNA of VSV NJ, Missouri strain 
NJNS.BAN = sequence of NS mRNA of VSV NJ, Ogden strain
Matched residues are indicated by *
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Figure 4.7
Comparison of the NS proteins of the Ogden and 
Missouri strains of VSV NJ. The two sequences have been 
aligned for maximum homology by the HOMOL program of Taylor 
(1984).
OP.RAE = sequence of NS protein of VSV NJ, Missouri strain 
OP.BAN = sequence of NS protein of VSV NJ, Ogden strain
Mismatched residues are indicated by an *.
NJ
AMINO ACIDS
B
IND
N J
NUCLEOTIDE3
Figure 4.8
Computer generated dot matrix comparisons of (A) the 
amino acid sequences and (B) the nucleotide sequences of 
the NS genes of VSV IND, San-Juan strain and VSV NJ, 
Missouri strain. In (A) a window of seven amino acid 
residues was used; in (B) a window of twelve nucleotides 
was used. Regions of homology are denoted by a diagonal 
line, and the level of homology by the thickness of the 
line.
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Figure 4.9
Comparison of the hydropathic profiles of the NS 
proteins from four strains of VSV as predicted by the 
program of Kyte and Doolittle (1982). The degree of 
hydrophobicity increases with distance above the mid-line; 
the degree of hydrophilicity increases with distance below 
the mid-line. Letters beneath the plots refer to amino acid 
residues.
A - V
B = VSV NJ , Ogden strain
C = VSV IND, San Juan strain
D = VSV IND, Mudd-Summers strain
Parameters: group length = 9
shift = 1
spacing betwen plotted points = 2
The four NS proteins from the different strains of VSV 
are broadly similar in that they are predominantly 
hydrophilic proteins.
Figure 4.10
Predicted secondary structure of the NS proteins of 
VSV IND, San Juan strain (A) and VSV NJ, Missouri strain
(B). The method of Chou and Fasman (1978) was used to 
predict the secondary structure of the proteins and the 
results were graphically displayed using the PLOTCHOU 
program contained in the University of Wisconsin Genetics 
Group Computer software package. The plots show the 
predicted locations of alpha coil (Ji/l/lrt) ; beta sheet ('*'****) 
and random coil (-— ^) from the amino terminus to the carboxy 
terminus. Shaded ovals represent hydrophobic regions and 
open ovals represent hydrophilic regions. A change of 
direction indicates -turn.
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Figure 4.11
Comparison of the four NS proteins of different 
strains of VSV. The amino acid sequences have been aligned 
for maximum homology using the HOMOL program of Taylor 
(1984). The shaded regions ( ) denote amino acids that
are conserved between the four strains. The filled circles 
denote conservative changes.
OG = Ogden strain, NJ serotype 
MIS = Missouri strain, NJ serotype 
SJ = San Juan strain, IND serotype 
M-S = Mudd-Summers strain, IND serotype
Domains I and III are regions of higher homology 
Domain II is a region where there is no exact homology
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Figure 4.12
Alignment of the NS proteins of four strains of VSV. 
Conserved phosphorylation sites are highlighted. Eighteen 
potential phosphorylation sites are conserved between the 
four proteins. The five potential phosphorylated residues 
conserved in the domain marked (A) are the proposed sites of 
constitutive phosphorylation.
Table 4.1 Amino Acid Composition of the NS Protein 
of VSV New Jersey, Missouri strain Compared 
with that of an 'Average' Protein
Amino
Acid
NS Protein VSV 
Missouri Strain
NJ 1 Average' 
Protein
No of Residues % %
Alanine (A) 10 3.6 9.0
Arginine (R) 11 4.0 4.7
Asparagine (N) 9 3.6 4.4
Aspartic Acid (D) 26 9.5 5.5
Cysteine (C) 4 1.5 2.8
Glutamine (Q) 13 4.7 3.9
Glutamic Acid (E) 26 9.5 6.2
Glycine (G) 12 4.4 7.5
Histidine (H) 3 1.1 2.1
Isoleucine (I ) 15 5.5 4.6
Leucine (L) 24 00 CO 7.5
Methionine (M) 10 3.6 1.7
Phenylalanine (F) 6 2.2 3.5
Proline (P) 14 5.1 4.6
Serine (S) 33 12.0 7.1
Threonine (T) 13 4.7 6.0
Tryptophan (W) 5 1.8 1.1
Tyrosine (y) 10 3.6 3.5
Valine (V) 9 3.3 6.9
Klapper (1977)
Table 4.2 Assumed Charges of Amino Acids at pH7.0
Amino Acid Charge
Lysine +1
Arginine +1
Histidine +0.5
Aspartic Acid -1
Glutamic Acid -1
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Table 4.4 Comparison of the Amino Acid Composition 
of the NS Proteins of Four Strains of VSV
% Amino Acids in NS Protein of VSV
Ami no
Acid NJ Serotype IND Serotype
Hazelhurst Missouri Mudd-Summers San-Juan
Phe 2.2 2.2 3.0 3.0
Val 4.4 3.3 6.0 6.4
Al a 3.3 3.6 5.7 6.0
Asn 3.3 3.3 2.6 2.3
Cys 1.5 1.5 0.4 0.4
Leu 10.6 8.8 9.1 8.3
Ser 10.9 12.0 9.1 10.2
Ty r 4.4 3.6 4.2 4.2
Lys 8.0 7.7 6. 8 6. 8
Trp 1 .8 1.8 1. 5 1 . 5
H e 4.0 5.5 4 . 2 3 . 8
Pro 5.5 5.1 4.5 4 . 5
Hi s 0 . 7 1.1 1 . 9 ]_ K
Asp 9.1 9.5 7.2 / . Z
Ar g 3.6 4.0 3.8 3 . 4
Met 2.9 3.6 1.5 1 . 9
Thr 5 . 5 4.7 5.3 5.3
G1 u 4 .0 4.7 6.0 6.0
Girt 10.2 9.5 10.9 11.7
Gly 4.0 4.4 5.7 5.7
Table 4.5 Actual Homology and Homology Including
Conservative Changes Between the Four MS 
Proteins of VSV
% Homology
Actual Including
Conservative Changes
Overall 33 52
Domain I 62 76
Domain II er
Domain III 68 90
Domains I, II and III are defined in Figure 4.11
Chapter 5
SEQUENCE DETERMINATION AND ANALYSIS OF THE 
COMPLEMENTATION GROUP E MUTANTS AND THEIR REVERTANTS
12 2
The site of the t_s lesions in the complementation 
group E mutants of VSV NJ, Missouri strain have been shown 
to be in the NS gene (Evans et al , 1979; Lesnaw et al,
1979). The three mutants (tsEl, tsE2 and tsE3) classified 
in group E form a heterogenous group. They exhibit a 
variety of phenotypes and their NS proteins migrate 
differently from both wild-type virus and one another on 
SDS-polyacrylamide gels. Figure 5.1 shows an in vitro 
translation of RNA isolated from cells infected with 
wild-type and mutant viruses. The 10%, 12% and 15% 
SDS-polyacrylamide gels show the characteristic migration 
pattern of the wild-type and mutant NS proteins. In our gel 
system the NS proteins of wild-type, tsEl, tsE2 and tsE3 
viruses migrate with apparent molecular weight of 59,000, 
50,000, 52,000 and 54,000 respectively.
The complementation group E mutants were isolated from 
wild-type VSV NJ, strain Missouri after exposure to the base 
analogue 5-FU (Pringle et al, 1971). Revertants of tsEl and 
tsE3 are quite readily isolated; however, revertants of tsE2 
have never been detected (Pringle, 1986). The NS proteins 
of all of the revertant viruses isolated by Pringle 
co-migrate with the NS protein of wild-type virus on 
SDS-polyacrylamide gels (Evans et al , 1979; Lesnaw et a l ,
1979) . The mutants of complementation group E and their 
revertants have proved useful in the study of the role of NS 
protein in the replicative cycle of VSV (Lesnaw et a l , 1979; 
Ongradi and Szilagyi, 1981; Cngradi et al , 1985a).
The variety of phenotypes exhibited by the 
complementation group E mutants has led to the proposal of a 
multifunctional role for the NS protein in the VSV
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lifecycle. Because tsEl was found to be defective in the 
RNA replication pathway at the restrictive temperature, 
Lesnaw et al (1979) concluded the NS protein has a role in 
replication. The role of the NS and L proteins in 
transcription was studied by reconstitution-dissociation 
experiments using wild-type virus, tsEl and tsEl/Rl (Ongradi 
and Szilagyi, 1981; Ongradi et al, 1985a,b).
A number of workers have studied the nature of the 
mutations affecting the complementation group E mutants and 
attempted to correlate their findings with the pattern of NS 
protein migration seen on SDS-polyacrylamide gels (Lesnaw et 
a_l, 1979; Maack and Penhoet, 1980). Maack and Penhoet 
(1980) reported that the NS protein of tsEl migrated faster 
than the NS protein of wild-type virus on a number of gel 
systems not containing SDS, and concluded that differential 
SDS binding was not responsible for the aberrant mobility of 
the complementation group E mutants. They isolated 
revertant viruses of tsEl which contained NS proteins which 
were identical to or larger than the NS of tsEl. Analysis 
of tryptic peptides of NS protein labelled with inorganic 
32p showed that these revertants of tsEl contained one more 
non-phosphorylated peptide than tsEl (Maack and Penhoet,
1980). Maack and Penhoet (1980) proposed that the 
differential migration pattern exhibited by the 
complementation group E mutants was due to differences in 
amino acid chain length.
Lesnaw et al (1979), however, proposed that the 
aberrant migration pattern of the complementation group E 
mutants on SDS-polyacrylamide gels was due to conformational 
rather than size differences since the wild-type and mutant
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NS proteins migrated at the same rate when electrophoresed 
in polyacrylamide gels containing 4M urea in addition to 
SDS. Peptide maps obtained by limited proteolysis of the NS 
protein from wild-type and mutant viruses with V8 protease 
and papain suggested that the mutation would involve an 
aspartic or glutamic acid residue (Lesnaw et al , 1979).
In order to precisely map the position of the 
mutation(s) in the NS genes of each virus of complementation 
group E, it was decided to clone and sequence the cDNA of 
the NS mRNAs of tsEl, tsE2, tsE3 and the revertant viruses 
tsEl/Rl and tsE3/Rl.
1. SEQUENCE DETERMINATION OF THE NS mRNAS OF THE 
COMPLEMENTATION GROUP E MUTANTS
The nucleotide sequences of the insert fragments of 
pNJNSEl, pNJNSE2, pNJNSE3, pNJNSRl and pNJNSR3 were 
determined by the dideoxy-chain terminator method as 
previously described for the insert in pNJNSl.
The inserts were sequenced and analysis of the data 
revealed that all three plasmids contained the 5* and 3 ‘ 
consensus sequences (already described in Chapter 4) known 
to be at the ends of the VSV mRNAs. Thus the five plasmids 
contain full-length cDNA copies of the NS mRNAs from each of 
the five viruses.
Figure 5.2(a) shows the nucleotide and predicted 
protein sequence of the NS mRNA of wild-type VSV NJ,
Missouri strain, with the positions of the mutations marked. 
Both tsEl and tsE3 have a single mutation; _tsE2 has two 
mutations. Figure 5.2(b) compares the sequence tracks in
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the region where the mutations occur with the wild-type 
sequence. The gels show quite clearly the single nucleotide 
changes summarised in Figure 5.2(a).
Three out of the four mutations lie in a small region 
of 18 nucleotides and interestingly this region encodes the 
most hydrophilic region of the protein as indicated in 
Figure 5.3. This region is possibly a 'hot-spot' of 
mutation. All of the mutations cause a change in the charge 
of the amino acid affected.
The fact that tsE2 is a double mutant might explain 
why revertants have never been isolated. The possibility of 
viruses reverting to wild-type at both of these positions is 
so small that detection would require the screening of many 
more plaques than have been analysed already (C.R. Pringle, 
personal communication).
2. SEQUENCE DETERMINATION OF NON-ts REVERTANTS 
OF tsEl AND tsE3
Figure 5.4 shows the nucleotide and predicted protein 
sequence of the NS mRNA of wild-type VSV NJ, Missouri strain 
with the changes found in tsEl/Rl and tsE3/Rl marked.
At the sites of the mutations of tsEl and tsE3 the 
revertant viruses have both reverted to the wild-type virus 
sequence. However, the NS mRNAs of tsEl/Rl and tsE3/Rl were 
found to have two further changes later in their nucleotide 
sequence at exactly the same position. Only one of the 
changes actually alters an amino acid.
I am confident that the sequence changes detected in 
the two revertant viruses are not the result of cloning
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artefacts. The cDNA cloning and sequence determination of 
inserts from the resultant recombinant plasmids were done at 
separate times. Furthermore, when the changes were detected 
inserts from three other plasmids identified as being 
tsEl/Rl NS gene-specific were sequenced and yielded the same
altered sequence at the positions shown in Figure 5.4.
3. PROPOSED MECHANISMS BY WHICH THE MUTATIONS IN 
COMPLEMENTATION GROUP E MUTANTS MIGHT AFFECT 
PROTEIN MOBILITY ON SDS-POLYACRYLAMIDE GELS
Table 5.1 is a summary of the sequence data from the 
three complementation group E mutants. All of the mutations 
change the charge of the amino acid they affect. None of 
the mutations generate a stop codon which would lead to 
premature termination of protein synthesis. Thus the 
conclusion reached by Maack and Penhoet (1980) that the 
aberrant electrophoretic mobility of the group E mutants was 
due to the synthesis of a short NS protein must be 
discounted. The sequence data show that, for the most part, 
single base changes are responsible for the dramatic 
alterations in mobility observed on SDS-polyacrylamide gels.
Lesnaw et al (1979) concluded that the aberrant 
mobility of the NS proteins of the complementation group E 
mutants is due to a conformational change in the protein 
brought about by the mutation(s). Their conclusion is,
indeed, supported by the sequence data. The change in
charge of a single amino acid in the very small region where 
most of the mutations lie could be sufficient to alter 
protein conformation such that there would be differential
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binding of SDS. Alterations in the charge of amino acids 
occurring in other regions of the protein do not seem to be 
as important to mobility as those in the region of the three 
mutations of tsEl, tsE2 and tsE3. Both tsEl/Rl and tsE3/Rl 
possess NS proteins with the same mobility as wild-type NS 
protein yet both have a change at position 168 (see Figure 
5.4) which alters the charge of the amino acid. In gels the 
presence of 4M urea in addition to SDS might be sufficient 
to relieve the conformational change so that the NS proteins 
from wild-type and mutant viruses have the same mobility 
(Lesnaw et al , 1979).
The predicted secondary structure of the NS proteins 
of t_sEl, t sE2, t sE3 and a revertant virus were determined as 
previously described. Figure 5.5(a) and 5.5(b) show the 
results of the analysis. Substantial alterations are 
predicted in protein structure in all three complementation 
group E mutants when compared to wild-type virus (see Figure 
5.5(a)). In tsEl there is a new area of -turn and a 
region of o^-helix is lost; the first mutation in tsE2 
causes an area of f-turn to be lost and the second mutation 
a region of .oc-YvaUx to be inserted; in tsE3 an area of 
°C-helix is lost. The predicted secondary structure of the NS 
protein of the revertant virus (Figure 5.5(b)) is exactly 
the same as the wild-type but for a very minor alteration 
around the position of the changed amino acid (position 
150-175) . The change has been predicted to cause a small 
hydrophilic area in this region.
The overall conclusion from the analysis of the NS 
proteins of wild—type virus and virus classified in 
complementation group E is that quite minor changes, for
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most part single base changes, in a certain region can 
affect the protein such that it migrates in an anomalous 
manner on SDS-polyacrylamide gels. Since the proteins are 
all the same length the minor changes must have caused quite 
marked conformational changes in the protein.
0  i
Figure 5.1
10%, 12% and 15% polyacrylamide gels showing the 
electrophoretic mobility differences between the NS proteins 
of wild-type and the three complementation group E mutants - 
t_sEl, tsE2 and tsE3. RNA was extracted from infected cells 
and translated in vitro. The marker track (M) consists of 
viral proteins extracted from infected cells. The solid 
arrows indicate the positions of the NS proteins translated 
from total infected cell RNA. The mol wt of the NS protein 
of each virus was calculated as the average mol wt obtained 
from the relative migration of the NS protein to the G 
(62,000), N (47,800) and M (26,000) proteins on each gel.
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Figure 5.2(a)
Nucleotide and predicted amino acid sequence of the NS 
protein of VSV NJ, Missouri strain with the positions of the 
mutations in tsEl, tsE2 and tsE3 marked. Three out of the 
four mutations lie in an area of 18 nucleotides. All of the 
mutations change the charge of the amino acid they affect.
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Figure 5.2(b)
Sequence gels showing the nucleotide changes in the 
tsEl / tsE2 and tsE3 mutants compared to the wild-type 
sequence.
(A) Position 91-1$0 - wild-type sequence.
(B) Position 102-106 - tsEl sequence.
(C) Position 106-110 - tsE2 sequence.
(D) Position 95-91 (minus strand) - tsE3 sequence. For 
direct comparison with wild-type the complementary 
sequence is written.
(E) Position 347-355 showing the second mutation in tsE2 
compared to (F) showing the wild-type sequence in the 
same region.
The gels show clearly the A-G changes in tsE2 and tsE3 
and the G-A change in tsEl.
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Figure 5.3
Hydropathic profile of the NS protein of VSV NJ, 
Missouri strain as predicted by the program of Kyte and 
Doolittle (1982). The area where three out of the four 
mutations detected in the complementation group E mutants 
lie is highlighted. This region represents the most 
hydrophilic region in the molecule.
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Figure 5.4
Nucleotide and predicted amino acid sequence of the NS 
mRNA of VSV N J , strain Missouri with the positions of the 
two changes in the revertant viruses tsEl/Rl and tsE3/Rl 
marked. One of the nucleotide changes is silent in that the 
amino acid (position 154) is not affected. Whereas the 
other causes a methionine to arginine change (position 168).
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Figure 5.5
Predicted secondary structure of the NS proteins of
(A) wild-type VSV NJ, strain Missouri, the three 
complementation group E mutants (tsEl, tsE2 and tsE3) and
(B) revertant virus tsEl/Rl. The method of Chou and Fasman 
(1978) was used to predict secondary structure and the 
results were graphically displayed using the PLOTCHOU 
program contained in the University of Wisconsin Genetics 
Group Computer software package. The whole of the wild-type 
and revertant structures are shown but only the regions 
where the mutations affect the predicted structures in tsEl, 
tsE2 and tsE3 are displayed. The arrows indicate the 
differences in predicted secondary structure.
(l\AA/\) = alpha coil 
(m w )  = beta sheet 
- random coil
Shaded ovals are hydrophobic; open ovals are hydrophilic. 
Change of directions indicates ^ -turn.
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1. cDNA CLONING
The RNA template in the cDNA synthesis reactions was 
purified from infected cells and was fairly 'crude' in that 
it was not poly(A) selected to enrich for mRNA. It was 
calculated that the frequency of NS gene containing plasmids 
in our library was 0.7%. This figure of 0.7% meant that low 
density screening for NS gene—specific plasmids was quite 
feasible. Previously many workers have synthesised their 
template RNA in very large reactions (typically between 10ml 
and 20ml) in vitro and then poly(A) selected full-length 
mRNA (Gallione et al, 1981; Gill and Banerjee, 1985; Rose 
and Gallione, 1981). The large volume of the in vitro mRNA 
synthesis reactions makes them very expensive (in terms of 
the amounts of reagents required) and difficult to handle in 
the latter stages of RNA purification. The work described 
here has shown that RNA synthesised in vivo and easily 
purified from the infected cells is an efficient template 
for cDNA synthesis even when it is not poly(A) or size 
select ed.
The method used to synthesise cDNA was described by 
Gubler and Hoffman (1983). It is both rapid and efficient 
since it eliminates the need for the SI nuclease mediated 
cleavage step of the hairpin loop which is formed between 
first and second strands in 'classical' cDNA synthesis 
(Ef stradiat is et al, 1976). The cleavage step not only 
lowers the efficiency of the reaction but also often removes 
5' terminal sequences from the cloned mRNAs. Gubler and 
Hoffman (1983) reported that, in their hands, the method was 
10- to 50-fold more efficient than methods which used the SI
130
nuclease cleavage. The method enabled the construction of 
plasmids which contained full-length copies of the NS mRNA 
from wild-type, mutant and revertant viruses from five 
different cloning experiments.
2. SEQUENCE DATA FROM cDNA CLONES
Schubert et al (1984) discovered extensive 
heterogeneity in cDNA clones prepared from the VSV L gene. 
There is no evidence for proofreading mechanisms in RNA 
viruses and this fact might explain why these viruses 
exhibit the very high mutation rate which contributes to 
their rapid evolution and general variability (Holland e_t 
a l , 1982). The L gene is 6,380 nucleotides in length and 
Schubert et al (1984) detected over 20 nucleotide 
differences between cDNA clones of the same regions. If 
expressed, these changes would have created stop codons 
resulting in incomplete L proteins. When determining the 
sequence of a cDNA clone one is essentially looking at an 
individual which has been derived from a diverse population 
and this was demonstrated by work of Domingo et al (1978) 
who estimated that wild-type populations of the RNA phage 
contained 15% of the most abundant or 'master sequence', the 
remaining 85% being a multitude of different variants.
Virion RNA is a mixture of all the viral genomic species and 
so when used as a template for sequence determination it 
yields a consensus sequence directly.
However, I am confident that there is no reason to question 
the sequence presented here because it was derived from cDNA 
clones. No variation was found in the sequence of two cDNA
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clones of the wild-type NS gene and four cDNA clones of the 
NS gene of tsEl/Rl. Furthermore, the sequence agrees with 
limited sequence data from D. McGeoch and A. Dolan 
(unpublished results). They determined part of the NS gene 
sequence of wild-type, mutant and revertant viruses from 
virion RNA by primer extension synthesis using a synthetic 
primer corresponding to a terminal sequence of the N gene. 
The aim of this work was to lay the foundation for future 
study of the NS protein by providing full-length cDNA clones 
which could be expressed in eukaryotic cells.
3. COMPARISON OF THE NS PROTEINS
The four NS gene sequences now available have allowed 
detailed comparisons at the nucleotide and amino acid level 
which have given some insight into the structurally 
important domains on the NS protein and ideas on the 
possible evolution of the protein.
Although there is generally only limited sequence 
homology between the four NS proteins, taeu domains are quite 
clearly conserved and these have been designated I —  III 
(Figure 4.11). When conservative amino acid changes are 
considered the carboxy-terminus region (domain III) is over 
90% homologous. The high degree of conservation in domain 
III might mean that this region is of fundamental importance 
to NS protein function (Dover and Flavell, 1984). Domain 
III is a very basic region and it shares limited sequence 
homology, shown in Figure 6.1 (43% when conservative amino 
acids are considered), with both the L gene (amino acids 
784-804) of VSV IND (Schubert et al, 1984) and the sigma
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subunit (amino acis 365-388) of the RNA-dependent-RNA 
polymerase of E.coli (Burton et al , 1981). The L gene is 
thought to be the viral polymerase (Schubert et al , 1984). 
The sigma subunit of the E .coli RNA polymerase has been 
shown to play an important role both in selective binding of 
polymerase to promoters and in the efficient initiation of 
transcription (Burgess et al , 1969; Chamberlin, 1974).
Interestingly, the NS protein of VSV and the sigma 
subunit of the E .coli RNA polymerase share a number of 
similarities. The sigma subunit, although much larger than 
the NS protein, has an overall negative charge with the 
acidic residues situated predominantly in the amino terminal 
. p d v f o f  the molecule. When compared to the ‘average'
' of Klapper (1977) the sigma subunit like NS protein
is relatively rich in aspartic acid but low in glycine 
(Burton et al, 1981). The sigma protein also exhibits an 
aberrant mobility on SDS-polyacrylamide gels. The mol wt of 
70,263 calculated from sequence data (Burton et a l , 1981) is 
significantly lower than the values of 82,000 and 90,000 
estimated by the protein's migration on SDS-polyacrylamide 
gels (Lowe et a l , 1979). Burled et al (1981) suggested 
that the anomalous behaviour of the sigma protein on 
SDS-polyacrylamide gels could be due to its unusually high 
negative charge.
4. ROLE OF NS PROTEIN IN VSV TRANSCRIPTION AND REPLICATION
The information from the comparison of the four NS 
gene sequences and their homology with other proteins has 
given some clues as to the possible role of NS protein in
133
VSV transcription and replication.
Mellon and Emerson (1978) showed by dissociation- 
reconstitut ion experiments that the L protein only binds to 
template in combination with NS protein whereas NS protein 
alone binds to purified template. Thus they suggested that 
the NS protein directs binding of the L protein. The 
results of methylation protection experiments have shown 
that NS protein binds to an A+U-rich sequence in the middle 
of the leader gene in plus or minus sense genomic RNA (Isaac 
and Keene, 1982; Keene et al, 1981). The part of the NS 
protein that could conceivably function in an interaction 
between the L protein and template is the carboxy terminus 
(domain III). The carboxy terminus is highly conserved (90% 
homology between strains) and basic as one would expect of a 
region that interacts with nucleic acid (Hudson et al ,
1986). The sigma protein which shares some similarity and 
homology with the NS protein has a similar function (Burgess 
et a l , 1979; Chamberlin, 1974) and is known to interact with 
promoter DNA and short nascent RNA (Hillel and Wu, 1977; 
Simpson, 1977; Sverdler et al, 1980).
Once transcription or replication is initiated 
dissociation of the N protein from the RNA is required so 
that the L protein can continue polymerisation. De and 
Banerjee (1985) proposed that the NS protein performs an 
'RNA unwinding' function which displaces N protein from the 
genome RNA thus allowing the L protein access. There is 
evidence supporting the idea that highly phosphorylated 
forms of NS are capable of mimicking RNA thus causing 
transient dissociation of the N protein from the RNA (Hudson 
et al, 1986). It is known that hyperphosphorylated forms of
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NS protein have increased activity in transcription assays 
(Hsu et a l , 1982; Kingsford and Emerson, 1980) and Keene and 
co-workers have suggested that the nucleocapsid binds RNA 
mainly through the phosphate groups (Isaac and Keene, 1982; 
Keene et a l , 1981). The idea of a highly charged molecule
being able to mimic nucleic acid is not without precedent
since it has been reported that heparin (a highly negatively 
charged molecule) can be used as a nucleic acid analogue in 
DNA binding studies (Zillig et al , 1970; Yaun et al, 1975; 
Bickle et al , 1977).
It is known from the results of several workers that 
purified N protein or N protein synthesised in the absence 
of other viral proteins tends to form large aggregates which 
do not seem suitable for assembly of the RNPs (Blumberg et_ 
al, 1983; Blumberg et al, 1981; Sprague et al, 1983). The 
fact that complexes of N and NS have been detected both in 
the cytoplasm of infected cells and in vitro using 
monoclonal antibodies directed against N or NS proteins 
(Bell et a l ; Peluso and Moyer, 1984; Arnheiter et al, 1985;
Wertz et a l , 1985) suggests that NS binds to N protein
(probably via the phosphate groups as suggested by Keene and 
co-workers) and so ensures there is N protein available for 
encapsidat ion.
5. EVOLUTION OF THE NS PROTEIN
The various isolates of VSV have been passaged a 
number of times in laboratories throughout the world (see 
Clewley et al , 1977; Reichmann et al, 1978) and so sequence 
comparisons may not be directly applicable to the original
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isolates. However, the sequence data do give some idea 
about the evolution of the various genes. The extended 
structural homology coupled with the lack of sequence 
homology between the NS genes implies that the gene has 
undergone quite divergent evolution from a common ancestor.
A number of workers have compared the sequence of 
analogous genes from both serotypes (Colonno and Banerjee, 
1978; Banerjee et al , 1984; Gallione and Rose, 1983; Gill 
and Banerjee, 1986). A summary of their results is shown in 
Table 6.1.
The homology between the G genes is surprising since 
they code for the glycoproteins which are the major 
antigenic determinants on the virus. One might expect that 
the G protein of the two serotypes be more different. 
Interestingly, the NS gene is flanked by two homologous 
genes (the N and M ) . The group II (NS) mutants of VSV IND 
have higher reversion rates than mutants in most other genes 
(Pringle, 1977) indicating that a number of mutational 
changes can restore NS gene function. It seems that apart 
from the conserved regions (domain I «-rj III) the other 
regions of the NS protein can evolve quite rapidly. As long 
as the mutations do not disrupt the overall structure of the 
region it seems that they do not affect the function of the 
protein.
6. THE COMPLEMENTATION GROUP E MUTANTS AND REVERTANTS
The sequence determination of the three 
complementation group E mutants and the two revertant 
viruses revealed that three out of the four mutations lie in
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a region of 18 nucleotides (Figure 5.2a) indicating that the 
region is potentially a 'hot spot' for mutation. Secondary 
structure predictions of the mutant proteins (Figure 5.5a) 
indicate quite extensive alterations in the area of the 
mutation in all three complementation group E mutants. The 
idea that a single amino acid substitution can have dramatic 
effects on the folding and mobility of a protein on SDS 
polyacrylamide gels has support from work in other areas, 
de Jong (1978) compared the mobilities of the —crystallin
chains of a number of mammalian species and showed that 
single amino acid changes were responsible for the differing 
electrophoretic mobilities of these proteins on SDS 
polyacrylamide gels. The amino acid changes involved 
alterations in side chain hydrophobicity or proline 
residues. Recently, Carstens et al (1986) compared the DNA 
sequence of the Autographa californica nuclear polyhedrosis 
virus polyhedrin gene with that of the polyhedrin gene from 
M5 (a morphology mutant). They found that a single point 
mutation (which caused a leucine to proline change) was 
responsible for the cubic polyhedron and altered mobility on 
SDS polyacrylamide gels of the mutant protein. Comparison 
of predicted secondary structures of the mutant and 
wild-type proteins revealed extensive changes caused by the 
single mutation.
The complementation group E mutants were isolated from 
wild-type VSV NJ, strain Missouri after exposure to the base 
analogue 5-FU (Pringle et al, 1971). 5-fluorouraci1 is an
analogue of uracil which was first synthesised by Duchinsky 
et al (1957). It can exist in two forms as shown in Figure 
6.2. In the more common keto form 5-FU can take the place
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of uracil in RNA, however, unlike uracil, it has the ability 
to form hydrogen bonds with guanine. Thus 5-FU mutagenesis 
usually results in uracil to cytosine transitions. When 
5—FU exists in the rare enol form it can take the place of 
cytosine.
Table 5.1 shows that three of the four mutations 
induced by 5-FU mutagenesis are adenine to guanine changes. 
The adenine to guanine changes have occurred in the mRNA and 
so uracil to cytosine changes have occurred in the genome 
(see Figure 6.3). However, one change is the opposite - 
guanine to adenine ie. there has been a cytosine to uracil 
change in the genome. For this change to have occurred it
is possible that 5-FU was incorporated into the RNA, in its
1V">
less common enol form (see Figure 6.2),/\ . a cytosine.
Having been incorporated into the RNA the 5-FU might then 
have undergone a tautomeric shift to exist in the keto form 
and so base-pair with adenine (see Figure 6.3). The
majority of mutations induced by 5-FU are lethal and so it
is possible that 5-FU acts to increase the relative number 
of naturally occurring spontaneous mutants in a population.
It could be that the mutant with the guanine to adenine 
change in the mRNA is a spontaneous mutant which was 
detected by chance.
Sequence analysis of the revertant viruses tsEl/Rl and 
tSE3/R1 showed that the two viruses had reverted to the 
wild-type sequence at the positions of the mutations (Figure 
5.4). However, two further changes were detected in the 
nucleotide sequence of the revertant viruses when compared 
to the wild-type virus. One of the nucleotide changes 
caused a change in the amino acid sequence. . . ■ -
Apart from the possibility that the revertant stocks have 
been mixed up in the laboratory (which cannot be exclude) , 138
there are two ways to explain this
The two viruses, t_sEl/Rl and tsE3/Rl, might represent 
a variant of wild-type virus present in low numbers in the 
wild-type population which was somehow able to contaminate 
the revertant selection procedure. However, this 
explanation is unlikely in view of the fact that the two 
revertant viruses were isolated in separate experiments 
(C.R. Pringle, personal communication).
The two viruses could indeed be true revertant viruses 
that have changed at two extra positions. Evidence that 
reversion to wild-type can be accompanied by a variety of 
other changes comes from the work of Maack and Penhoet 
(1980) and Gallione and Rose (1985).
Maack and Penhoet (1980) isolated a number of 
revertants of tsEl whose NS proteins had different migration 
patterns on SDS-polyacrylamide gels from wild-type and the 
mutant NS proteins. These revertants could have arisen in a 
number of ways. They could be true revertants in which 
reversion has been accompanied by other mutations. They 
could be pseudorevertants ie. the mutations were replaced by 
other changes which restored function but affected the 
migration. Alternatively, the altered migration could be 
due to the presence of suppressor mutations. Gallione and 
Rose (1985) determined the sequence of three cDNA clones 
encoding the G proteins of tsQ45 (a spontaneous mutant 
isolated by Flamand (1970) with a reversible block in G 
transport), parent and revertant viruses and found that 
reversion had been accompanied by two further changes. The 
reversion events in t_sEl/Rl and tsE3/Rl have been 
accompanied by the same changes in both viruses. It might
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be expected that the accompanying changes be more random but 
it is possible that the conditions used for selecting the 
revertant viruses favoured these two extra changes. It 
would be of interest to isolate and sequence other 
revertants of tsEl and tsE3 in order to test this 
hypothesis.
7. EVIDENCE FOR A SECOND OPEN READING FRAME IN THE 
NS PROTEIN OF VSV
A number of negative strand viruses employ overlapping 
reading frames in their replicative strategy. The 
phenomenon was originally described for influenza virus 
(Lamb and Lai, 1980; Lamb et al, 1981) and has been found in 
Sendai virus (Giorgi et a l , 1983) ; measles virus (Bellini ejt 
al, 1985); bunyaviruses (Akashi and Bishop, 1983; Ihara et_ 
al, 1984, 1985; Cabradilla et al, 1983); and possibly in the 
Arenaviruses (Akashi and Bishop, 1983) . In measles and 
Sendai virus the second open reading frame (ORF) is found in 
the genes coding for the phosphoprotein. The group of 
proteins coded by the internal ORF has been designated the C 
class (Bellini et al, 1985). The function of the C class 
proteins is unknown although Bellini et al (1985) have 
proposed a role in replication or transcription for the 
measles C protein due to its colocalisation with the
nucleocapsid protein.
Examination of the four NS gene sequences available
reveals the potential of all four to encode (65 or
67 amino acid), basic protein in a second ORFj. Figure 6.4 
shows the potential second ORF of the NS gene of wild-type
140
VSV NJ, strain Missouri.
At the moment, the evidence for a second protein
encoded by the NS gene of VSV is circumstantial. Table 6.2
compares the amino acid composition of the proteins encoded
by the second ORF in the four NS genes.
With the exception of the relative proportions of acidic and
basic amino acids there is little similarity between
serotypes in the composition of the four proteins.
- . Like the NS
proteins, those encoded by the second ORF show a high degree 
of homology within subtypes for IND serotypes, ')0% for
NJ serotypes) and a low degree of homology between serotypes 
%) . The predicted proteins are small (mol wt 7500) and
so would not have been detected on the gels previously used
to visualise the proteins. However, preliminary experiments 
using high percentage gels to analyse infected cell extracts 
radiolabelled with a variety of different amino acids have 
failed to detec-fca second NS protein (R.M. Elliott, personal 
communication).
All initiation codons in the VSV genes so far
sequenced are preceded directly by the triplet ATC. Hence,
one point of evidence against there being a second protein 
coded by the NS gene is that in the Missouri strain of the 
NJ serotype the initiating methionine is preceded by CTT and 
in the Mudd-Summers strain of the IND serotype it is
preceded by TAG.
The NS protein although relatively small is an 
important protein and serves a number of functions in the
ug i i f ecycle. More study is required so that its precise 
role and mode of action can be elucidated. Expression of
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full-length cDNA clones now available under the control of 
an appropriate promoter allied to the advanced techniques of 
site-directed mutagenesis will make the NS protein more 
amenable for study in the near future.
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8. FUTURE PROSPECTS
The work presented in this thesis provides the 
foundation of future work on the analysis of the structure 
and function of the NS gene of VSV. The future work can be 
broadly divided into firstly, the expression of the cDNA 
clones of the wild-type and mutant virus mRNAs, in 
eukaryotic cells and then, detailed analysis of the NS gene 
by site-directed mutagenesis of these cDNA clones.
(i ) Expression of cDNA Clones
The full-length cDNA clones of the NS genes of 
wild-type, mutant and revertant viruses can be expressed in 
eukaryotic cells under the control of an appropriate 
promoter eg. the cDNA clones could be ligated into the 
pJC119 expression vector as used by Sprague et al (1983) for 
the expression of the VSV N gene. p J C H 9  is a derivative of 
pML2 which employs the SV40 late promoter to initiate 
transcription of inserted sequences and also supplies the 
SV40 splicing and polyadenylation signals (Sprague et al, 
1983) .
The recombinant plasmids can then be transfected into 
COS-1 cells, a simian line that constitutively expresses 
SV40 T antigen (Gluzman, 1981). Because the plasmid 
sequences interrupt^ the early region of the SV40 T antigen 
must be supplied in order that the recombinant be 
replicated.
There are a number of ways by which expression of the 
NS protein can be monitored eg. immunofluorescence or 
immunoprecipi tat ion. The biological activity of the
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expressed protein can be monitored by its ability to 
complement the complementation group E mutants at the 
non-permissive temperature.
(ii) Site—directed Mutagenesis
Oligonucleotide-directed mutagenesis (Zoller and 
Smith, 1982) could be used to introduce single nucleotide 
changes, insertions or deletions into the cDNA. The ease by 
which oligonucleotides can be synthesised means there are no 
constraints on the types of mutation that can be introduced.
The biological activity of the mutated cDNAs can be 
tested by transfecting them into COS-1 cells and testing 
their ability to complement the complementation group E 
mut ants.
It would be of immediate interest to assess the 
results of:
(a) mutating one or more of the conserved phosphorylation 
sites in the wild-type gene especially the constitutive 
phosphorylation sites of Hsu and Kingsbury (1985)
(b) changing amino acid residues in the conserved domains 
(I and III) of the wild-type gene eg. insert acidic 
residues in the basic carboxy terminus (domain III)
(c) deleting domain II in the NS gene of the NJ serotype or 
inserting this region into the NS gene of the IND 
serotype
(d) changing one or other of the mutations of tsE2 to 
wild-type sequence
(e) deleting the putative second ORF
Future studies of the type described will help answer 
many questions concerning the role of the NS protein in VSV 
transcription and replication.
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Figure 6.2
Tautomeric forms of 5-fluorouracil. In the keto form 
can take the place of uracil in RNA and is capable of base 
pairing with guanine if it exists in the less common enol 
form as shown opposite.
IEoc
(D
O)
UJ
w h- 
> <
£ 5  <  UJ
9 5 
. j  dc
CL UJ 
UJ I—tr z
<
it ®  E
E
o 0
:)LL
I
If)
CM
l
o
Eoc
0)
o>
?
UJ
J-
<
2 — 
2 a
DC w
UJ
i-
z
<
Z  u  _
DC O flc
E
Z>
* CD ■* O
Figure 6.3
Two possible modes of action of 5-fluorouracil.
(1) 5-FU takes the place of a uracil in genomic RNA
(- sense) and subsequently base pairs with guanine 
during synthesis of replicative intermediate RNA 
(+ sense). Thus incorporation of 5-FU causes a U-^-C 
change in genomic RNA (- sense) or an A-^-G change in 
mRNA (+ sense) and replicative intermediate RNA 
(+ sense).
(2) 5-FU in its less common enol form takes the place of
cytosine in genomic RNA (- sense). However, it
undergoes a tautomeric shift and base pairs with adenine 
in subsequent rounds of replicative intermediate
( + sense) synthesis. Thus in this case 5-FU action 
leads to a C-^U change in genomic RNA (- sense) and a 
G-^a  change in mRNA (+ sense) and the replicative 
intermediate ( + sense).
10
*
20
*
30
*
40
*
50
*
60
*
CAG AGA TCA TGG ACA GTA TTG ATC GGC TCA AAA CTT ACT TGG CTA CTT ATG ATA
VU_
ATT TGG
“Tvy*
10
*
80
*
90
*
100
*
110
*
120
*
ATT CTG 
IU Lx*
TGC
S
AGG ATG CAA
O  A
ATG
Met
AGT
Ser
CTG
Leu
AAG
Lys
AAA
Lys
GAA
Glu
GAG
Glu
AGG
Arg
ATA AAT 
lie Asn
ATC
lie
TCC
Ser
AAG
Lys
130
*
140
*
150
*
160
*
170
*
180
*
ACC
Thr
TCT
Ser
TCA
Ser
TCG
Ser
AAG
Lys
ATC AAG 
lie Lys
GAG
Glu
ATA
lie
AAC
Asn
CAA
Gin
CTC
Leu
CGT
Arg
CAT
His
ATT
lie
ATC AGG 
lie Arg
AAG
Lys
AAG
Lys
AAT
Asn
190
*
200
*
210
*
220
*
230
★
240
*
CGT CAG 
Arg Gin
ATT
H e
CAG
Gin
ATA
lie
CTG ACT 
Leu Thr
ATA
lie
ATG
Met
CTG
Leu
AAC
Asn
ATC
lie
TTA
Leu
CGA TGT TGT CGC CGG 
Arg Cys Cys Arg Arg
ATG
Met
AAA
Lys
250 260 270 280 290 300
* * * * * *
GAA TAG ACA AAT GGG AAG AAG ATT TGC CCG AAT TGG AAA AGA TTG ATG ATG ATA TAC CAG
Glu —
310 320 330 340 350 360
* * * * * *
TAA CTT TTT CTG ACT GGA CAC AAC CTG TAA TGA AGG AAA ACG GAG GGG AGA AAT CAC TAT
370 380 390 400 410 420
*  *  *  *  *  *
CTC TGT TTC CTC CGG TTG GAT TAA CAA AAG TTC AGA CAG ACC AAT GGA GGA AGA CAA TTG
430 440 450 460 470 480
* * * * * *
AGG CAG TCT GTG AGA GCT CTA AAT ATT GGA ATT TGT CAG AAT GTC AGA TTA TGA ACT CAG
490 500 510 520 530 540
* * * * * *
AAG ATC GTC TTA TCC TCA AAG GCC GAA TTA TGA CTC CTG ACT GCA GTT CAT CAA TCA AAT
550 560 570 580 590 600
* * * * * *
CTC AGA ACT CCA TAC AGA GTT CCG AAT CTC TCT CCT CCT CGC ATT CAC CCG GTC CAG CAC
610 620 630 640 650 660
* * * * * *
GAA AGT CAC GGA ATC AAC TAG GTC TAT GGG ATT CAA AAT CAA CAG AAG TAC AAC TGA TCT
670 680 690 700 710 720
* ★ * * *
CQA AGA GGG CCG GAG TGA AGG ACA TGA TGG TGA AAT TGA CAG ACT TTT TTG GAA GTG AAG
730 740 750 760 770 780
* * * * ^
AGG AAT ATT ATT CAG TAT GCC CAG AAG GGG CCC CAG ATT TGA TGG GAG CAA TCA TCA TGG
790 800 810 820 830 840
W  TAA AAC ATA AAA AGC TTT TTA ACC AAG CAA GAA TGA AGT ATC GTA TCT AAT TAA TTC
850
*
CGA TGA TCA ATA TG
Relation begun with base number 84 
anslated to base number 248 
s <luence printed from base number 1 to base number 
e(Juence numbered beginning with base number 1
Nucleotide sequence of the NS mRNA of VSV NJ, Missouri 
strain with the translation of the protein encoded by the 
second open reading frame.
Table 6.1 Nucleotide and Amino Acid Homology between the
Genes of VSV Indiana and New Jersey Serotypes
Genes
Nucleot ide 
Homology 
%
Amino Acid* 
Homology 
%
Reference
Leader
Template
80 - Colonno and Banerjee 
(1978b)
N 68 68 Banerjee et al (1984)
M 57 62 Gill and Banerjee 
(1986)
G 54 51 Gallione and Rose 
(1983)
* Homology excluding conservative replacement 
of amino acids
Table 6.2 Amino Acid Composition of the Proteins Encoded 
by the Second Open Reading Frame m  the NS 
Protein of VSV
Amino
Acid
New Jersey Serotype Indiana Serotype
Ogden
%
Hazelhurst
%
Mudd-Summers
%
San-Juan 
%
Phe 0.0 0.0 1.5 1.5
Val 0.0 0.0 0.0 1.5
Ala 0.0 0.0 3.0 1.5
Asn 7.7 6.2 4.5 4.5
Cys 4.6 4.6 3.0 3.0
Leu 9.2 9.2 14.9 14.9
Ser 6.2 7.7 9.0 10.4
Tyr 0.0 0.0 3.0 1.5
Lys 10.8 12.3 14.9 14.9
Trp 1.5 1.5 1.5 1.5
H e 21.5 20.0 9.0 9.0
Pro 3.1 1.5 3.0 3.0
His 3.1 1.5 1.5 3.0
Asp 1.5 0.0 0.0 0.0
Arg 12.3 12.3 7.5 6.0
Met 7.7 7.7 6.0 7.5
Thr 1.5 3.1 4.5 3.0
Glu 4.6 6.2 7.5 9.0
Gin 4.6 6.2 3.0 3.0
Gly 0.0 0.0 3.0 1.5
Basic 26.2 26.4 23.9 23.9
Acidic 6.1 6.2 7.5 9.0
Ser + Thr 7.7 10.8 13.5 13.4
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APPENDIX
Figure 1
Nucleotide sequence and deduced amino acid sequence of 
the protein encoded by the putative second open reading 
frame (ORF) in the NS mRNA of
(a) VSV NJ, Missouri strain
(b) VSV NJ, Ogden strain
(c) VSV IND, Mudd-Summers strain
(d) VSV IND, San Juan strain
The tables of codon usage, base composition and amino 
acid composition are printed below.
Figure 2
Comparison of the proteins encoded by the putative
second open reading frame in the mRNAs of
(i) VSV NJ, Missouri strain and VSV NJ, Ogden strain 
(ii) VSV IND, San Juan strain and VSV IND, Mudd-Summers 
strain
(iii) VSV NJ, Missouri strain and VSV IND, San Juan strain 
The sequences have been aligned for maximum homology 
by the HOMOL program of Taylor (1984).
Matched residues are indicated by *
Figure 3
Comparison of the hydropathic profiles of the proteins 
encoded by the putative second open reading frame in the NS 
mRNAs of the four strains of VSV are as predicted by the 
program of Kyte and Doolittle (1982). The degree of 
hydrophobicity increases with distance above the mid-line; 
the degree of hydrophilicity increases with distance below 
the mid-line. Letters below the plots refer to amino acid 
residues.
1 VSV NJ, Missouri strain
2 VSV IND, San Juan strain
3 VSV IND, Mudd-Summers strain
4 VSV NJ, Ogden strain
Parameters: group length' f
shift = 1
spacing between plotted points = 10
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CTT L e u 0 0.02 CCT Pro 1 1 .52 CAT His 1 1.52 CGT A r g 2 3 . 1 2
CTC L e u 1 1.52 CCC Pro 0 0.02 CAC His 1 1.52 CGC A r g 0 0.07
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CTG L e u 4 6.22 CCG Pro 0 0.02 CAG Gin 2 3.12 CGG A r g 1 1.52
ATT lie 5 7.72 ACT Thr 0 0.02 AAT Asn 3 4.62 AGT Ser 0 0.02
ATC lie 4 6.22 ACC Thr 1 1.52 AAC Asn 2 3.12 AGC Ser 0 0.02
ATA lie 5 7.72 ACA Thr 0 0.02 AAA Lys n 3.12 AGA Arg 0 0.02
ATG Met 5 7.72 ACG Thr 0 0.02 AAG Lys 5 7.72 AGG Arg 4 6.22
GTT Vsl 0 0.02 GCT Als 0 0.02 GAT Asp 0 0.02 GGT Gly 0 0.02
GTC Vs1 0 0.02 GCC Als 0 0.02 GAC Asp 1 1 .52 GGC Gly 0 0,02
GTA Vsl 0 0.02 GCA Als 0 0.02 GAA Glu 1 1 .52 GGA Gly 0 0.02
\GTG Vsl 0 0.02 GCG Als 0 0.02 GAG Glu o 3.12 GGG Gly 0 0.02
BASE COMPOSITION
T C A G y R ALL
NUMBER 226 162 281 185 388 466 854
PERCENT 26.5 19.0 32.9 21 . 7 45.4 54. 6 100, 0
AMINO ACID COMPOS 3 TI ON
RES NUM 2 RES NUri 2 RES NUM •4 R : NUM 2
Phe 0 0.0 Leu 6 9. 2 H e 1 4 21 . 5 he I 5 7.7
Vsl k 0.0 Ser 4 6, 2 Pr o 2 3 . 1 Tht 1 1 . 5
Als 0 0.0 Tyr 0 0.0 His 2 3. 1 Gin 3 4 . t
Asn 5 7.7 Lys 7 10,8 As? 1 1 .5 Glu 3 4 . t
Cys 3 4.6 Trp 1 1 . 5 Ar q e 12.3 G 3 y e 0. 0
10 20 30 40 50 60
* * * * * *
ATG AAA AAA ACT AAA CAG ATA TCA TGG ATA ATC TCA CAA AAG TTC GTG AGT ATC TCA AGT
7 0  6 0  9 0  1 0 0  1 1 0  1 2 0
* 1 I » 9 9
CCT ACT CTC GTC TAG ATC AGG CGG TAG GAG AGA TAG ATG AGA TCG AAG CAC AAC GAG CTG
Met Arg Ser Lys His Asn Glu Leu
1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  1 6 0
* * * * * *
AAA AGT CCA ATT ATG AGT TGT TCC AAG AGG ACG GAG TGG AAG AGC ATA CTA GGC CCT CTT
Lys Ser Pro lie hot Ser Cys Ser Lys Arg Thr Glu Trp Lys Ser H e  Leu Gly Pro Leu
1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
* * * * 9 9
ATT TTC AGG CAG CAG ATG ATT CTG ACA CAG AAT CTG AAC CAG AAA TTG AAG ACA ATC AAG
lie Phe Arg Gin Gin Met lie Leu Thr Gin Asn Leu Asn Gin Lys Leu Lys Thr lie Lys
2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  3 0 0
9 * * * 9 9
GCT TGT ATG TAC CAG ATC CGG AAG CTG AGC AAG TTG AAG GCT TTA TAC AGG GGC CTT TAG
Ale Cys Met Tyr Gin lie Arg Lys Leu Ser Lys Leu Lys Ale Leu Tyr Arg Gly Leu
3 1 0  3 2 0  3 3 0  3 4 0  3 5 0  3 6 0
* * * * 9 *
ATG ACT ATG CAG ATG AGG ACG TGG ATG TTG TAT TCA CTT CGG ACT GGA AAC AGC CTG AGC
370 380 390 400 410 420
* * 9 * * 9
TTG AAT CCG ACG AGC ATG GAA AGA CCT TAC GGT TGA CAT TGC CAG AGG GTT TAA GTG GAG
430 440 450 460 470 480
9: 9 9 9 9 *
AGC AGA AAT CCC AGT GGC TTT TGA CGA TTA AAG CAG TCG TTC AAA GTG CCA AAC ACT GGA
490 500 510 520 530 540
9 9 9 * 9 9
ATC TGG CAG AGT GCA CAT TTG AAG CAT CGG GAG AAG GGG TCA TCA TAA AAA AGC GCC AGA
550 560 570 580 590 600
9 9 9 9 9 9
TAA CTC CGG ATG TAT ATA AGG TCA CTC CAG TGA TGA ACA CAC ATC CGT ACC AAT CAG AAG
610 620 630 640 650 660
9 9 9 9 9 9
CCG TAT CAG ATG TTT GGT CTC TCT CAA AGA CAT CCA TGA CTT TCC AAC CCA AGA AAG CAA
670 680 690 700 710 720
9 9 9 9 9 9
GTC TTC AGC CTC TCA CCA TAT CCT TGG ATG AAT TGT TCT CAT CTA GAG GAG AAT TCA TCT
730 740 750 760 770 780
9 9 9 9 9 9
CTG TCG GAG GTA ACG GAC GAA TGT CTC ATA AAG AGG CCA TCC TGC TCG GTC TGA GGT ACA
790 808 810 820 830 840
9 9 9 9 9 9
AAA AGT TGT ACA ATC AGG CGA GGG TCA AAT ATT CTC TGT AGA CTA TGA AAA AAA GTA ACA
850
9
GAT ATC AC
TTT Phe 0 0.02 TCT Ser 0 0.02 TAT Tyr 0 0.02 TGT Cys 2 3.02
TTC Phe i 1.52 TCC Ser 1 1.52 TAC Tyr 2 3.02 TGC Cys 0 0,02
TTA Leu i 1.52 TCA Ser 0 0.02 TAA 0 _ T G A --- 0
TTG Leu 2 3.02 TCG Ser 1 1.52 TAG -- 0 — TGG Trp 1 1.52
CTT Leu 2 3.02 CCT Pro 1 1.52 CAT His 0 0.02 CGT Arg 0 0.02
CTC Leu 0 0.02 CCC Pro 0 0.02 CAC His 1 1.52 CGC Arg 0 0.02
CTA Leu 1 1.52 CCA Pro 1 1.52 CAA Gin 0 0.02 CGA Arg 0 0.02CTG Leu 4 6.02 CCG Pro 0 0.02 CAG Glr. 5 7.52 CGG Arg 1 1.52
ATT lie 3 4.52 ACT Thr 0 0.02 AAT Asn 1 1.52 AGT Ser 2 3, 02
ATC lie 2 3.02 ACC Thr 0 0.02 AAC Asn 2 3.02 AGC Ser 2 3.02
ATA lie 1 1.52 ACA Thr n 3.02 AAA Lys n 3.02 AGA Arg 1 1.52
ATG Met 4 6.62 ACG Thr 1 1.52 AAG Lys & 11,92 AGG Arg 3 4.52
GTT Vsl 0 0.02 GCT Ale 2 3.02 GAT Asp 6 0.02 GGT Gly 8 0.02
GTC Vel 0 0.02 GCC Als 0 0.02 GAC Asp 0 0.02 GGC Gly 2 3.02
GTA Vsl 0 0.02 GCA Ale 0 0.02 GAA Glu 0 0.02 GGA Glu 0 0.02GTG Vsl 0 0.02 GCG Als 0 0.02 GAG Glu 2 3.02 GGG Gly 0 0.02
- BASE COMPOSITION
T C A G Y R ALL
NUMBER 199 171 275 203 370 478 848
PERCENT 23.5 20.2 32.4 23.9 43.6 56, 4 100.0
------  AMINO ACIB COMPOSITION
RES NUM 2 RES NUM 2 RES NUM 2 RES NUM 2
Phe 1 1. 5 Leu 10 14. 9 lie 6 9.0 Met 4 6.0
Vel 0 0 .0 5er 6 9. 0 Ft  o 2 3.0 Thr 3 4.5
Ale n 3. 0 Tyr 3.0 H i e 1 1 .5 Glr, 5 7.5
A t n 3 4 • 5 L M E 10 14*.9 Asp 0 0.0 Glu 2 3.0
Cys 3 . 0 Trp 1 1 . Arg 5 7.5 Gly 2 3.0
I B  2 0  3 0  4 0  5 0  6 0
* * * * * t »
CAG ATA TCA TGG ATA ATC TCA CAA AAG TTC GTG AGT ATC TCA AGT CCT ATT CTC GTC TGG
? 0  8 0  9 0  1 0 0  l i e  120
* * * * * *
ATC AGG CGG TAG GAG AGA TAG ATG AGA TCG AAG CAC AAC GAG CTG AAA AGT CCA ATT ATG
Met Arg Ser Lys His Asn Glu Leu Lys Ser Pro H e  Met
1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  1 8 0
* * * * * *
AGT TGT TCC AAG AGG ATG GAG TGG AAG AGC ATA CTA AGC CCT CTT ATT TTC AGG CAG CAG
Ser Cys Ser Lys Arg Met Glu Trp Lys Ser lie Leu Ser Pro Leu lie Phe Arg Gin Gin
1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
*  *  *  *  *  4
ATG ATT CTG ACA CAG AAT CTG AAC CAG AAA TTG AAG ACA ATC AAG GTT TGT ATG CAC CAG
Met lie Leu Thr Glr. Asn Leu Asn Gin Lys Leu Lys Thr lie Lys V*1 Cys Met His Gin
2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  3 0 0
* * * * * *
ATC CAG AAG CTG AGC AAG TTG AAG GCT TTA TAC AGG GGC CTT TAG ATG ACT ATG CAG ATG 
lie Gin Lys Leu Ser Lys Leu Lys Ale Leu Tyr Arg Gly Leu ---
3 1 0  3 2 0  3 3 0  3 4 0  3 5 0  3 6 0
*  *  4  4  4  *
AGG AAG TGG ATG TTG TAT TTA CTT CGG ACT GGA AAC AGC CTG AGC TTG AAT CTG ACG AGC
3 7 0  3 8 0  3 9 0  4 0 0  4 1 0  4 2 0
*  *  *  *  4 4
ATG GAA AGA CCT TAC GGT TGA CAT CGC CAG AGG GTT TAA GTG GAG AGC AGA AAT CCC AGT
4 3 0  4 4 0  4 5 0  4 6 0  4 7 0  4 8 0
* * * * * *
GGC TTT CGA CGA TTA AAG CAG TCG TGC AAA GTG CCA AAT ACT GGA ATC TGG CAG AGT GCA
4 9 0  ' 5 0 0  5 1 0  5 2 0  5 3 0  5 4 P
4  4  4 4 4  4
CAT TTG AAG CAT CGG GAG AAG GGG TCA TTA TGA AGG AGC GCC AGA TAA CTC CGG ATG TAT
5 5 0  5 6 0  5 7 0  5 8 0  5 9 0  6 0 0
4  4 4 4  4  4
ATA AGG TCA CTC CAG TGA TGA ACA CAC ATC CGT CCC AAT CAG AAG CAG TAT CAG ATG TTT
6 1 0  6 2 0  6 3 0  6 4 0  6 5 0  6 6 0
4  4  4  4  4  4
GGT CTC TCT CAA AGA CAT CCA TGA CTT TCC AAC CCA AGA AAG CAA GTC TTC AGC CTC TCA
6 7 0  6 8 0  6 9 0  7 0 0  7 1 0  7 2 0
4 4 4 4 4  4
CCA TAT CCT TGG ATG AAT TGT TCT CAT CTA GAG GAG AGT TCA TCT CTG TCG GAG GTG ACG
7 3 0  7 4 0  7 5 0  7 6 0  7 7 0  7 8 0
4  4 4 4 4 4
GAC GAA TGT CTC ATA AAG AGG CCA TCC TGC TCG GCC TGA GAT ACA AAA AGT TGT ACA ATC
7 9 0  8 0 0  8 1 0
4  4  4
AGG CGA GAG TCA AAT ATT CTC TGT AGA CTA TG
TAT Tyr 
TAC Tyr
T A A ---
T A G ---
TTT Phe 0 0.0Z TCT Ser 0 0.0Z
TTC Phe 1 1.5Z TCC Ser 1 1.5Z
TTA Leu 1 1,5Z TCA Ser 0 0.0Z
TTG Leu 2 3.0Z TCG Ser 1 1,5Z
CTT Leu 2 3.0Z CCT Pro 1 1.5Z
CTC Leu 0 0,0Z CCC Pro 0 0,0Z
CTA Leu 1 1,5Z CCA Pro i 1 ,5Z
CTG Leu 4 6.0Z CCG Pro 0 0.0Z
CAT His 
CAC His 
CAA Gin 
CAG Glr.
0 0.■ 0Z TGT Cys n> 3.,0Z
1 1,, 5Z TGC Cys 0 0.,02
0 — TGA -- 0 —
1 — TGG Trp i 1., 52
0 0.,0Z CGT Arg 0 0.,02
2 3,,02 CGC Arg 0 0.,02
0 0.,02 CGA Arg 0 0.,02
6 9, 02 CGG Arg 0 0.,02
3 4.5Z ACT Thr 0 0.0Z AAT Asn 1 1 ,52
2 3,02 ACC Thr 0 0,02 AAC Asn r2 3,02
1 1.52 ACA Thr 2 3.02 AAA Lys 2 3.02
5 7,52 ACG Thr 0 0. 02 AAG Lys 8 11.92
ATT lie
ATC lie - __
ATA H e  1 1.52       2 Z AGA Arg 1 1.5Z
AGT Ser 2 3.0Z
AGC Ser 3 4.52
ATG Met
GTT Vel 1 1.5Z GCT Ale
GTC Vel 0 0.0Z GCC Ale
GTA Vel 0 0.02 GCA Ale
GTG Vel 0 0,02 GCG Ale
AGG Arg 3 4.5Z
1 1 ,.52 GAT Asp 0 0.02 GGT Gly 0 0.,02
0 0.,02 GAC Asp 0 0.,02 GGC Gly 1 1,
0 0.,02 GAA Glu 0 0.,02 GGA Gly 0 0.,02
0 0.,02 GAG Glu n 3,,02 GGG Gly 0 0.,02
  BASE COMPOSITION ------
T c A G r R ALL
NUMBER 196 163 250 203 359 453 .J?1*
PERCENT 24,1 20,1 30,8 25,0 44,*. 5u,8 100,0
  AMINO ACID COMPOSITION
RES NUM 2 RES NUM 2
Phe 1 1,5 Leu 10 14.9
Vsl 1 1.5 Ser 7 10.4
Ale 1 1.5 Tyr 1 1.5
Asn 3 4.5 L m s 10 14.9
Cys 9 3.0 Trp 1 1 . 5
RES NUM RES NUM 2
H e 6 9*0 Met 5 7.5
Pro n 3.0 Thr 2 3.0
His 2 3,0 Glr. 6 9.0
Asp 0 0.0 Glu 2 3.0
Arg 4 6.0 Gly 1 1.5
First sequence: N J  MVS' 
Second sequence: N T 0 4
1 M I IW I LPCRMQMSLKKEER IMISKTSSSKIKEINQLRHI IRKKNRQIQILTIMLNILRCCRRMKE 
********** * * * ********************************* ********* **** 
1 M I IW ILPCRMPMNLRKDERINISKTSSSKIKEINQLRH11RKKNRQIQIL11MLNILRCCHRMKE
MATCHED = 59 OUT OF 65 PERCENT 90
Mutation weight = 5 Gap weights ~ 3k + 7, k up to 2000
£V0L.UTI0NARY~ DISTANCE = 3O
First sequence: i m o ST
Second sequence: i n o M-S
1 MRSKHNELKSPIMSCSKRTEWKSILGPLIFRQQMILTQNLNQKLKTIKACMYQIRKLSKLKALYRGL 
****************** ****** ********************** ** ** * * * * * * * * * * * *
1 MRSKHNELKSPIMSCSKRMEWKSX LSPLIFRQQMILTQNLNQKLKTIKVCMHQIQKLSKLKALYRGL
MATCHED = 62 OUT OF 67 PERCENT 92
Mutation weight = 5 Gap weights — 3k + 7, k up to 2000
EVOLUTIONARY DISTANCE = 25
First sequence: NX Mil £
Second sequence: jmo sT
1 M I IWI LPCRMQMSLKKEERINI SKTSSSK I KE I NQLRH 11 RKKNRQ IQI LT I MLN I LRCCRRMKE
*  *  * *  * * *  *  * *  *  *
1 MRSKHNELKSPIMSCSKRTEWKSILGFLIFRQQMILTQNLNQKLKTIKACMYQIRKLSKLKALYR GL
MATCHED = 12 OUT OF 72 PERCENT 16
Mutation weight = 5 Gap weights = 3k + 7, k up to 2000
EVOLUTIONARY DISTANCE = 290
-4®.
MIIWILPCRMQMSLKKEERINISKTSSSKIKEINQLRHIIRKKNRQIQILTIHLNILRCCRRMKE
--40
V
-40
MRSKHNELKSPIMSCSKRTEUKBILGPLIFRQQMILTQNLNQKLKTIKACMYQIRKLSKLKALYRGL
40
-40
HRSKHNELKSPIMSCSKRMEUKSILSPLIFRQQMILTQNLNQKLKTIKVCMHQIQKLSKLKALYRGL
- 40
-40_____________________________ ___________________
MIIUILPCRMPMNLRKDERINISKTSSSKIKEINQLRHIIRKKNRQIQILIIMLNILRCCHRMKE
J  a>wv?cl v f  G b * \ qa* k,
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SUMMARY
Temperature sensitive (t^) mutants of vesicular stomatitis 
virus, New Jersey serotype, classified in complementation group E 
contain lesions in the NS gene, which manifest as marked 
electrophoretic mobility differences of the mutant NS proteins in SDS 
polyacrylamide gels. We have cloned full-length cDNA copies of the 
mutant NS mRNAs, and have determined their nucleotide sequences. tsEl 
and tsE3 have single nucleotide changes, and tsE2 has two nucleotide 
changes, compared to the wild-type NS gene. Three of the mutations 
are clustered in a region of 18 nucleotides. All the nucleotide 
differences result in amino acid substitutions, which in each case 
change the charge of the amino acid concerned. Analysis of the 
wild-type and mutant NS protein sequences by the method of Chou and 
Fasman indicate that single amino acid substitutions can radically 
alter the predicted secondary structure, and these data are discussed 
in relation to the observed electrophoretic mobility differences.
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INTRODUCTION
The negative strand RNA genome of vesicular stomatitis virus 
(VSV) encodes five proteins, L, G, N, NS and M. The L, N and NS 
proteins, together with the genomic RNA, comprise the
ribonucleoprotein core of the virus particle, and the M and G proteins 
form the viral envelope (Wagner, 1975). The NS protein is a component 
of the RNA polymerase complex (Banerjee et al, 1977) but its precise 
role(s) in transcription and replication is still uncertain. Complete 
nucleotide sequences of the NS mRNAs encoded by representative viruses 
of the two VSV serotypes (Indiana, IND and New Jersey, NJ) have been 
reported, and predict the molecular weight of the NS protein of IND 
viruses to be 29,900 (Gallione et al, 1981; Hudson et al, 1986) and 
that of NJ viruses to be 31,400 (Gill and Banerjee, 1985; Rae and 
Elliott, 1986). However, the NS proteins migrate on SDS 
polyacrylamide gels with apparent molecular weights of 40-70,000, 
depending on the degree of bisacrylamide cross-linking (Bell et al, 
1984; Bell and Prevec, 1985; Kingsford and Emerson, 1980; Knipe et al, 
1980; Obijeski et al, 1974; Wunner and Pringle, 1972). The aberrant 
mobility of NS is clearly seen when it migrates more slowly than the N 
protein, which has a molecular weight of 47,300 (IND serotype;
Gallione et al, 1981) or 47,800 (NJ serotype; Banerjee et al, 1984) 
eg. the studies reported by Lesnaw et al (1979), Maack and Penhoet 
(1980), Patton et al (1984) and Pringle et al (1981). The NS protein 
is phosphorylated but the phosphate groups are not responsible for the 
anomalous mobility - indeed, the more heavily phosphorylated NS 
molecules migrate faster in SDS polyacrylamide gels (Hsu et al, 1982) 
while NS that has been dephosphorylated with bacterial alkaline 
phosphatase migrates more slowly (Hsu and Kingsbury, 1980). The NS 
protein contains many acidic residues (Gallione et al, 1981; Gill and 
Banerjee, 1985; Hudson et al, 1986; Rae and Elliott, 1986), and it is
3hought that these residues hinder SDS binding which results in the 
aberrant migration (discussed by Marnell and Summers, 1984).
Temperature sensitive mutants of VSV-NJ were isolated by Prin gle 
et al (1971) following 5-fluorouraci1 treatment of infected cells. 
Three mutants, classified in complementation group E, were shown to 
have lesions in the NS gene (Evans et al, 1979; Lesnaw et al, 1977; 
Maack and Penhoet, 1980). These mutants form a heterogenous group 
with respect to their phenotype, accompanied by marked differences in 
the electrophoretic migration of the NS protein. In order to 
characterise these mutants further, we have determined the nucleotide 
sequence of cloned full-length cDNA copies of their NS mRNAs. We 
report here that a single amino acid substitution in an NS protein can 
radically alter its electrophoretic mobility in SDS polyacrylamide 
gels .
4MATERIALS AND METHODS
Molecular Cloning and Nucleotide Sequencing
Stocks of VSV-NJ tsEl, tsE2, t^E3, tsEl/Rl and tsE3/Rl were 
generously provided by J.F. Szilagyi and were used directly to infect 
cells for RNA preparation without further passage. BHK-C13 cells were 
infected in the presence of actinomycin D and total cellular RNA 
prepared by the guanidinium thiocyanate-CsCl method exactly as 
described previously (Chirgwin et al, 1979; Rae and Elliott, 1986). 
cDNA synthesis followed the method of Gubler and Hoffman (1983) as 
modified by Rae and Elliott (1986) and mutant NS gene specific 
plasmids were identified by in situ colony hybridisation (Grunstein 
and Hogness, 1976) using a 32p_iat>en e(3 fragment (the large Pst I 
fragment, bases 1-523) from the wild-type NS gene plasmid pNJNSl (Rae 
and Elliott, 1986). Full-length cDNAs were identified by sizing in 
agarose gels and designated pNJEl, pNJE2 and pNJE3. Nucleotide 
sequences were determined by the dideoxy chain terminator method 
(Sanger et al, 1977) by subcloning restriction enzyme fragments into 
M13mpl8 DNA as detailed previously (Rae and Elliott, 1986).
In Vitro Translation and SDS Polyacrylamide Gel Electrophoresis
RNAs were translated in a rabbit reticulocyte lysate (Amersham 
International Ltd, Bucks, UK) using lOug total RNA in a 25pl reaction 
containing 50pCi 35S-methionine. Radiolabelled translation products 
were separated on SDS polyacrylamide gels (acrylamide:bisacrylamide 
75:1; Watret et al, 1985) using the discontinuous buffer system of 
Laemmli (1970) .
Computer Analysis
Nucleotide sequences were stored and manipulated with a DEC 
PDPll/44 computer using the programs devised by Staden (1982).
5ropathy profiles were generated using the SOAP algorithm of Kyte 
d Doolittle (1982). Protein secondary structure predictions used 
the method of Chou and Fasman (1978), and were graphically displayed 
using the PLOTCHOU program contained in the updated package of the 
University of Wisconsin Genetics Computer Group (originally described 
by Devereux et al, 1984). The graphic output was drawn on a Hewlett 
Packard HP7475A plotter in the Department of Molecular Biology, 
University of Edinburgh, with the assistance of Dr a . Coulson.
6RESULTS
olecular Cloning and Nucleotide Sequence Determination of the 
NS mRNAs of tsEl, tsE2 and tsE3
Total cellular RNA was extracted from actinomycin D-treated 
infected cells (Rae and Elliott, 1986), and an aliquot analysed by in 
vitro translation in a reticulocyte lysate. As seen in Figure 1 the 
NS proteins of tsEl, tsE2 and tsB3 had different electrophoretic 
mobilities in an SDS 12% polyacrylamide gel compared to the wild-type 
NS protein. The in vitro products were also analysed on gels 
containing 10% and 15% polyacrylamide (data not shown), and the 
apparent molecular weights of the NS proteins were determined relative 
to the G (62,000), N (47,800) and M (26,000) proteins. The averages 
of estimations from the three different concentrations of gels are 
given in Table 1.
No evidence of revertants, as would be indicated by the presence 
of an NS protein with wild-type migration pattern (Evans et al, 1979), 
was observed in any of the mutant virus mRNA preparations. Therefore, 
other aliquots of the same RNA preparations were used as templates for 
cDNA synthesis, which followed the method previously described for 
cloning cDNA to wild-type NS mRNA (Rae and Elliott, 1986). Mutant NS 
specific recombinant plasmids were identified by in situ hybridisation 
using a probe prepared from the wild-type NS plasmid, pNJNSl (Rae and 
Elliott, 1986). Digestion with Pst1 revealed that the mutant NS gene 
inserts all contained an internal Pstl restriction enzyme site, 
characteristic of the wild-type NS gene insert. Apparently 
full-length cDNA clones, as judged by the size of the insert, were 
obtained and designated pNJEl (from tsEl) pNJE2 (from tsE2) and pNJE3 
(from tsE3). Nucleotide sequence analysis confirmed that these three 
mutant NS cDNA clones were complete copies since they all contained 
the 5' and 3' consensus sequences found in all VSV mRNAs (McGeoch,
7; Rose, 1980).
The complete nucleotide sequences of the mutant NS genes (Figure 
) were determined by the dideoxy chain terminator method (Sanger et 
al, 1979). All the mutant NS mRNAs were the same length (876 bases
excluding polyadenylic acid) and encoded the same length of
polypeptide (274 amino acids) as the wild-type NS mRNA. tsEl and tsE3
each had single nucleotide changes while tsE2 had two nucleotide
substitutions. Portions of representative sequencing gels showing 
these changes are displayed in Figure 3. Three of the nucleotide 
changes occur within an 18 base regions (nucleotide 93-108) while the 
second mutation in tsE2 is at position 413 (Figure 2). In all cases 
the nucleotide change resulted in an amino acid substitution with a 
change in the charge of amino acid concerned. These are summarised in 
Table 1.
Figure 4 shows a hydropathy profile (Kyte and Doolittle, 1982) 
of the wild-type NS protein. The region marked 'a', the most 
hydrophilic domain of the protein, is where three amino acid 
substitutions are clustered, and 'b' indicates the position of the 
second mutation in tsE2.
The amino acid sequences of the wild-type and mutant NS proteins 
were analysed using the secondary structure prediction algorithm of 
Chou and Fasman (1978), and a graphic output obtained (Figure 5). 
Although these predictions are based solely on the primary amino acid 
chain, and do not take into account the effect of post-translation 
modifications such as phosphorylation, it is obvious that mutations 
occuring in amino acid residues 28-33 have a marked effect on the 
predicted secondary structure. The mutation in tsEl predicts a loss 
of a region of^-helix and a change in the position of a - turn.
The mutation in tsE3 manifests as a loss of the same (?C-helical 
region, although no change in ^  -turn is predicted. The mutation at 
amino acid 32 is tsE2 results in an additional region of 0^,-helix
8additional p  -turns, whereas the mutation at amino acid 114 has a 
inor effect in establishing a small region of (X-helix. No other 
effects of these mutations were predicted in the remainder of the NS 
protein.
Nucleotide Sequence Determination -of Non-ts Revertants 
of tsEl and tsE3
We have also cloned and sequenced full-length cDNA copies of the 
NS mRNA of non-ts revertants of tsEl (tsEl/Rl; Szilagyi and Pringle, 
1979) and tsE3 (tsE3/Rl; Evans et al, 1979) [it is worth noting that 
no revertants have yet been isolated from the double mutant tsE2]. 
These revertants have a wild-type pattern of RNA synthesis and 
electrophoretic mobility of the NS protein (Evans et al, 1979). The 
revertant NS genes were identical to the wild-type sequence (Rae and 
Elliott, 1986) at the site of mutation, but two additional point 
mutations were noted: a silent T to C change at position 471 and a T 
to G change at position 513 which results in a Met to Arg substitution 
(amino acid 168; Figure 2). Both revertant NS gene sequences were 
identical. The region encompassing the additional changes in the NS 
gene (ie. nucleotides 471 and 513) was sequenced in three other 
independent plasmid isolates containing the tsEl/Rl NS insert, and 
confirmed the substitutions given above. The amino acid substitution 
at residue 168 did not affect the predicted secondary structure of the 
revertant NS protein compared to wild-type (data not shown).
9DISCUSSION
The complementation group E mutants of VSV-NJ exhibit a variety 
of phenotypes and different electrophoretic mobility patterns of the 
NS protein (Pringle et al, 1970; Evans et al, 1979). By determining 
the nucleotide sequences of cloned cDNA copies of the mutant NS mRNAs 
we have precisely mapped the lesions in the NS genes. Our data show 
that the altered migration of the mutant NS proteins is not due to the 
synthesis of truncated proteins but rather the effects of amino acid 
subst itut ions.
The relative electrophoretic mobility of proteins in 
polyacrylamide gels containing SDS is a widely used method of 
estimating their molecular weights (Shapiro et al, 1967). The 
migration of the protein depends on a high level of SDS binding (1.4g 
of SDS per lg of protein) so that an approximately constant negative 
charge per unit mass is achieved (Creighton, 1983); under these 
conditions the electrophoretic mobility in gels is proportional to the 
logarithm of the length of the polypeptide chain. However, the amino 
acid composition or conformation of the protein may perturb the 
stoichiometric binding of SDS, resulting in aberrant electrohphoretic 
migration. De Jong et al (1978) reported that the mobility of C<. 
-crystallin A chains was altered by single amino changes, and Carstens 
et al (1986) reported that a single amino acid substitution in a 
mutant baculovirus polyhedral protein affected its electrophoretic 
migration. In addition, the latter workers showed that the single 
amino acid change grossly affected the predicted secondary structure 
of the mutant protein. Our data also demonstrate that single amino 
acid substitutions can radically influence the predicted secondary 
structure of a protein.
A potential criticism of our approach is that we have sequenced 
cloned cDNAs rather than obtaining a consensus sequence derived from
oxy sequencing on an RNA template. However, our results are in 
plete agreement with the data of D. McGeoch and A. Dolan who 
btained sequence information for approximately 200 nucleotides at the 
5' end of the NS genes of tsEl, tsE2, tsE3, tsEl/Rl and tsE3/Rl by 
primer extension on genomic RNA (D. McGeoch, personal communication; 
and data cited in Pringle, 1986). Therefore we feel that the 
sequences presented here are an accurate reflection of the differences 
in the wild-type, mutant and revertant NS genes.
We do not think that the presence of additional changes in the 
NS genes of the revertant viruses is due to a cloning artefact, since 
the recombinant plasmids were isolated in different cloning 
experiments which were performed on separate occassions. Furthermore, 
four individual clones of the tsEl/Rl NS genes contained the 
additional base substitutions. It also seems unlikely that these 
changes represent a variant wild-type virus which had somehow 
contiminated the revertant selection procedures, since these were also 
carried out at different times (C.R. Pringle, personal communication). 
The occurrence of other changes in the NS genes of non-ts revertants 
is implied from the data of Maack and Penhoet (1980) who isolated 
non-ts revertants of tsEl with different mobilities of the NS protein 
compared to both tsEl and wild-type viruses. We suggest that this 
could be due to a different amino acid substitution at position 32, or 
additional amino acid changes elsewhere in the NS protein, any of 
which could influence the conformation of the protein.
In contrast to the situation in VSV M gene mutants, where point 
mutations have been located throughout the M protein (Gopalkrishna and 
Lenard, 1985), three of the four mutations in the NS mutants are 
clustered around the most hydrophilic region of the NS protein (Figure 
4). This region of the NS protein represents an obvious area to 
explore via in vitro mutagenesis in order to correlate active sites in 
the protein with the different functions ascribed to NS.
11
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FIGURE LEGENDS 
Figure 1
Electrophoretic mobility differences in the NS proteins of 
wild-type (wt) and ts mutants El, E2 and E3 of VSV-NJ. RNA extracted 
from infected cells was translated in a rabbit reticulocyte lysate, 
and the translation products analysed on a 12% polyacrylamide gel. M, 
wild-type VS virion proteins as marker. Viral proteins are identified 
at the right, and solid arrows denote the position of the NS protein.
Figure 2
Nucleotide and deduced amino acid sequence of the NS mRNA of VSV 
NJ, showing the changes detected in the NS mRNAs of tsEl, tsE2 and 
tsE3, as well as the additional changes observed in the non-ts 
revertants tsEl/Rl and tsE3/Rl (rev).
Figure 3
Portions of representative sequencing gels showing the mutations 
in the NS genes of the E group mutants
(a) wild-type NS, positions 91-110 are indicated
(b) tsEl, showing G-A change at position 104
(c) tsE2 showing A-G change at position 108
(d) tsE3 showing A-G change at position 93. This gel actually shows
the minus strand sequence; the complementary sequence is written
as well to compare with (a)
(e) tsE2, showing A-G change at position 353 compared to the
wild-type sequence shown in (f)
Hydropathy profile of the NS protein of VSV-NJ. ’a' indicates 
the region (amino acids 28-33) where three mutations are clustered, 
and 'b‘ indicates the position of the second mutation (amino acid 115) 
in tsE2.
Predicted secondary structures of the NS proteins of wild-type 
and complementation E group mutants VSV-NJ. The generation of these 
graphic representations is described in Methods. The complete plot of 
wild-type (wt) NS protein is given, and the relevant portions of the 
plots of the E group mutants. The arrows indicate differences in the 
predicted secondary structures due to amino acid substitutions. W
Figure 5
represents C)C helix,'vw" represents 
and a change of direction turn. The open ovals represent
hydrophilic regions, and shaded ovals hydrophobic regions.
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Conservation of Potential Phosphorylation Sites in the NS Proteins of the 
New Jersey and Indiana Serotypes of Vesicular Stomatitis Virus
By B R E N D A N  P. R A E  a n d  R IC H A R D  M. E L L IO T T *
M RC Virology Unit, Institute o f  Virology, Church Street, Glasgow G il  5JR, U.K.
(Accepted 18 March 1986)
SUM M ARY
A full length cD N A  copy of the NS m RNA of the Missouri strain (Hazelhurst 
subtype, New Jersey serotype) of vesicular stomatitis virus (VSV) has been cloned and 
sequenced. The mRNA is 856 nucleotides long (excluding polyadenylic acid) and 
encodes a protein of 274 amino acids (mol. wt. 31000). Comparison with the NS gene of 
the Ogden strain (Concan subtype, New Jersey serotype) showed 15% difference at the 
nucleotide level and 10% difference at the amino acid level; the majority of the changes 
were located in the 3' half o f the m RNA. Comparison with the NS genes o f two strains 
representing the Indiana serotype showed about 50% nucleotide and 33% amino acid 
sequence homology between the serotypes. In a four-way comparison of the proteins, 
two regions of higher homology were noted which may be of functional importance. 
Eighteen potential phosphorylation sites (Ser or Thr) were conserved between the four 
proteins; five of these sites correspond to the residues which have been suggested to be 
constitutively phosphorylated and may be essential for NS activity.
IN T R O D U C T IO N
The NS (so-called non-structural) protein of vesicular stomatitis virus (VSV) is multifunc­
tional and has been shown to play a role in m RNA transcription, genome replication and virion 
maturation (for review, see Pringle, 1986). In the virus particle NS is complexed with the L 
protein and is closely associated with the negative strand RNA-nucleocapsid (N) protein 
complex. NS is a phosphoprotein with a molecular weight of about 30000 (Gill & Banerjee, 
1985) although in SDS-polyacrylamide gels its migration is anomalously slow probably due to its 
highly acidic nature (Marnell & Summers, 1984). It is documented that the degree of 
phosphorylation of NS plays a regulatory role in transcription in vitro (Kingsford & Emerson, 
1980; Hsu et al., 1982) and the ability to bind nucleocapsids (Clinton et al., 1978), and recently 
Sanchez et al. (1985) reported that the viral L protein specifically phosphorylates NS in vitro.
Detergent treatment of VSV particles yields a transcribing ribonucleoprotein complex (TNP), 
comprising the virion RNA and L, N and NS proteins, which retains essentially all the 
transcriptase activity of the virion (Bishop & Roy, 1972; Emerson & Wagner, 1972; Szilagyi & 
Uryvayev, 1973). Fractionation and reconstitution experiments with TNP have been used in an 
attempt to define the roles of the different proteins in transcription but have generated 
conflicting results. Ongradi et al. (1985 a,b) have suggested that L alone is the transcriptase while 
NS exerts a controlling effect, whereas the laboratories of both Emerson and Banerjee have 
reported that a combination of L and NS is required to synthesize RNA in vitro (Emerson & Yu, 
1975; Mellon & Emerson, 1978; Kingsford & Emerson, 1980; De & Banerjee, 1984, 1985).
As an alternative approach to studying the role of NS we undertook to clone a cD N A  copy of 
the NS mRNA with the long term view to express the cD N A  in a eukaryotic system. For these 
studies we chose the Missouri strain of the New Jersey serotype of VSV because temperature- 
sensitive mutants of this strain with lesions in the NS gene had previously been isolated and 
characterized in our Institute (Pringle etal.,X 91\\ Evans et al. .1979). Here we report the cloning
OOOi -7046 ©  1986 SG M
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of a full length cD N A  o f the Missouri strain NS m RNA, its complete nucleotide sequence and a 
comparison with the NS genes of three other VSV strains which indicates conservation of 
certain potential phosphate-accepting amino acids.
M ETH O D S
Virus and cells. The Missouri strain  o f VSV New Jersey serotype was obtained from J. F. Szilagyi. Virus stocks 
were prepared and titra ted  in BHK-21 cells as described by Pringle et al. (1971).
Production o f  infected cell R N A . B H K  cells were infected with 10 p.f.u./cell o f VSV in the presence o f 10 pg/m l 
actinom ycin D. A fter adsorption for 1 h at 31 °C, the m onolayers were washed w ith m edium  and incubated for 6 h 
at 31 °C in the presence of actinom ycin D. The cells were then  harvested by scraping and w ashed w ith phosphate- 
buffered saline. Total cellular R N A  was prepared by the guanidinium  isothiocyanate/caesium  chloride m ethod of 
C hirgw in et al. (1979).
Synthesis o f  complementary D NA. D ouble-stranded cD N A  was synthesized according to the m ethod of G ubler & 
Hoffm an (1983), using 50 pg total cellular R N A  as tem plate, 1 pg o f oligo(dT)12.i8 as p rim er and 40 units of 
reverse transcriptase in a 40 pi first-strand reaction. D ouble-stranded cD N A  was tailed w ith dC M P  residues, 
annealed to dG M P-tailed  A rtl-cut pBR322 D N A  (Bethesda R esearch Laboratories), and recom binant plasm ids 
used to transform  com petent Escherichia coli M C I061 (Pringle et al., 1984).
Identification o f  N S  gene-specific recombinant plasmids. Tetracycline-resistant, am picillin-sensitive transform ed 
E. coli were initially screened w ith a 32P-labelled, partially alkali-digested vesicular stom atitis virion R N A  probe 
by colony hybridization (Pringle et al., 1984) to identify VSV cD N A -contain ing  clones. NS gene-specific plasmids 
were identified by a com bination o f N orthern  blot hybridization and message selection/m vitro translation of 
infected cell R N A  using m ethods detailed by Pringle et al. (1984) and E lliott (1985).
Nucleotide sequence determination and analysis. The NS gene cD N A  insert was excised from  the pBR322 vector 
by P stl digestion, and purified by agarose gel electrophoresis. T he insert was further digested w ith H pall, H aelll 
o r H infl and ligated into bacteriophage M 13m pl8 D N A . N ucleotide sequence determ ination followed the 
dideoxy chain term ination  m ethod of Sanger et al. (1977, 1980). Sequence data  were m anipulated and analysed 
w ith a D EC  PDP11 com puter as described previously (Lees et al., 1986).
R E S U L T S  A N D  D IS C U S S IO N  
Cloning and identification o f NS gene cDNA
Total cellular R N A  extracted from actinomycin D-treated, VSV-infected BHK cells was used 
as the template for cD N A  synthesis. With oligo(dT)12.i8 as primer and the reaction conditions 
of Gubler & Hoffman (1983) double-stranded D N A  was produced and, following dCMP tailing, 
the cD N A  was annealed to dG-tailed, Pstl-cut pBR322 plasmid D N A . Colony hybridization 
with 32P-labelled VSV genomic R N A  was used to identify plasmids containing VSV-specific 
inserts, and greater than 15% of the colonies screened contained viral sequences. This high 
proportion presumably reflects the inhibitory effect o f the actinomycin D treatment on cellular 
m RNA synthesis and the efficient production of VSV m RNAs. NS cDNA-specific plasmids 
were identified by a combination of Northern blotting and message selection/f/i vitro translation. 
For this, plasmid D N A  was prepared from 5 ml overnight cultures (Birnboim & Doly, 1979), 
and a sample of the D N A  was 32P-labelled by nick translation. The radiolabelled D NA  was then 
hybridized to infected cell RNA which had been fractionated by agarose gel electrophoresis and 
immobilized on a nitrocellulose membrane (Pringle et al., 1984). VSV-infected cell RNAs 32P- 
labelled in vivo were included as markers. An example is shown in Fig. 1 (a): it can be seen that 
the M and NS m RNAs were poorly resolved and therefore hybridization to this region of the 
blot identified both M and NS cDNA-containing plasmids. To distinguish between these, 
plasmid D N A s were immobilized on nitrocellulose filters and hybridized to infected cell RNA. 
After extensive washing the hybridized R N A  was eluted, translated in an in vitro system and the j 
products were analysed by polyacrylamide gel electrophoresis (Elliott, 1985). The M and NS , 
proteins were clearly resolved by electrophoresis (Fig. lb), enabling NS cDNA-containing ; 
plasmids to be identified. For comparison, the behaviour of an N  gene cDNA-containing j 
plasmid in these experiments is also shown in Fig. 1 (a) and (b). Digestion of the NS-specific ; 
plasmids with Pstl showed that the inserts contained a characteristic internal Pstl site (Fig. 1 c). | 
The frequency of NS gene-containing plasmids was estimated to be 0-7% in our library. One . 
plasmid, designated p N JN S l, contained an insert of approximately 900 base pairs in total, and 
was selected for sequence determination.
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Met Asp Ser lie Asp Arg Leu Lys Thr Tyr Leu Ala Thr Tyr Asp Asn Leu 17
AACAGAGATC ATG GAC AGT ATT GAT CGG CTC AAA ACT TAC TTG GCT ACT TAT GAT AAT TTG 61
T G
Val
I3 G A C
Asp
GAT
Ser
TCT
Ala
GCC
Leu
TTG
Gin
CAG
Asp
GAT
Ala
GCA
C
Asn
AAT
Glu
GAG
A
Ser
TCT
Glu
GAA
G
Glu
GAA
Arg
AGA
Arg
AGA
C
Glu
GAG
Asp
GAT
Lys
AAA
Tyr
TAT
Leu
CTC
Gin
CAA
37
121
Asp
GAC
Leu
CTC
Phe
TTC
lie
ATC
Glu
GAA
Asp
GAT
Gin
CAA
Gly
GGA
Asp
GAT
Lys
AAA
Pro
CCA
Thr
ACT
Pro
CCG
Ser
TCA
Tyr
TAT
Tyr
TAT
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Glu
GAA
Glu
GAA
57
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Ser
TCG
Ser
TCA
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GAT
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TCA
Asp
GAT
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TAT
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AAT
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His
CAT
Leu
CTT
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ACG
Met
ATG
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TTG
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GAT
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GAA
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Arg
AGA
H e
ATA
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GAC
Lys
AAA
G
Trp
TGG
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GAA
Glu
GAA
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GAT
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TTG
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CCC
T
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TTG
A
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GAA
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AAG
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ATT
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GAT
Asp
GAT
Asp
GAT
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G
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Val
GTA
G
Thr
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C
Phe
TTT
Ser
TCT
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T
Trp
TGG
Thr
ACA
Gin
CAA
G
Pro
CCT
Val
GTA
Met
ATG
Lys
AAG
Glu
GAA
Asn
AAC
T
Gly
GGA
G
Gly
GGG
A
Glu
GAG
Lys
AAA
Ser
TCA
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CTA
G
117
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TCT
Leu
CTG
Phe
TTT
C
Pro
CCT
Pro
CCG
A
Val
GTT
C
Gly
GGA
G
Leu
TTA
Thr
ACA
Lys
AAA
G
Val
GTT
A
lie
Gin
CAG
A
Thr
ACA
Asp
GAC
A
Glu
Gin
CAA
Trp
TGG
Arg
AGG
AA
Lys
Lys
AAG
A
Thr
ACA
C
lie
ATT
137
421
Glu
GAG
Ala
GCA
G
Val
GTC
T
Cys
TGT
Glu
GAG
Ser
AGC
T
Ser
TCT
A
Lys
AAA
Tyr
TAT
Trp
TGG
Asn
AAT
Leu
TTG
A
Ser
TCA
Glu
GAA
Cys
TGT
C
Gin
CAG
A
lie
ATT
Met 
ATG 
C T 
Leu
Asn
AAC
Ser
TCA
TG
Leu
157
481
Glu
GAA
Asp
GAT
C
Arg 
CGT 
A C 
Ser
Leu
CTT
C
lie
ATC
T
Thr
Leu
CTC
Lys
AAA
Gly
GGC
Arg
CGA
lie 
ATT 
T G 
Leu
Met
ATG
Thr
ACT
Pro
CCT
Asp
GAC
T
Cys
TGC
T
Ser
AGT
Ser
TCA
T
Ser
TCA
H e  
ATC 
G A 
Val
Lys
AAA
177
541
Ser
TCT
Gin
CAG
A
Asn
AAC
T
Ser
TCC
T
lie 
ATA 
G C 
Val
Gin
CAG
G
Arg
Ser
AGT
G
Arg
Ser
TCC
A
Glu
GAA
Ser
TCT
C
Pro
Leu
CTC
Ser
TCC
A
Tyr
Ser
TCC
Ser
TCG
T
His
CAT
Ser
TCA
T
Pro
CCC
A
Gly
GGT
Pro
CCA
C
Ala
GCA
C
Pro
197
601
Pro
CCA
TC
Leu
Lys
AAG
Ser
TCA
GT
Val
Arg
CGG
TCA
Ser
Asn
AAT
GAG
Glu
Gin
CAA
TCC
Ser
Leu 
CTA 
A C 
lie
Gly
GGT
AA
Asn
Leu
CTA
T
Trp
TGG
Asp
GAT
Ser
TCA
T
Leu
Lys
AAA
G
Ser
TCA
C
Thr
ACA
T
Glu
GAA
Val
GTA
Gin
CAA
Leu
CTG
T
lie
ATC
217
661
Ser
TCG
C
Lys
AAG
Arg
AGG
A
Ala
GCC
Gly
GGA
Val
GTG
T
Lys
AAG
Asp
GAC
Met
ATG
Met
ATG
CA
Thr
Val
GTG
C
Lys
AAA
Leu
TTG
Thr
ACA
Asp
GAC
Phe
TTT
C
Phe
TTT
Gly
GGA
Ser
AGT
Glu
GAA
G
237
721
Glu
GAG
A
Glu
GAA
G
Tyr
TAT
Tyr
TAT
Ser
TCA
Val
GTA
Cys
TGC
Pro
CCA
Glu
GAA
Gly
GGG
Ala
GCC
G
Pro
CCA
Asp
GAT
C
Leu
TTG
Met
ATG
Gly
GGA
Ala
GCA
T
lie
ATC
lie
ATC
Met
ATG
257
781
Gly
GGA
Leu
CTA
G
Lys
AAA
G
His 
CAT 
T C 
Tyr
Lys
AAA
G
Lys
AAG
A
Leu
CTT
C
Phe
TTT
C
Asn
AAC
T
Gin
CAA
G
Ala
GCA
Arg
AGA
Met
ATG
Lys
AAG
A
Tyr
TAT
Arg
CGT
lie 
ATC 
C T 
Leu
TAA TTAATTC 
CC T
274
842
CGATGATCAATATG 856
TC
Fig. 2. N ucleotide sequence and deduced am ino acid sequence of the NS m R N A  of the Missouri strain 
o f VSV. The com plete sequence o f the NS m R N A  was obtained by subcloning fragm ents of the insert of 
p N JN S l into M 13m pl8 D N A  and using the methodology of Sanger et al. (1977, 1980). The sequence is 
com pared w ith th a t o f the O gden strain  (Gill & Banerjee, 1985) and differences are indicated below the 
M issouri strain sequence.
Nucleotide sequence o f  the N S mRNA o f VS V (Missouri strain) 
The two insert fragments of pN JN Sl were digested with H pall, HaeIII or HinU, subcloned 
into bacteriophage M13mpl8 and their sequence was determined by the dideoxy chain 
termination method (Sanger et al., 1977,1980). The sequence spanning the internal Pstl site was
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obtained by digesting intact pN JN Sl with H pall, isolating the appropriate fragment from a 
polyacrylamide gel and ligating the purified fragment into M13mpl8 DNA.
The complete sequence of the insert from pN JN Sl is shown in Fig. 2, and reveals that 
pN JN Sl contains a full length cD N A  copy of the NS mRNA because (i) at the 5' end of the 
insert, following a string of approximately 25 G residues (not shown on figure) is the sequence 
AACAGAGATC, which corresponds to the consensus sequence 5'-AACAGNNAUC-3' 
reported to be at the 5' end of all VSV mRNAs (McGeoch, 1979; Rose, 1980; Franze-Fernandez 
& Banerjee, 1978), and (ii) at the 3' end there is the sequence TATG followed by a polyadenylate 
stretch of 12 residues [corresponding to the oligo(dT)! 2.\8 primer] before a ‘tail’ of approximately 
25 C residues (not shown in the figure). Rose (1980) and Rhodes & Banerjee (1980) reported that 
the sequence . . . UA UG AA A A  . . . occurs at the m RNA-poly(A) junction in each mRNA. 
Furthermore, the sequence of approximately 200 bases at the 5' end of the NS mRNA is 
identical to the sequence obtained independently by D. J. McGeoch and A. Dolan by primer 
extension on the viral genomic RNA from within the N gene, across the intergenic region and 
into the NS gene (D. J. McGeoch, personal communication).
The NS m RNA is 856 nucleotides long excluding the 3' poly(A) tract, and encodes a protein of 
274 amino acids (mol. wt. 31000) beginning at AUG (bases 11 to 13) and terminating at UAA  
(bases 833 to 835). The next largest AUG-initiated open reading frame in either the ( +  ) 
[mRNA]- or ( —) [genomic RNA]-sense RNA would encode a protein of 65 amino acids, 
beginning at bases 51 to 53 in the mRNA. The amino acid composition of the NS protein 
indicates that the protein is relatively rich in aspartate and methionine residues, and relatively 
deficient in alanine and glycine residues compared to an ‘average’ protein (Klapper, 1977), i.e. 
Asp 9-2% compared to 5-5%, Met 4-2% compared to 1-7%, Ala 3-5% compared to 9-0% and Gly 
4-2% compared to 7-5%. There are a total of 46 potential phosphorylated residues in the NS 
protein (33 Ser and 13 Thr). The NS protein has an overall charge of — 18-5 at pH 7-0, assuming 
+  1 charge for Lys and Arg, +0-5 for His and —1 charge for Asp and Glu at this pH.
Comparison o f VSV NS genes and proteins
Nucleotide sequences of the NS genes of four strains of VSV, representative of the New Jersey 
(NJ) and Indiana (IND) serotypes, are now available, and a summary of the comparisons of 
these sequences is given in Table 1.
The m RNAs of the New Jersey serotype strains are both 856 nucleotides in length (excluding 
polyadenylic acid) compared to 814 nucleotides for the Indiana serotype strains. There is about 
50% nucleotide homology between the NS genes of the two serotypes and the distribution of 
homology is displayed as a computer-generated dot matrix in Fig. 3 (a). This shows that there are 
only short regions of significant homology scattered throughout the gene sequences. For 
comparison the nucleotide sequences of the G and N genes of the NJ and IND serotypes show 
54% and 68% homology respectively (Gallione & Rose, 1983; Banerjee et al., 1984).
The two NJ strains are 85% homologous at the nucleotide level, and as shown in Fig. 2 the 
majority of the nucleotide differences occur in the 3' half of the mRNA. A limited comparison of 
151 bases at the 5' end and 208 bases at the 3' end of the N protein mRNAs of the Missouri and 
Ogden strains showed a similar degree of homology ( D. J. McGeoch, personal communication; 
Pringle, 1986).
Comparison of the amino acid sequences of the NS proteins showed about 33% homology 
between the two serotypes, although the dot matrix comparison (Fig. 3 b) indicated a clear 
similarity between the two proteins. The conservation of the NS proteins is thus considerably 
lower than that of the G proteins (51 %) or the N proteins (69 %) of the two serotypes (Gallione & 
Rose, 1983; Banerjee et al., 1984). There are 27 amino acid differences between the Missouri and 
Ogden strains (Fig. 2), notably a stretch of six contiguous mismatched residues at positions 190 
to 195. The 10% difference in the amino acid sequences between the NS proteins of the Missouri 
and Ogden strains [which represent the Hazelhurst and Concan subtypes of the NJ serotype 
(Reichmann et al., 1978)] manifests itself as a difference in the electrophoretic mobility of the 
proteins in SDS-polyacrylamide gels (Schnitzlein & Reichmann, 1985). The only other available 
comparison of VSV gene sequences is from Gopalakrishna & Lenard (1985) who compared the
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Fig. 3. Com puter-generated dot m atrix com parisons o f (a) the nucleotide sequences and (b) the amino 
acid sequences o f  the NS genes o f the Missouri strain (New Jersey serotype) and the San Juan strain 
(Indiana serotype) o f VSV. In (a) a window of 12 nucleotides was used and in (b) a window of 7 am ino 
acid residues was used. Regions o f homology are denoted by a diagonal line, and the level o f homology 
by the thickness o f the line (60% homology is the m inim um  plotted).
M genes of three strains of VSV IN D  (namely San Juan, Glasgow and Orsay), and reported 1-8% 
nucleotide and 2-6% amino acid difference between the three strains.
The classification of VSV isolates into the IN D  and NJ serotypes was based on the finding of 
little or no reciprocal cross-neutralization of infectivity (Cartwright & Brown, 1972). The IND  
serotype was further subdivided into four subtypes (Indiana, Argentina, Brazil and Cocal) and 
the NJ serotype into the Hazelhurst and Concan subtypes on the basis of neutralization, RNA  
hybridization, oligonucleotide fingerprinting and interference by defective interfering particles 
(Cartwright & Brown, 1972; Clewley et al., 1977; Crick & Brown, 1973; Federer et al., 1967; 
Reichmann et al., 1978; Repik et al., 1974). It is apparent from the literature that the various 
isolates of VSV have been passaged many times in different laboratories (see Clewley et al., 
1977; Reichmann et a l ,  1978) and hence conclusions drawn from sequence comparisons of these 
laboratory-passaged strains may not be strictly extrapolated to the original isolates. However, 
the information given above suggests that the IN D  serotype contains more closely related strains 
than the NJ serotype. It will be interesting to see whether this trend is maintained when 
sequence data from other strains become available. However, it is worth noting that Schnitzlein 
& Reichmann (1985) regard the Hazelhurst subtype as ‘an uncommon manifestation of the New  
Jersey serotype’ because of its apparently more limited host range, and this may account for the 
greater sequence divergence than in the IN D  serotype.
Fig. 4 is a four-way comparison of the amino acids of the NS proteins which have been aligned 
using the HOMOL program of Taylor (1984). Three regions of the sequences are of note. First, 
the regions designated A and C which have relatively high homology (62% and 68%) compared 
to the overall homology of 33%. The conservation of the amino acid sequences in these regions 
suggests that they may be of functional significance. Second, the region designated B where 
there is the most difference between the two NJ strains, and a deletion in the IN D  sequences was 
introduced in order to align the proteins. This suggests that this domain is a non-essential or 
dispensable portion of the protein. It would be of considerable interest to determine whether 
deletion of this region in the NJ protein affected its function.
Eighteen potential phosphorylation sites (Ser and/or Thr) are conserved between the four NS 
proteins. This represents 48% of the sites in the Mudd-Summers strain which contains the 
fewest Ser or Thr residues. None of the aligned potential phosphate acceptors is found in the
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NJ O G  1 MDSVDRLKTYLATYDNLDSALQDANESEERREDKYLQDLFIEDQGDKPT-PSYYQEEESSDSDTDYNAEHLTML
NJ MIS 1 MDSIDRLKTYLATYDNLDSALQDANESEERREDKYLQDLFIEDQGDKPT-PSYYQEEESSDSDTDYNAEHLTML
IND SJ 1 MDNLTKVREYLKSYSRLDQAVGEIDEIEAQRAEKSNYELFQEDGVEEHTKPSYFQAADDSDTESEPEIEDNQGL
IND M - S  1 MDNLTKVREYLKSYSRLDQAVGEIDEIEAQRAEKSNYELFQEDGVEEHTRPSYFQAADDSDTESEPEIEDNQGL
• • • • •
7 4 -SPDERIDKWE— EDLPELEKIDDDIPVTF-SDWTQPVMKENGGEKSLSLFPPVGLTKIQTEQWKKTIEAVCES
74 -SPDERIDKWE— EDLPELEKIDDDIPVTF-SDWTQPVMKENGGEKSLSLFPPVGLTKVQTDQWRKTIEAVCES
75 YAPDPEAEQVEGFIQGPLDDYADEEVDWFTSDWKQPELESDEHGKTLRLTSPEGLSGEQKSQWLSTIKAVVQS 
75 YVPDPEAEQVEGFIQGPLDDYADEDVDWFTSDWKQPELESDEHGKTLRLTLPEGLSGEQKSQWLLTIKAVVQS
B
1 • • • • 1 1 •
144 SKYWNLSECQILNLEDSLTLKGRLMTPDCSSSVKSQNSVRR-SEPLYSSHSPGPPLKVSESINLWDLKSTEVQL 
144 SKYWNLSECQIMNSEDRLILKGRIMTPDCSSSIKSQNSIQS-SESLSSSHSPGPAPKSRNQLGLWDSKSTEVQL
149 AKYWNLAECTFEASGEGVIMKERQITPDVYKVTPVMNTHPSQSEAVSDVWS----------------LSK-TSMTF
149 AKHWNLAECTFEASGEGVIIKKRQITPDVYKVTPVMNTHPYQSEAVSDVWS----------------LSK-TSMTF
• • 1 1
217 ISKRAGVKDMTVKLTDFFGSEEEYYSVCPEGAPDLMGAIIMGLKYKKLFNQARMKYRL 
217 ISKRAGVKDMMVKLTDFFGSEEEYYSVCPEGAPDLMGAIIMGLKHKKLFNQARMKYRI 
208 QPKKASLQPLTISLDELFSSRGEFISVGGDGRMSHKEAILLGLRYKKLYNQARVKYSL 
20 8 QPKKASLQPLTISLDELFSSRGEFISVGGNGRMSHKEAILLGLRYKKLYNQARVKYSL
Fig. 4. A lignm ent o f the NS proteins o f four strains o f VSV using the H O M O L program  of Taylor 
(1984). The shaded regions denote am ino acids conserved betw een the four strains and the filled circles 
denote conserved potential phosphorylation sites (Ser or Thr). The regions A, B and C are described in 
the text. O G , Ogden strain , N J serotype; M IS, M issouri strain , N J serotype; SJ, San Juan strain, IN D  
serotype; M -S, M udd-Sum m ers strain , IN D  serotype.
conserved carboxy terminal domain (region C in Fig. 4). Phosphorylation of the NS protein has 
been studied in a number of laboratories by analysis of the products generated by enzymic or 
chemical cleavage of the protein. Hsu et al. (1982) reported that NS1 (the less phosphorylated 
class of NS molecules) was phosphorylated primarily at residues in two chymotryptic peptides, 
while the more highly phosphorylated molecules contained additional chymotryptic phospho- 
peptides. Studies by Marnell & Summers (1984) and Bell & Prevec (1985) indicated that the 
majority of phosphate residues resided in the amino terminal portion of the NS molecule, and 
Hsu & Kingsbury (1985) localized these residues to a peptide lying between amino acids 35 and 
78. As shown in Fig. 4, our comparison reveals five potentially phosphorylated residues in this 
region which are conserved in the four VSV strains. Hsu & Kingsbury (1985) suggested that the 
same five sites were constitutively phosphorylated in NS and might be essential for a basal level 
of NS activity. The availability of a full length cD N A  clone for expression in eukaryotic cells 
and the advent of oligonucleotide mediated site-directed mutagenesis (Zoller & Smith, 1982) will 
enable us to test this hypothesis experimentally.
We are most grateful to D uncan M cG eoch for helpful discussions and access to his unpublished sequence data, 
and to Bob Lazzarini for supplying the M udd-Sum m ers sequence prior to publication. W e thank  U lrich 
Desselberger and D uncan M cG eoch for their com m ents, and L inda Shaw for typing the m anuscript. B.P.R . 
received a postgraduate studentship from the Science and Engineering R esearch Council.
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